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ABSTRACT  
Tendons and ligaments play key roles in the musculoskeletal system in both man and 
animals. Both tissues can often be injured as result of contact based accidents or ageing and 
disease, causing discomfort, pain and increased susceptibility to degenerative joint disease.  
To date, tendon and ligament biology is relatively under-studied in healthy, non-diseased 
tissues. This information is essential to understand the pathology of these tissues and vital 
for future development of tendon and ligament tissue-engineered structures. 
This thesis aims to investigate the molecular and cellular differences between tendons and 
ligaments around the canine stifle joint. The biochemical composition, structural, and 
morphological characteristics were identified between the different regions of the intra- 
articular cranial cruciate ligament (CCL) and extra-articular medial collateral ligament (MCL), 
and the positional long digital extensor tendon (LDET) and energy storing superficial digital 
flexor tendons (SDFT). Differences in proteome composition were also assessed between 
CCL and LDET. Cells isolated from canine CCL and LDET were cultured in a 3D in vitro fibrin 
culture model and measured for differences in structural, biochemical and proteome 
composition.  
Statistical significant differences in extracellular matrix (ECM) composition in terms of 
glycosaminoglycan (GAG) and elastin content were primarily detected in CCL in comparison 
to the other three tissues. The CCL was also found to have morphological differences 
including less compact collagen architecture, differences in cell nuclei phenotype, and 
increased (GAG) and elastin content. Proteomic comparison between CCL and LDET resulted 
in significantly abundant fibrocartilage proteins such as collagen type II, aggrecan, versican 
and chondroadherin in CCL, while the LDET was more abundant in asporin and 
thrombospondin-4. 3D tendon and ligament constructs were able to recapitulate tendon 
and ligamentous tissue characteristics particularly with regards to ECM proteins present, 
however both construct were less abundant in ECM protein and contained a greater 
proportion of cellular proteins, corresponding with low collagen and high level of DNA 
content measured in both constructs. 3D tendon and ligament constructs derived from 
tendon and ligament cells had similar ECM, proteomic and structural composition, indicating 
that cell source may not be an important factor for tendon or ligament tissue engineering.  
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1 CHAPTER 1 
GENERAL INTRODUCTION 
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1.1 CONNECTIVE TISSUE 
 
There are four basic types of tissues in the human or animal body, namely epithelial, 
muscle, nervous and connective tissue. Of these, connective tissues are one of the most 
abundant, being extensively distributed and encompassing a variety tissues with differing 
functional properties (Van de Graaff et al. 2010, Tortora and Derrickson 2013). 
 In general, the key functions of connective tissues are to bind, support and strengthen 
other body tissues, protect and insulate internal organs, and serve as major transport with 
the body (Van de Graaff et al. 2010, Tortora and Derrickson 2013). Connective tissues 
consist of cells and an extracellular matrix  (ECM) of fibres, fluid and ground substance (Ross 
and Pawlina 2006, Tortora and Derrickson 2013). The role and function of the various 
connective tissues is reflected in the types of cells, fibres and the character of ground 
substance in the ECM (Ross and Pawlina 2006). The ground substance is a unstructured 
material that fills the space between cells and fibres of connective tissue and is primarly 
composed of water and proteoglycans and cell adhesion proteins (Marieb and Hoehn 2007). 
Connective tissue classification is not always clear due to some similarity between 
characteristics of the many tissues and is therefore somewhat subjective and open to 
dispute. Based on differences of composition and organisation of the cellular and ECM 
component and functional properties, connective tissues could be classified into embryonic 
connective tissue, connective tissue proper and specialised connective tissue subgroups 
(Aughey and Frye 2001, Ross and Pawlina 2006) (Figure 1.1).   
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Figure 1.1. Classification of connective tissues. Connective tissues are categorised  into 
subgroups based on differences in cellular and ECM composition, organisation and 
functional properties adapted from Ross and Pawlina (2006) and Aughey and Frye (2001)   
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 Embryonic connective tissue 1.1.1
Almost all connective tissues develop from the mesoderm, which is the middle embryonic 
germ layer that forms through proliferation and migration of the mesodermal and specific 
neural crest cells into primitive connective tissue referred to as mesenchyme (Ross and 
Pawlina 2006, Marieb and Hoehn 2007). The mesenchyme is established in the early embryo 
and leads to the formation of several connective tissues such as cartilage, tendon or bone 
(Lorda-Diez et al. 2014). It also develops into other tissues e.g. muscle, vascular and 
urogenital systems (Ross and Pawlina 2006). Mesenchymal tissue consist of unspecialised 
cells, that have a homogenous and spindle shaped appearance, and ECM with a sparse 
arrangement of fine reticular fibres and ground substance (Ross and Pawlina 2006, Tortora 
and Derrickson 2013).  
Another subtype of embryonic connective tissue is mucous connective tissue, which is 
located in the umbilical cord. The mucous connective tissue cells are widely scattered and 
appear much like fibroblasts and are embedded in a jelly-like extracellular matrix, known as 
Wharton’s jelly (Aughey and Frye 2001, Ross and Pawlina 2006, Tortora and Derrickson 
2013). 
 
 Connective tissue proper  1.1.2
Within this category connective tissues is further categorised into loose connective tissue 
and dense connective tissue. 
  Loose connective tissue  1.1.2.1
Loose or areolar connective tissue is a cellular connective tissue with thin, sparse and 
loosely arranged collagen fibres, however it has an amorphous ground substance (Ross and 
Pawlina 2006). It contains many scattered cells of various types and it is widespread 
throughout the body surrounding vessels and nerves (Aughey and Frye 2001). Loose 
connective tissue has a space-filling function between organs and structures; for instance 
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between skin and musculature and between muscle fibres.  It is found underneath epithelial 
tissue and is also a component of lamina propria (Krstić 1985). 
 
 Dense connective tissue  1.1.2.2
Dense connective tissues have substantially less cells, but contain more fibres that are 
thicker and more tightly packed together compared to loose connective tissue. This subtype 
can further be divided into dense irregular and regular subcategories (Aughey and Frye 
2001, Tortora and Derrickson 2013). 
Dense Irregular Connective Tissue: This type of tissue contains sparse cells and little ground 
substance, but a high proportion of collagen fibres that are usually irregularly arranged.  The 
fibres are arranged in bundles and run in more than one plane. This irregular arrangement 
allows tissues of this type to resist extensive stretching and extension (Ross and Pawlina 
2006, Marieb and Hoehn 2007). Examples of dense irregular connective tissue include the 
fascia, dermis of skin and the fibrous covering that surround some organs such as the heart 
and kidney (Marieb and Hoehn 2007, Tortora and Derrickson 2013).  
Dense Regular Connective Tissue: This type of tissue provides strong attachment between 
various structures, which are able to withstand tension along long axis of fibres (Tortora and 
Derrickson 2013). Unlike in dense irregular connective tissue, collagen fibres are arranged in 
parallel array and are tightly packed to provide maximum strength. Ligaments and tendons 
are examples of dense regular connective tissue, where ligament joins bone to bone and 
tendon joins muscle to bone (Aughey and Frye 2001, Ross and Pawlina 2006). The structure 
of tendon and ligaments are being examined in this thesis and will be discussed in further 
detail later on in this Chapter.  
 
 Specialised connective tissue 1.1.3
Specialised connective tissues include cartilage, bone, adipose tissue, blood, hemapoietic 
tissue and lymphatic tissue. Similar to the other connective tissues, specialised connective 
tissue consists of cells and ECM, however the cell characteristics and the components of the 
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ECM differ in quantity, type and organisation (Ross and Pawlina 2006). For instance one 
feature that distinguishes bone from other connective tissues is the addition of collagen 
fibres and mineralisation of the bone matrix, giving it substantial strength and rigidity 
(Weatherholt et al. 2012). Conversely blood is a connective tissue that consists of different 
types of cells and a liquid ECM, allowing it to travel and transport nutrients, wastes, 
enzymes, plasma proteins and hormones (Marieb and Hoehn 2007, Tortora and Derrickson 
2013). Another example of specialised connective tissue is cartilage, which contains 
specialised cells, chondrocytes, that maintain the ECM. Unlike other connective tissues 
cartilage does not contain nerves or blood vessels in its ECM. Cartilage resists both tension 
and compression, as it is composed of large amounts of glycosaminoglycans, firmly bound 
collagen fibres and has a high water content (Marieb and Hoehn 2007).  
  
1.2 TENDON  
 Tendon function and gross structure 1.2.1
Tendons are dense connective tissues and are dominated by regularly arranged collagen 
fibres. They serve primarily to transfer the pull of muscles to bone (Benjamin and Ralphs 
1998). They also play a fundamental role in locomotion, transferring  the forces generated 
by our muscles to the skeleton, and thus facilitating movement  (Screen 2009).  In addition, 
they stabilise the joint, and act as shock absorber to limit muscle damage (Clegg et al. 2007). 
Some tendons have an additional energy storing function which when stretched under load 
they then recoil. This lessens the energetic cost of locomotion, as a reduced muscular effort 
is required to return the limb to the starting position (Birch et al. 2013). Examples of energy 
storing tendons are the human Achilles tendon and equine superficial digital flexor tendon 
(SDFT) (Thorpe et al. 2012, Birch et al. 2013). However, tendons such as the human anterior 
tibialis tendon and the equine common digital extensor tendon (CDET) act purely to position 
the limb and are relatively inextensible to allow efficient transfer of force from muscle to 
bone and precise placement of the limb  (Thorpe et al. 2012). 
Macroscopically healthy tendons are white in colour and have a fibro-elastic texture 
(Kannus 2000). They can vary remarkably in shape and size and in the way they are attached 
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to the bone; some tendon can be rounded or cord-like, straplike bands appear like, or 
flattened ribbons (Benjamin and Ralphs 1997, Kannus 2000, Benjamin et al. 2008). The point 
of unification of tendon to the muscle is referred to as the myotendinous junction (MTJ) and 
the point of unification of tendon with bone as the osteotendinous junction (OTJ). The 
connection of the proximal tendon of a muscle to bone is called the muscle origin, and the 
distal tendon connection is known as an insertion (Kannus 2000).The MTJ is important for 
force transmission of contracted muscle to tendon (Benjamin et al. 2002, Kostrominova et 
al. 2009). At this region collagen fibres of tendon are inserted into deep recesses formed by 
myocyte processes, which allows the tension that has been generated by contractile 
proteins of muscle fibres to be transferred to the collagen fibrils (Sharma and Maffulli 2005). 
The OTJ or enthesis is the interface between tendon and bone and is classified in to four 
zones: fibrous tissue, fibrocartilage, mineralised fibrocartilage and bone (Benjamin et al. 
1986, Benjamin et al. 1995, Doschak and Zernicke 2005). The presence of fibrocartilage in 
tendon is an adaptation to resist compression and/or shear forces (Benjamin and Ralphs 
1998). 
 
1.3 LIGAMENT  
 Ligament function and gross structure  1.3.1
Ligament is another dense regular connective, that joins bone to bone (Ross and Pawlina 
2006). Similar to tendons, ligaments vary in size, form, orientation and location (Frank 
2004). Grossly, ligament appears white, firm, homogenous and fibrous (Frank et al. 1985). 
Ligament can be categorised into at least two major subgroups; those found in the 
musculoskeletal system (usually crossing joints) and those connecting other soft tissues, for 
instance the suspensory ligament in the abdomen. They are named based on the point of 
bony attachment, shape, function, their relation to joints or surfaces and their relationship 
to each other (Frank et al. 1985). 
Skeletal ligaments play essential roles for accurate joint function. They passively stabilise the 
joint and are responsible for guiding movement of the joint through a normal range of 
motion. They are responsible for preventing or blocking abnormal joint movement within 
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set limits. Another function of articular ligament role in joint is in proprioception, which 
provides feedback relating position space of the joint and contributes to the coordinated 
movement of the limbs (Frank 2004, Birch et al. 2013).  
Ligament contains different regions similar to what has been previously described in 
tendon. For instance the anterior cruciate ligament has a proximal origin from the femur 
and a distal insertion on the tibia (Zantop et al. 2006). The direct insertion or enthesis of 
ligament to bone also consists of four gradual transition zones as mentioned earlier 
(Doschak and Zernicke 2005), while indirect insertion of the ligament passes along the 
surface of the bone rather than bony or gradient transition zone. The cruciate ligaments of 
the knee joint are examples of ligaments with direct entheses at both the femural and tibial 
insertions, whilst medial collateral ligament (MCL) has an indirect enthesis at the tibial 
insertion (Woo et al. 2006).   
The formation of fibrocartilaginous matrix in both tendon and ligament is thought to occur 
at sites that are under compression. Cells in both tendon and ligament are capable of 
detecting changes in mechanical load and co-ordinate their response to alter the 
composition of ECM (Benjamin and Ralphs 1998) 
 
1.4 STRUCTURE OF TENDON AND LIGAMENT  
 Hierarchical structure 1.4.1
The collagen- rich composition of ligaments and tendons are organised in a complex 
hierarchical structure. This was first reported in tendon by Kastelic et al. (1978), who 
summarised that tropocollagen molecules are synthesised by tenocytes then self-assembled 
and grouped together in a highly ordered fashion to form fibrils, fibres and fascicle (fibre 
bundles). Each fascicle is separated by a loose connective tissue of interfascicular matrix 
termed endotendon. Grouped fascicles form the entire tendon, which is enclosed by 
another connective tissue referred to as epitenon (Figure 2.1) (Kastelic et al. 1978). In the 
ligament the endotendon is referred to endoligament, and the epitenon is called 
epiligament (Chowdhury et al. 1991, Lo et al. 2002). 
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The orientation of collagen fibrils tends to be in the direction of applied force (Kastelic et al. 
1978) relative to the axis of tendon or ligament. In tendon forces are applied in a uniaxial 
direction, resulting in parallel alignment of collagen fibrils. However, in ligament collagen 
fibrils are not as uniformly orientated as forces are applied in more than one direction (Amis 
1998, Rumian et al. 2007). 
 
 
 
Figure 1.2. Hierarchical structure of tendon and ligament. Image from Kastelic et al. (1978) 
and Thorpe et al. (2012). 
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1.5 TENDON AND LIGAMENT COMPOSITION   
 Cells  1.5.1
Both tendon and ligament cells reside between collagen fibres within the fascicle and at the 
interfascicular regions (Lo et al. 2002, Clegg et al. 2007) (Figure 1.2). In both tendon and 
ligament the major cell type is the fibroblast which is responsible for the synthesis and 
assembly of ECM molecules (Tozer and Duprez 2005). Fibroblasts are referred to as 
tenoblasts/tenocytes in tendon and ligamentoblast/ligamentocytes in ligament, and 
comprises about 90-95% of the cellular element of both tissues (Kannus 2000, Hoffmann 
and Gross 2007). In tendon and ligament different morphological appearances of fibroblasts 
have been reported (Murray and Spector 1999, Kannus 2000, Clegg et al. 2007, Smith et al. 
2012) Other populations of cells are also present but in lower number (5-10%)(Riley 2005, 
Hoffmann and Gross 2007) and include chondrocyte-like cells (fibrochondrocytes) at the 
bone origin and insertion sites, synovial cells, and vascular cells (Kannus 2000, Riley 2005, 
Hoffmann and Gross 2007). The existence of stem cells has also been documented in both 
tendon (Bi et al. 2007) and ligament tissue (Zhang et al. 2011). 
Cells in tendon communicate by intercellular communication sites known as gap junctions, 
which are also necessary for strain-induced collagen synthesis (McNeilly et al. 1996, Clegg et 
al. 2007). Connections occur through cell cytoplasmic extensions that extend for long 
distances and connects to cytoplasmic extension of adjacent cells, forming an elaborate 3-
dimensional structure (McNeilly et al. 1996). A similar intercellular communication system 
has also been described in ligament (Lo et al. 2002). The detection of gap junctions in 
association with these cell connections has also raised the possibility that cells coordinate 
cellular and metabolic responses throughout ligament and tendon tissue via cell- to-cell 
communication (McNeilly et al. 1996, Ralphs et al. 1998, Lo et al. 2002). 
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 Extracellular matrix  1.5.2
The ECM is the non-cellular structural network that is secreted by cells, and provides not 
only essential physical scaffolding for the cellular constituents but also initiates essential 
biochemical and biomechanical cues that are required for tissue morphogenesis, 
differentiation and homeostasis (Benjamin and Ralphs 1997, Kjaer 2004, Frantz et al. 2010). 
The general ECM composition of tendon and ligament consists of water and collagens, 
proteoglycans, elastin and glycoproteins, which are further described below (Benjamin and 
Ralphs 1997, Frank 2004, Thorpe et al. 2013).    
 
 Water  1.5.2.1
Tendon and ligament are composed of two–thirds water (Frank 2004, Kjaer 2004). A 
significant amount of this is associated with proteoglycans (PGs). The water and 
proteoglycans are thought to have spacing and lubricating roles necessary for the gliding of 
the fibres in the ECM of ligament and tendon (Amiel et al. 1995, Kjaer 2004). 
 Collagen  1.5.2.2
Collagen is the most abundant protein in the human body and makes up to 30% of its total 
protein content (Liu et al. 1995). Collagens are important for a wide range of functions 
including tissue scaffolding, maintaining the tissue structure, cell adhesion, chemotaxis, cell 
migration and the regulation of  tissue remodelling during growth, morphogenesis and 
wound healing (Myllyharju and Kivirikko 2004, Kadler et al. 2007). Tendon and ligament 
contain approximately 70-80% dry weight collagen, of which ~85-95% is type I collagen 
(Frank 2004, Kjaer 2004, Riley 2005) depending on the type of tendon or ligament.  
Collagen Classification- At least twenty eight collagens have been identified (Canty and 
Kadler 2005, Kadler et al. 2007), they are grouped based on their structure and 
supramolecular organisation into fibril forming collagens, fibril-associated collagens with 
interrupted triple helices (FACITs), network-forming collagens, transmembrane collagens, 
anchoring fibrils, beaded filament forming, endostatin producing collagens and others with 
unique functions (Kadler et al. 2007) (Table 1.1).  
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Collagen type  Classification  Distribution   
I Fibril –forming  Fibrils in tendon, bone, skin, cornea and blood vessels walls  
II Fibril-forming Fibrils in cartilage 
III Fibril-forming Forms heterotypic fibrils with type I collagen, especially in 
embryonic skin and hollow organs 
IV Network-forming  Network in basement membrane 
V Fibril-forming Forms heterotypic fibrils with type I, especially in embryonic skin 
and in cornea 
VI Beaded  
filament-forming 
Ubiquitous distribution, especially in muscle 
VII Anchoring fibrils Fibrils in skin at the dermal/epidermal junction 
VIII Network- 
forming 
Descement’s membrane 
IX FACIT Associated with type II collagen fibril, especially in cartilage 
X Network-forming Hypertrophic cartilage 
XI Fibril-forming Heterotypic fibrils with type II 
XII FACIT Associated with type I fibrils  
XII Transmembrane  Neuromuscular junction, skin 
XIV FACIT Associated with type I fibrils 
XV Endostatin  Specialised basement membranes, close structural  homology to 
XVIII 
XVI FACIT  Specialised components of fibrillin 1 microfibrils and collagen 
fibrils  
XVII  Transmembrane Transmembrane component of hemidesmosomes, which attach 
epidermis to basement membrane skin 
XVIII Endostatin Associated with basement membranes  
XIX FACIT Infrequent, localised to basement membrane zones; contributes 
to muscle physiology and differentiation 
XX FACIT Ubiquitous, most dominant in corneal epithelium  
XXI FACIT Wide spread expression pattern 
XXII FACIT Localised in specific tissue junctions such as myotendinous 
junction, cartilage and synovial fluid, hair follicle dermis 
XXIII Transmembrane Limited tissue distribution  
XXIV Fibril-forming Expressed in tissues containing type I collagen 
XXV Transmembrane Precursor protein for CLAC (collagenous Alzheimer amyloid 
plaque component) 
XXVI Beaded filament 
forming 
Expressed in testis and ovary of adult tissues 
XXVII Fibril-forming  Widespread expression especially in cartilage  
Ectodysplasin Transmembrane Ectoderm 
Gliomedlin Transmembrane Myelinating Schwan cells  
Table 1.1. Collagen types, classification and distribution. Table adapted from Canty and 
Kadler (2005) and Kadler et al. (2007).  
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Collagen Structure- Collagen molecules consist of three polypeptide chains called α chains,  
in which each chain comprises a repeating Gly-X-Y triplet, where X and Y can be any residue 
but are usually proline and hydroxyproline respectively (van der Rest and Garrone 1991, 
Myllyharju and Kivirikko 2004). This triplet motif results in a left-handed helix that 
intertwines with two other helices to form a right hand triple-helical structure (van der Rest 
and Garrone 1991).  
Collagen fibrils are the principal source of tensile strength in mammalian tissue. Fibrils can 
be identified by a characteristic banding pattern with 67nm axial periodicity. Fibrils can be 
up to millimetres in length and range in diameter from 12 nm to approximately 500nm, 
depending on the tissue and stage of development (Canty and Kadler 2005, Kadler et al. 
2007). The three polypeptide α1 or α2 chains combine together to form a heterotrimer (two 
or three different chains) or a homotrimer (three identical chains) (Riley 2005). Fibrillar 
collagen type I is a heterotrimeric collagen, as it consists of two α1 chains and one α2 chain 
(Kadler et al. 2007). Heterotrimeric type I collagen is the main constituent of tendon and 
ligament and contributes to the high tensile strength of both tissues. Collagen type III is 
another fibrillar collagen present in both ligaments and tendon (Frank 2004, Kjaer 2004, 
Riley 2005). Collagen type III is believed to regulate the size of collagen type I fibrils and has 
been demonstrated to be important for normal fibrillogenesis (Kadler et al. 2007). Type III 
collagen has been found to be predominately localised at endotendon (Duance et al. 1977, 
Sodersten et al. 2013). Other types of collagen are also present but are present in much 
lower amounts. These include the fibrillar collagens type II and V, basement membrane 
collagen type IV and beaded filament forming collagens VI, XII and XIV (Frank 2004, Riley 
2005).  
 
Collagen Assembly- Collagen biosynthesis is characterised by the presence of an extensive 
number of co- and post-translational modifications of the polypeptide chains (Kjaer 2004). 
The formation of collagen fibrils starts with the synthesis of polypeptide chains on 
membrane bound ribosomes. The collagen polypeptides are secreted into lumen of the 
endoplasmic reticulum (ER) in which the following steps occur (Myllyharju and Kivirikko 
2004): 
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a) Cleavage of the signal peptides 
b) Hydroxylation of certain proline and lysine residues:  
Hydroxylation to 4-hydroxyproline, 3-hydroxyproline and hydroxylysine is due to 
action of the three hydroxylases; prolyl-4-hydroxylase  (P4H), proline 3-hydroxylase 
(P3H) and lysine hydroxylase.  
c) Glycosylation of some of the hydroxylysine residues to  galactosylhydroxylysine and 
glucosylgalactosylhydroxylysine 
d) Glycosylation of certain aspargine residues in the C or both N and C propeptides 
e) Association of three C propeptides directed by specific recognition sequences 
f) Creation of intramolecular and intermolecular disulfide bonds 
After association of C propeptides and hydroxylation of around 100 proline residues, a 
nucleus for the assembly of the triple helix is formed in the C-terminal region and the triple 
helix is propagated towards the N-terminus (Myllyharju and Kivirikko 2004). The procollagen 
molecules are transported from the ER through the Golgi stacks and are aggregated during 
transport to form secretory vesicles. Subsequently, the N and C propeptides are cleaved by 
procollagen propeptides (Myllyharju and Kivirikko 2004). This process of N and C 
propeptides cleavage in tendon has been described by Canty and others to occur 
intercellulary, where N propeptides have been found to be removed earlier in the secretory 
pathway than the C propeptides (Canty and Kadler 2005, Canty-Laird et al. 2012). The ECM 
secreted collagen molecules are assembled in fibrils in a quarter stagger pattern to give D-
periodic characteristics to the fibril (Kadler et al. 1996, Canty and Kadler 2005). This process 
is also referred to as collagen fibrillogenesis. Several molecules are involved in the 
regulation of tendon collagen fibrillogenesis such as collagen type III, small leucine 
proteoglycans and cartilage oligomeric matrix protein (COMP) (Banos et al. 2008). 
Formation of covalent crosslinks occurs within and between the formed triple-helical 
collagen molecules in fibrils (Figure 1.3) (Myllyharju and Kivirikko 2004, Canty and Kadler 
2005).  
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Figure 1.3 Intracellular and extracellular synthesis and processing of the collagen triple helix. Image adapted 
from Myllyharju and Kivirikko (2004). 
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Collagen Crosslinks- After extracellular fibril formation, covalent crosslinks are formed 
between collagen molecules (Kielty and Grant 1993). The type of cross-link can vary 
according to type of tissue, but is generally divided into three types; immature, mature and  
non-enzymatic (Knott and Bailey 1998). 
 Tendon and ligament contain both of the immature hydroxylysine aldehyde derived cross-
links and the lysine aldehyde derived cross-links. Ligament mainly contains hydroxylysine 
aldehyde derived cross-links; whilst tendon has a higher content of lysine aldehyde derived 
cross-links (Amiel et al. 1984). Ligament also poses significant amount of type III collagen 
and a higher level of lysyl hydroxylation. This phenomenon might be due to the differences 
in turnover rate between these two tissues (Amiel et al. 1984).   
 
 Elastic Fibers 1.5.2.3
Although collagen fibrils are the principal source of tensile strength in ligament and tendon, 
(Canty and Kadler 2005), other non-collagenous components may contribute to the overall 
mechanical function of the tendon and ligament complex (Benjamin and Ralphs 1997, Frank 
2004, Kjaer 2004, Thorpe et al. 2013)  
Elastic fibres are major ECM assemblies that provide elasticity and resilience to many 
vertebrate tissues including arteries, lung, ligament, tendon, skin and elastin cartilage 
(Mithieux and Weiss 2005). Elastic fibres have at least three critical functions: 1) important 
mechanical properties in tissue elastic recoil and resilience (Butler et al. 1978, Eriksen et al. 
2001), 2) regulation of cell functions such cell migration, and differentiation (Ito et al. 1997, 
Wendel et al. 2000) 3) regulation of the activity of the growth factor TGFβ family 
(Charbonneau et al. 2004, Feng and Derynck 2005). The arrangement, structure and 
organisation of elastic fibres are reflected in the function of the tissue. For instance, in 
arteries, elastic fibres are organised in concentric rings, while in the lung elastic fibres form 
fine branched network throughout the organ. In ligaments and tendons fibres are oriented 
longitudinally, parallel to collagen fibrils (Mithieux and Weiss 2005).  
Elastic fibres are composed of a central cross-linked to core of elastin, surrounded by a 
sheath of fibrillin rich microfibrils. The fibrillin microfibrils are formed first and act as a 
 17 
 
scaffold where secreted elastin molecules are deposited on the surface (Kielty 2006). The 
absence of fibrillin microfibrils during elastogenesis results in elastin sheets rather than 
formation of elastic fibres (Ross and Pawlina 2006).   
Molecular Composition Of Elastic Fibres- Elastin is the most abundant component of elastin 
fibres and is extremely durable with little turnover in healthy tissues (Mithieux and Weiss 
2005, Kielty 2006). Like collagen, elastin is rich in proline and glycine, but is not glycosylated 
and contains some hydroxylysine but no hydroxyproline (Alberts et al. 2002). Elastin is 
secreted as a 65-70 kDa protein, whose length depends on alternate splicing and is formed 
through lysine mediated crosslinking. Tropoelastin has a multidomain structure with 
repeating hydrophobic and lysine-rich crosslinking domains, each encoded by separate 
exons. Crosslinked elastin is formed through the action of the enzyme lysyl oxidase (LOX) 
and other members of this family (Mithieux and Weiss 2005, Kielty 2006). Proteoglycans, 
including biglycan have been detected within the elastin core (Baccarani-Contri et al. 1990). 
Moreover, it has been demonstrated that the elastin assembly may be influenced by the 
presence of sulphated proteoglycans (Kozel et al. 2004).    
Microfibrils are considered to have a structural role in ligament and tendon and may have 
key roles in cellular matrix interactions (Ito et al. 1997, Wendel et al. 2000) as well as in the 
extracellular regulation of transforming growth factor (TGF) β (Charbonneau et al. 2004).  
Microfibrils (MFs) are chiefly composed of the structural glycoproteins fibrillin-1, fibrillin-2, 
and microfibril-associated glycoprotein-1 (MAGP1). Bundles of microfibrils are known as 
oxytalan fibres. Collectively, oxytalan and elastin fibres are referred to as elastic fibres 
(Kielty 2006, Smith et al. 2011). The fibrillins are large proteins (350 kDa) composed of 
multiple calcium-binding growth factor (cbEGF)-like domains and several eight-cysteine-
containing (TB) motifs (Kielty et al. 2002, Kielty 2006). Fibrillin-1 and fibrillin-2 have 
overlapping expression patterns where fibrillin-2 is strongly expressed in developing tissues, 
whereas fibrillin-1 is expressed throughout life (Zhang et al. 1994, Charbonneau et al. 2003). 
Fibrillin 1 and 2 have been shown to co-localise within MFs and may overlap in function 
(Carta et al. 2006). The microfibril- associated molecule MAGP-1, a 31kDA glycoprotein, is 
most likely to be a structural component and widely co-localises with microfibrils (Cain et al. 
2006). Other proteins associated with elastin microfibrils include MAGP-2 and latent TGF-β 
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binding protein (LTBP)-1, which also co-localise in certain tissues such as nuchal ligament 
and dermis (Gibson et al. 1998, Kielty 2006).  
Elastic fibres are thought to account for about 1-2% of the dry weight of tendon (Kannus 
2000) and ligament (Frank 2004), however this can vary between tendon and ligament type. 
For instance nuchal ligament has been found to contain 7.8% elastin (Uitto 1979), while the 
ACL was found to contain 5% elastin (Dodds and Arnoczky 1994). The distribution of elastic 
fibres in bovine tendon (Grant et al. 2013) and canine cruciate ligament complex (Smith et 
al. 2011) has been described, with elastic fibres being sparse and microfibrils abundant in 
both tissue types. In bovine tendon both fibrillins 1 and 2 were found to co-localise with 
elastin (Grant et al. 2013), while in ligament  the majority of fibrillin 2 fibres did not stain for 
elastin (Smith et al. 2011). This different localisation of fibrillin 2 between ligament and 
tendon may demonstrate a fundamental difference between these two tissues. 
 
 Proteoglycans  1.5.2.4
Proteoglycans have numerous biological functions such as assembly and maintenance of 
ECM, participation in cell proliferation through interaction with growth factors, tumor cell 
growth and invasion (Halper 2014). In tendon and ligament proteoglycans play a role in 
collagen fibrillogenesis and organisation of collagen fibrils (Zhang et al. 2005, Franchi et al. 
2007), and they interact with collagen fibres to yield viscoelastic properties (Rees et al. 
2000, Woo et al. 2006, Franchi et al. 2007). They also contribute to the fibril and fibre 
structural integrity performing an important role alongside the fibrous elements of the ECM, 
by forming interfibrillar linkages (Franchi et al. 2010). Proteoglycans are a special class of 
glycoproteins that are heavily glycosylated, consisting of a core protein with one or more 
covalently attached glycosaminoglycans (GAGs). The function of different proteoglycans is 
determined by structure of the protein core and GAG chains (Parkinson et al. 2011).  Most 
GAGs consist of repeating units containing uronic acid (glucuronic acid or iduronic acid) and 
an N-acetylated sugar (N-acetyl glucosamine or N-acetyl galactosamine). At least one of the 
repeating units has a negatively charged carboxylate group, apart from hyaluronic acid, 
which is not sulphated (Styrer 1996). The negatively charged carboxyl group of GAGs results 
in the hydrophilic nature of proteoglycans, which provides lubrication and water retention 
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(about 70% water) within tissues (Franchi et al. 2010). GAGs are distinguished according to 
their sugar, the type of linkage between sugars, and the number and location of sulphate 
groups (Alberts et al. 2002). These are: 
1. Chondroitin sulphate (CS) and dermatan sulphate (DS) 
2. Heparan sulfate (HS) 
3. Keratan sulphate (KS) 
4. Hyaluronan 
 
Chondroitin sulphate plays a role in articular cartilage and bone metabolism by controlling 
cartilaginous matrix integrity and bone mineralisation. It contains disaccharide repeats of 
glucuronic acid and N-acetylgalactosamine (Bali et al. 2001). Dermatan sulphate 
proteoglycans are widely distributed in the ECM of skin, sclera, tendon and a wide variety of 
connective tissues. Its chains are a variant of chondroitin sulphate and are also O-linked to a 
protein core via a serine xylose-galactose-galactose structure (Rosenberg et al. 1986). 
Keratan sulphate is primarily found in cornea and skeletal tissues and brain. It is the only 
GAG without uronic acid residues. The hexosamine residue is commonly sulphated at its 6-
position, but sulphation may also occur at the 6-position of the galactose residues (Yoon and 
Halper 2005). Heparan sulphate is present on the cell surface of all human and animal cells. 
It has a similar tetrasaccharides linkage as CS, and an analogous consensus sequence for 
attachment to serine residues (Yoon and Halper 2005). Hyaluronan serves as a lubricant and 
is believed to have a role in resisting compressive forces in tissues and joints as well as being 
an important component of joint fluid (Alberts et al. 2002). Within the GAGs hyaluronan is 
unique, as it does not contain a sulphate chain. In addition unlike the other GAGs, 
hyaluronan is not covalently attached to the proteoglycan protein core and binds indirectly 
to proteoglycans (Ross and Pawlina 2006).  
The concentration of GAGs in ligaments and tendon can differ, and is thought to be related 
to their viscoelastic properties. Rabbit cruciate ligaments have been found to contain 2-4 
times more GAG then any tendons studied (Vogel et al. 1993). Amiel et al. (1984) also found 
similar differences between rabbit cruciate ligaments and tendons (Achilles and patellar 
tendons). In addition, a comparative study in an ovine model showed that the ligaments 
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(ACL and PCL) have a higher GAG content than tendons (LDET, SDFT, and PT) (Rumian et al. 
2007). 
Proteoglycans are usually divided into two classes of small and large proteoglycans (Halper 
2014). Their overall structure with their associated GAG chain is shown in Figure 1.4.  
Small Leucine Rich Proteoglycans (SLRPs)- These proteoglycans are tissue organisers by 
orientating and ordering collagen fibrils during ontogeny, wound healing, tissue repair and 
interact with a number of surface receptors and growth factors (Iozzo et al. 2011). The 
central part of SLRPs contains 10 leucine-rich repeats region forming a parallel beta sheet 
which comprises a site for collagen binding (Halper 2014). The SLRPs are dividided into five 
classes (Halper 2014), however members of the first two classes are only described in this 
Chapter. 
In tendon, SLRPs act to modulate formation and diameter of collagen fibrils during 
fibrillogenesis (Parkinson et al. 2011). The four principal SLRPs in ligament and tendon are 
decorin, biglycan, fibromodulin and lumican  (Ilic et al. 2005, Yoon and Halper 2005). 
Decorin is a class I member SLRP with either single dermatan or chondroitin sulphate at its 
N-terminal region. At the leucine rich repeats region it contains binding sites for collagen 
type I, II, III and VI (Halper 2014). Decorin also binds to other proteins such as transforming 
growth factor β (TGFβ) (Hildebrand et al. 1994) and epidermal growth factor (EGF) (Santra 
et al. 2002). Apart from collagen fibrillogenesis, decorin hinders TGFβ activity (Hildebrand et 
al. 1994), normalises cell proliferation, stimulates the immune response (Yoon and Halper 
2005) and can substitute  for absent biglycan (Ameye and Young 2002).  
Biglycan is another member of class I SLRPs,  has similar homology to decorin and also plays 
important roles in collagen fibrillogenesis (Halper 2014). It has either two chondroitin or 
dermatan sulphate chains (Yoon and Halper 2005, Halper 2014) and can interact with 
collagen type I (Schonherr et al. 1995) and VI (Wiberg et al. 2002). Together, biglycan and 
aggrecan have been found to be increased at the fibrocartilaginous regions of tendon (Rees 
et al. 2009).  
Asporin is another member of class I SLRPs, but has no glycosaminoglycan chains attached 
to its core protein (Ikegawa 2008). Asporin competes with decorin for collagen binding with 
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the high affinity site located in the C-terminal part of the protein (Kalamajski and Oldberg 
2010). Asporin also plays a role in biomineralisation as it has the ability to bind to calcium in 
the polyaspartic N-terminal domain of the protein (Kalamajski et al. 2009).  
Fibromodulin and lumican are members of class II SLRPs that consist of four keratan chains 
that are bound to the core protein. Both SLRPS have a binding sites at the leucine rich region 
for collagen I and II, though these are different to the decorin binding site (Yoon and Halper 
2005, Halper 2014). Together decorin, biglycan, fibromodulin and lumican  SLRPs play an 
important roles in the organisation of collagen fibrils, as mice deficent in these SLRPs 
demonstrated irregular collagens fibril diameters and reduced tensile strenghth of tendon 
(Danielson et al. 1997, Svensson et al. 1999, Ameye and Young 2002, Chakravarti 2002). 
Keratocan is another member of class II SLRPS. Keratocan and lumican together are the 
major keratan sulfate containing SLRPs that are primarly found in the cornea (Carlson et al. 
2005). In the cornea the keratocan has been found to highly glycolysated, while in the 
tendon it is poorly sulphated. This SLRP is also likely to play an important role in regulating 
the collagenous matrix of tendon (Rees et al. 2009). 
 
Large Aggregating Proteoglycans- Proteoglycans that indirectly bind to hyaluranon form 
giant macromolecules and are there referred to large aggregating proteoglycans (Ross and 
Pawlina 2006). Aggrecan is one of large aggregating that contains numerous chondroitin and 
keratan sulphate GAGs and three globular domains (G1,G2,G3) (Hardingham and Fosang 
1992).  The CS and KS GAG chains are attached to specific sites between the G2 and G3 
domain, whilst the G1 domain interacts with hyaluronan (Hardingham and Fosang 1992, 
Riley 2005). Aggrecan is most abundant in cartilage. A major function of aggrecan is its 
capacity to retain water in this tissue due to the presence of many negatively charged GAG 
chains, which creates a strongly hydrophilic environment (Kiani et al. 2002, Heinegard 
2009).  
Versican is another large proteoglycan, present in a variety of soft tissues. It plays a role in 
cell adhesion, proliferation, migration and ECM assembly, regulation of cell phenotype 
(Wight 2002) and may be involved in chondrogenic changes (Zhang et al. 2001). Versican 
lacks a globular domain 2 and is divided into sections known as GAGα and GAGβ for its GAG 
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binding domain (Wight 2002). Versican has been found in bovine ligaments (Campbell et al. 
1996) and in tendon, where it forms an integral part of a pericellular matrix that organises 
the tendon cells in linear arrays between collagen fascicles (Ritty et al. 2003). Versican has 
been found to interact with other ECM proteins and plays a important role in ECM 
assembly. Versican interacts occurs with proteins such as hyaluronan, tenascin R, fibrillin-1, 
fibrillin-2 and elastic fibers (Wight 2002). It has been noted that Versican interacts with the 
elastic fibre associated protein fibrillin-1 and co-localises with microfibrils (Isogai, Aspberg et 
al. 2002). 
 
In general proteoglycans comprise less than 3% of the dry weight of ligaments and tendons 
(Ilic et al. 2005, Franchi et al. 2007, Parkinson et al. 2011). The major proteoglycan in 
tendons and ligament is decorin, which accounts for 80% and 90% of total proteoglycan in 
respectively (Samiric et al. 2004, Ilic et al. 2005). The other SLRPs including biglycan 
fibromodulin and lumican have been detected in both tendon and ligament (Rees et al. 
2009, Yang et al. 2012). These SLRPs are primarily located at the interfibrillar matrix, which 
are able to bind to collagen fibrils at specific sites in tendon (Thorpe et al. 2013). Other 
SLRPS that such as keratocan and asporin have been less characterised in both tendon and 
ligament. Keratocan has been identified in both the compresive and tensile regions of 
tendon (Rees et al. 2009) and asporin in tensile region of both tendon and ligament (Little et 
al. 2014).  The large aggregating proteoglycans, versican and aggrecan have been found to 
be present at similar levels in the tendon tensile region, though the versican might be 
predominant in the tensile region of ligament (Ilic et al. 2005).  
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Figure 1.4. Proteoglycans present in tendon and ligament. The structure of each proteoglycan 
with its associated GAGs is represented. This image is modified fromRiley (2005). 
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1.6 LIGAMENTS AND TENDONS OF THE KNEE JOINT  
 Functional anatomy  1.6.1
 The knee joint (tibiofemoral joint) is the largest and most complex joint of the body 
(Tortora and Derrickson 2013). The knee joint is a synovial joint formed between the three 
bones, tibia, femur and patella. It is a hinge joint allowing for wide range of flexion and 
extension. The articulations consist of the patellofemoral and tibiofemoral joint. The joint 
capsule within the knee is thin and attaches on the margin of the femur and tibia and 
encloses the joint (Gosling et al. 2008). The patellar tendon, medial collateral ligament 
(MCL) and lateral collateral ligament (LCL), oblique popliteal and arcuate popliteal ligaments 
are extracapsular. The patellar tendon is located below the patella. It inserts at the top of 
the tibia and spreads over the top of the patella where it connects to the quadriceps tendon 
(Figure 1.5). The MCL and LCL extend from the medial and lateral condyles of the femur to 
the medial condyle of the tibia and lateral side of the head of the fibula and provide stability 
of the inner and outer part of the knee, respectively (Tortora and Derrickson 2013).  
Knee intracapsular ligaments include the anterior cruciate ligament (ACL) and the posterior 
cruciate ligament (PCL). The cruciate ligaments (CLs) are the primary stabilisers of the kee 
joint which are attached to the tibia, located within the joint capsule and are surrounded by 
a layer of synovium. The ACL and PCL cross each other and are in intimate contact, forming 
the CL complex (Arnoczky and Marshall 1977, Woo et al. 2006, Smith et al. 2011). The PCL is 
twice the strength of ACL, and infrequently injured (Kannus et al. 1991). The increased 
strength of the PCL is thought to be with the large cross-sectional area of the PCL, and the 
large broad femoral attachment (Amis et al. 2006). 
The ACL plays a fundamental role in joint stability being the main restraint to anterior 
translation of the tibia with regard to the femur. It also functions as a key secondary 
restraint to internal rotation when the joint is near full extension and restraint to valgus 
angulation (Duthon et al. 2006). The ACL is enveloped by the synovial membrane from the 
knee joint capsule originating at the medial side of the lateral femoral condyle and runing an 
oblique course through the intercondylar fossa distoanteromedial to the insertion at the 
medial tibial eminence (Zantop et al. 2006, Petersen and Zantop 2007). The ACL has distinct 
functional bands, which vary the tension among the fibers in the ligament at different 
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ranges of motion. The ACL is differentiated into two distinct fibre bundles, namely the 
anteromedial (AM) and posterolateral (PL) bundle (Zantop et al. 2006, Petersen and Zantop 
2007). The AM bundle is thought to be important as a restraint to anterior–posterior 
translation of the knee, while the PL bundle is thought to be an important restraint to 
rotational moments about the knee (Woo et al. 2006).  
 
 
 
Figure 1.5. Anatomy of the human knee joint. Image adapted from Calmbach and Hutchens (2003). The 
patellar tendon has been cut to allow observation of cruciate ligaments. 
 
Translational animal models including mouse, rabbit, goat and sheep, pig, dog and horse are 
used to study the human knee structures. From this group, the dog model is thought to be 
the closest to a gold-standard animal model for knee osteoarthritis currently available 
(Gregory et al. 2012). The canine stifle (knee) joint is remarkably similar to the human knee. 
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Apart from size, the macroscopic and microscopic anatomical structures are very similar 
(Cook et al. 2010). As in the human knee joint, the canine stifle joint consists of medial and 
lateral femorotibial compartments and a patellofemoral compartment. The canine stifle 
joint also contains similar structures such as the ACL, PCL, menisci, meniscal ligament, fat 
pad and patellar tendon to the human knee joint (Cook et al. 2010). The major anatomical 
difference is that the canine stifle joint consists of sesamoid bones in the popliteus and 
lateral and medial heads of the gastrocnemius muscles and a long digital extensor tendon 
(LDET) that is intra-articulary located. In the canine stifle joint the ACL is referred as the 
cranial cruciate ligament (CCL) and is comparable to the human ACL (Arnoczky 1983).  
In this thesis, the canine stifle joint was the model chosen to examine knee joint tendon and 
ligaments including, the intra-articular CCL, LDET and extra- articular MCL and SDFT are 
studied. The CCL originates at lateral femoral condyle runs diagonally across and is inserted 
at the tibial eminence. The MCL runs its course from femur to tibia by fusing with the join 
capsule and medial meniscus. (Evans et al. 1979). The LDET originates from the extensor 
fossa on the lateral aspect of the femoral condyle and runs lateral to the stifle joint and 
becomes the muscle located along the lateral side of the tibia. The SDF muscle originates 
from the lateral supracondylar tuberosity of the femur, and continues distally into SDF 
tendon. The SDFT twists across the medial surface of the gastrocnemius muscle, travels 
distally over the tuber calcanei and attaches on each side. It then runs further distally before 
bifurcating at the tarsus and each of these tendons bifurcates to insert on the middle 
phalanges of digits II, III, IV and V. (Evans et al. 1979).  
 
 
 Blood supply  1.6.2
Tendons and ligaments have a low blood supply in comparison with other associated tissues 
such as the muscle, synovium or bone (Benjamin and Ralphs 1997). Blood supply and source 
of vasculature are different in specific tendons such as Achilles tendon (Ahmed et al. 1998) 
and posterior tibial tendon (Petersen et al. 2002). Ligaments such as the ACL and MCL have 
been reported to have a difference in vascular anatomy (Bray et al. 1990) 
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In this chapter we will first describe the general blood supply in tendon, ligament and the 
focus on ACL, MCL blood supply. 
General Tendon Blood Supply- The vascularisation of tendon and the presence of vessels is 
important for the normal function of tendon cells and the ability of tendons to repair. The 
vessels generally run longitudinally, parallel to the fascicle and within the endotenon  
(O’Brien 2005). The blood supply in tendons could occur from three main sources 1) the 
musculotendinous junction; 2) the osteotendinous juction; 3) the extrinsic system through 
the paratenon or the synovial sheath (Carr and Norris 1989, Fenwick et al. 2002, Sharma and 
Maffulli 2005). At the musculotendinous junction the blood supply is from the superficial 
vessels in surrounding tissues, in which perimysial vessels continue between the fascicles of 
the tendon (Carr and Norris 1989, O’Brien 2005). Blood vessels originating from the muscle 
are not likely to extend past the proximal third of tendons (Sharma and Maffulli 2005). In 
the middle portion of tendon the main blood supply is via the paratenon, in which small 
blood vessels run transversely towards the tendon, and branch several times before running 
parallel to the long axis of tendon. The vessels enter tendon along the endotenon and the 
arterioles run longitudinally flanked by two venules (O’Brien 2005). The blood supply from 
the osteotendinous region is limited, as vascular supply is at the lower one third of the and 
there is no direct communication between the vessels because of the avascular 
fibrocartilaginous layer between the tendon and bone (Benjamin et al. 1986, Carr and Norris 
1989, O'Brien 1992, O’Brien 2005).  
Blood Supply In ACL and MCL- The anterior cruciate ligament is supplied by branches of the 
lateral and medial inferior geniculate artery. Proximal and distal vessels support a synovial 
plexus from which small vessels run into the ACL and align longitudinally parallel to the 
collagen bundles (Arnoczky 1985, Zantop et al. 2005). Both ACL and PCL are covered by a 
synovial membrane consisting supplied with vessels. The synovial vessels divide into more 
branches and form a web-like network of periligamentous vessels ensheathing the entire 
ligament. These periligamentous vessels then enter the ligament transversely and 
anastomose with the network of endoligamentous vessels. These vessels then reach the 
attachment of the ligament to the femur and tibia (Arnoczky 1983).  
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The distribution of blood supply in the ACL is not homogenous, as the mid part of the 
cruciate ligaments is less vascularised than the proximal and distal parts. The PCL may have 
a more substantial blood supply as they appear to have more epiligamentous vessels 
(Arnoczky et al. 1979). In the ACL avascular zones are located within the fibrocartilaginous 
regions at the femoral and tibial insertion site and at the anterior part where the ligament 
faces the anterior rim of the intercondylar fossa (Petersen and Tillmann 1999, Petersen and 
Tillmann 2002). 
The ACL may gain nutrition from the synovial fluid, as even though the ACL has been 
considered extra-articular due to the enveloping synovial epiligament, free passage of 
macromolecules from intra-articular synovial fluid to the substance of the ACL has been 
demonstrated (Kobayashi et al. 2006).  
The MCL is supplied from the inferior medial geniculate artery, which travels longitudinally, 
transversely within and next to the substance of the ligament (Wallace and Amiel 1991). The 
MCL is more vascularised than ACL, as it has a relatively vascularised epiligament, with 
vessels penetrating the mid substance region (Bray et al. 2003).  
In the canine the LDET and SDFT blood supply is not well described. However in the horse 
the blood supply of SDFT is described to be afforded proximally and distally through 
connection with arterial supply of the SDFT muscle and by vessels carried through the digital 
sheath. The tendon is least well vascularised within its middle third and is dependent on the 
paratendinous covering with this region, which supplied by many branches arising from the 
medial palmar artery (Kraus‐Hansen et al. 1992).  
 
1.7 TENDON AND LIGAMENT INJURY AND DISEASE  
 Fatigue and stress 1.7.1
Tendons and ligament encounter loads as parts of everyday activities. These loads can 
either be due to tension, compression or shearing and can result in different tissue strain 
characteristics (Doschak and Zernicke 2005). A typical strain-stress curve of tendon and 
ligament consists of a toe region (Region I, Figure 1.6), which is the result of the waviness of 
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the collagen fibres (crimp) straightening out. The strain of the tissue at the end of this region 
has been reported to be between 1.5% and 4% (Butler et al. 1978). In the elastic region 
(Region II, Figure 1.6) the tendon or ligament shows a relatively linear response to stress, as 
the collagen fibres take up force, become more parallel and lose their wavy or crimped 
appearance. The slope of the curve in this region is often referred to as the elastic modulus 
or Young’s modulus of elasticity. Beyond the elastic limits of the tissue (Region III, Figure 
1.6), fibre failures occur strain limit the strain of this region (linear region). Higher levels of 
strain beyond the linear region result in tensile failure and shear failure occurring between 
the fibres progressing to complete rupture (Region IV, Figure 1.6) (Butler et al. 1978, Goh et 
al. 2003, Doschak and Zernicke 2005). 
 
 
 
Figure 1.6 A typical tensile stress-strain curve for tendon and ligament. Image from Butler 
and others. (Butler et al. 1978). 
 
Tendons and ligaments have precise mechanical properties to support their specific function 
(Birch et al. 2013). This difference in mechanical behaviour compared to other connective 
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tissues has been shown between tendons such as, the human Achilles tendon and the 
anterior tibialis, with the Achilles tendon possessing ultimate tensile strength (force to 
failure) of 4 kN and anterior tibialis 1.5 kN. Differences in mechanical properties have also 
been shown in material strength (ultimate stress) and stiffness between tendon and 
ligament, such as the equine suspensory ligament (SL), SDFT and CDET, where the SL was 
found to contain lower ultimate stress and elastic modulus (Birch et al. 2013). Similar 
findings have also been reported between human Achilles tendon, patellar tendon, 
meniscofemoral ligament and PCL, with both ligaments containing a lower elastic modulus 
and tensile strength than tendons (An et al. 2004, Harner et al. Martin et al. 1998). These 
diverse mechanical properties of tendons and ligaments are as result of a distinct matrix 
composition and structural alignment of these tissues and contribute to the understanding 
of how these two connective tissues function. 
 Tendon and ligament injuries  1.7.2
Tendon and ligament injuries are increasingly common in human and in comparative species 
such as the dog and horse (Burt and Overpeck 2001, Adirim and Cheng 2003, Comerford et 
al. 2011, Clegg 2012). More than 30 million tendon injuries are reported  per year worldwide 
(Maffulli et al. 2003), with 30-50%  of these being sports-related (Rees et al. 2009). In 
humans,  Achilles, rotator cuff and patellar tendon injuries are the most common and can be 
as a result of trauma or overuse (Moshiri and Oryan 2013). Whilst in the horse, SDFT 
lacerations are among the most common tendon injuries (Thorpe et al. 2010). Tendon 
injuries are divided into acute and chronic injuries and are caused by intrinsic or extrinsic 
factors either alone or in combination (Sharma and Maffulli 2005). Acute injuries are caused 
by trauma or overload, whilst chronic injuries are not associated with one traumatic event, 
but are caused by repeated microtrauma or overuse of tendon, which is thought to be the 
consequence of  repeated  exposure  to  low-magnitude  force (Riley 2004). The terminology 
of chronic tendon pathologies is unclear. Unless the presence of inflammation or 
degeneration has been clearly demonstrated, most tendon pain and dysfunction is best 
described as a ‘tendinopathy’. In chronic tendinopathy both intrinsic and extrinsic factors 
play a role. Intrinsic factors include age, bodyweight, disease, gender and extrinsic factors 
include occupation, physical load, environmental conditions and fatigue (Maffulli et al. 2003, 
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Riley 2004). Histological observation of tendinopathies shows different features such as 
collagen fibre disorganisation, cell rounding, cell density change, increased 
glycosaminoglycans deposition, lipid accumulation and calcification (Astrom and Rausing 
1995, Movin et al. 1997, Khan and Maffulli 1998, Riley et al. 2001, Riley 2005). 
The ACL is one of the most frequently injured ligaments (Woo et al. 2000), with ~37 tears 
per 100,000 people (Gianotti et al. 2009). The ACL together with the MCL accounts for 95% 
of all multi-ligament injuries in the knee joint (Funakoshi et al. 2007), resulting in significant 
joint instability causing pain and immobility in the affected individual (Woo et al. 1999). 
Injury also leads to significant functional impairment in athletes, and is associated with 
induction of degenerative joint disease such as osteoarthritis (OA) (Daniel et al. 1994, 
Maffulli et al. 2003). ACL injury caused by trauma or contact sport only accounts for about 
30 percent of ACL injuries. The remaining 70 percent of ACL tears are from non-contact 
injuries (Cimino et al. 2010). Risk factors such as age (Hasegawa et al. 2012), gender 
(Harmon and Ireland 2000, Toth and Cordasco 2000), bodyweight (Uhorchak et al. 2003) 
and genetics (Posthumus et al. 2009) are involved in the pathogenesis of non-contact 
ligament ruptures. Histological examination of degenerative ACL has been shown to be 
associated with an increase in cell number, disorientation of collagen fibres, inflammation 
and GAG accumulation and chondroid metaplasia (Hasegawa et al. 2012, Hasegawa et al. 
2013). Chondroid metaplasia is characterised by cells becoming more rounded with 
chondroid transformation that are being arranged in chains (Vasseur et al. 1985, Narama et 
al. 1996, Comerford et al. 2006).   
 
1.8 HEALING OF TENDINOUS AND LIGAMENTOUS TISSUE 
Tendon and ligament have slower healing rates than other connective tissues, most likely 
due to the hypocellular and hypovascular nature of these tissues (Tozer and Duprez 2005). 
The process of ligament and tendon healing is complex, with the responses of these specific 
tissues being dramatically different and ranging from spontaneous healing to little or no 
healing (Woo, Hildebrand et al. 1999; Jung, Fisher et al. 2009). 
For instance, some ligaments such as the MCL have good healing potential whereas others 
such as the ACL demonstrate poor healing, especially in the case of complete ligament 
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rupture (Murray 2009). Conventional ligament and tendon healing occurs in three phases: 
inflammation, proliferation, and matrix remodeling (Figure 1.7) (Woo et al. 1999, Sharma 
and Maffulli 2005, James et al. 2008).  
 
 
Figure 1.7. Typical tendon and ligament healing process. Image adapted from Lin et al. 
(2004). 
 
In tendon the healing starts with an inflammatory/haemostasis stage, where erythrocytes, 
platelets, neutrophils, monocytes, and macrophages migrate to the site of injury. 
Theinflammatory cells engage in the phagocytosis of necrotic tissue and debris breaking 
down the blood clot (Lin et al. 2004, James et al. 2008). During this phase, there is an 
increase in DNA, fibronectin, GAGs, water and collagen type III content (Lin et al. 2004). In 
the proliferative phase, type III collagen and DNA reach their peak amounts in the entire 
reparative process. Within this stage the wound has a scar-like appearance surrounded by 
an extensive blood vessel network. Water and GAGs content remain high during this stage 
(Sharma and Maffulli 2006, James et al. 2008). In the remodelling stage, which begins 6-8 
weeks after injury, there is a decrease in cellularity, reduced ECM synthesis, and collagen 
fibers begin to orient themselves longitudinally along the long axis of the tendon. As the 
scar enters the maturation phase there is a notable reduction of the type III to type I 
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collagen ratio, water, GAGs and DNA concentration (Lin et al. 2004, James et al. 2008). The 
repaired tendon tissue never achieves the mechanical properties it had prior to injury and 
the biochemical and ultrastructural characteristics remain abnormal even at 12 months post 
injury (Miyashita et al. 1997, Yang et al. 2013). Histologic studies of healing tissue have 
shown higher cell numbers and a less parallel collagen fibre organisation (Proctor et al. 
1997, Provenzano et al. 2001). These altered structural properties may contribute to 
degenerative changes, inferior function, and an increased risk of re-rupture (Proctor et al. 
1997, Rokito et al. 1999, Lin et al. 2004). Matrix metalloproteinases (MMPs) are important 
regulators of ECM network remodelling and are also altered during tendon and ligament 
healing (Foos et al. 2001, Ireland et al. 2001, Riley et al. 2002, Jones et al. 2006).  
The extra- articular MCL tends to heal successfully, whilst the intra-articular ACL has poor  
healing capacity (Murray 2009). This could be due to several factors such as inadequate 
blood supply of the ACL (Arnoczky et al. 1979, Vasseur et al. 1985, Bray et al. 1996), 
presence of synovial fluid (Kobayashi et al. 2006), deficiencies in stimulation or intrinsic 
deficiencies of cell migration or proliferation (Nagineni et al. 1992, Geiger et al. 1994, Amiel 
et al. 1995, Spindler et al. 1996). Murray et al. (2000) illustrated that following rupture 
repair of the human ACL undergoes four histological phases, inflammation, epiligamentous 
regeneration, proliferation, and remodelling, however the ligament ends retract by forming 
layers of synovial tissue over the ruptured surface, which may impede ligament repair. 
Studies on ACL and MCL healing have demonstrated differences in terms of cellular 
properties and proliferation (Yoshida and Fujii 1999, Chun et al. 2003), stem cells properties 
(Zhang et al. 2011), MMP expression (Zhang et al. 2009) and lysyl oxidase expression (Xie et 
al. 2013). 
As with tendons, healing of the MCL been shown to heal with a scar that is histologically, 
biochemically and biomechanically different to normal ligament. This scar is weaker and 
larger and creeps more than normal ligament (Thornton et al. 2000). Following healing of 
the MCL differences in structure and function such as altered collagen types (Amiel et al. 
1987), failure of collagen crosslinks to mature (Frank et al. 1995), altered proteoglycans 
(Plaas et al. 2000), presistence of small diameter collagen fibrils (Frank et al. 1992) and 
increased vascularity (Bray et al. 1996).  
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1.9 CURRENT METHOD OF TENDON AND LIGAMENT REPAIR AND TISSUE ENGINEERING  
The current methods of tendon and ligament repair depend on the grade of injury. In 
tendon, injuries with mild tissue defects have been found to respond to a gradual return to 
exercise (Soroceanu et al. 2012, Moshiri and Oryan 2013). About 80 percent of patients with 
mild tendon injury recover within 12 months with conservative therapy, however surgery 
may remain an option if the conservative therapy doesn’t work (Moshiri and Oryan 2013). 
Large tendon and ligament injuries require surgical treatment and/or surgical reconstruction 
(Ronel et al. 2004, Maffulli et al. 2012, Moshiri and Oryan 2013). Surgical reconstruction 
involves the use autografts or allografts as the current biological substitutes in large tendon 
and ligament injuries (Rodrigues et al. 2013), however both grafts have associated 
limitations. For example ACL replacement with allogeneic tissue which is from donor 
recipients, is associated with an increased risk of infection, disease transmission and graft 
rejection as well as limited tissue availability (Strickland et al. 2003, Robertson et al. 2006). 
Whilst ACL autogenous graft sources for ACL injury are from the patient’s own central third 
patellar or hamstring tendon, which can avoid complications associated with the use of 
allografts. Limitations with autografts include donor site morbidity, anterior knee pain, 
patella fracture, and residual hamstring weakness (Kartus et al. 2001, Tashiro et al. 2003). 
Tissue engineering of tendons and ligaments offers an attractive approach to treat tendon 
and ligament rupture and could have the potential to provide an alternative graft source 
that avoids the donor site morbidity and is readily available (Rodrigues et al. 2013). A variety 
of methods are being currently investigated for enhancing repair and regeneration of 
tendon such as cell therapy, growth factors and gene therapy (Sharma and Maffulli 2005, 
Moshiri and Oryan 2013, Hirzinger et al. 2014), however this thesis will only focus on 
currently described scaffold based tendon and ligament tissue engineering strategies  
The tissue engineering approaches commonly involve an artificial ECM (scaffold) on which 
cells can proliferate and differentiate with subsequent new tissue generation (Ahmed et al. 
2008). The ideal scaffold should provide a high surface area for cell-polymer interaction, 
sufficient space for ECM regeneration, and minimal constraint during in vitro culture. The 
scaffold should be biodegradable and resorb once it has served its purpose with its 
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degradation products not provoking inflammation or toxicity when implanted in vivo (Freed 
et al. 1994). 
Current tissue engineering strategies for tendon and ligament involve the use of natural or 
synthetic scaffolds that are biocompatible and biodegradable. Commonly used synthetic 
scaffolds for tendon and ligament tissue engineering include chemical substances such as 
poly-a-hydroxyesters, polyglycolic acid (PLGA) or polylactic acid (PLA) (Kuo et al. 2010, 
Rodrigues et al. 2013). Advantages of synthetic scaffolds include reproducibility of 
mechanical and chemical properties and degradation through hydrolysis (Kuo et al. 2010, 
Moshiri and Oryan 2013). However the lack of functional groups for signalling molecules, 
the release of acidic by-products and unnatural polyesters into the bloodstream during 
degradation may cause potential complications (Kuo et al. 2010). Collagen and fibrin are 
amongst the natural scaffolds. Both collagen and fibrin scaffolds allow cells to create three-
dimensional (3D) structures in vitro (Kapacee et al. 2008, Abraham et al. 2010). An 
important trait of fibrin gels that may benefit tendon/ligament tissue engineering is that 
they allow cells to freely migrate, proliferate, degrade fibrin and produce their own ECM 
(Huang et al. 2005). In comparison to collagen scaffolds, the fibrin scaffolds do not 
suppresses ECM synthesis and can promote greater collagen synthesis (Grassl et al. 2002). A 
recent comparison of fibrin and collagen scaffolds using tendon progenitor cells 
demonstrated increased tenogenic expression, improved ECM organisation and mechanical 
properties with fibrin tissue-engineered constructs (Breidenbach et al. 2014). This study 
indicates that fibrin-based constructs are more suitable for tissue-engineered 
tendon/ligament repair (Breidenbach et al. 2014). To date engineered tendon and ligament 
constructs with fibrin scaffolds have been created with cells from different species such rat 
tendon (Calve et al. 2004), chick embryonic tendon (Kapacee et al. 2008, Kalson et al. 2010, 
Paxton et al. 2010, Herchenhan et al. 2012), human bone marrow stem cells (Kapacee et al. 
2010), human adult ACL (Hagerty et al. 2012) and human adult tendon cells (Bayer et al. 
2010), whilst in the dog tendon and ligament cells have not previously been cultured in 3D 
fibrin culture. 
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1.10  SUMMARY OF TENDON AND LIGAMENT COMPARISON STUDIES 
Studies have demonstrated that while tendons and ligaments are composed of similar 
proteins, they contain different proportions of ECM macromolecules. This has been 
demonstrated in both rabbit (Amiel et al. 1984) and ovine (Rumian et al. 2007) tendons and 
ligaments. While the above studies used biochemical analysis, a recent proteomic study 
between human patellar tendon and ACL demonstrated differential protein expression of 
several ECM proteins (Little et al. 2014). These findings might relate to different functions 
between these tissue types. However function can also be related to the dissimilar structure 
of tendon and ligament tissue types. Structural differences between tendon and ligament 
have been demonstrated to some extent by Amiel et al. (1984), Rumian et al. (2007) and  
Zhu et al. (2012). Amiel et al. (1984) showed a different cell morphology between rabbit 
intra- and extra-articular ligaments and tendons, while Rumian et al. (2007)  demonstrated 
different collagen fibril diameters between ovine tendons and ligaments, with ligaments 
(ACL, MCL and LCL) containing a greater proportion of smaller diameter fibrils. Zhu et al. 
(2012) compared structural differences between human ACL and hamstring tendon and 
found a more complex arrangement of collagen fibres and a different proteoglycan and 
distribution in ACL. Neither of the above mentioned studies fully examined the distinct 
morphological and structural characteristics and the arrangement of ECM components 
between tendons and ligaments at the different regions.  
As highlighted in Section 1.9, tendon and ligament fibroblasts from different species have 
been used for the creation of tissue engineered tendon and ligament constructs (Bayer et al. 
2010, Hagerty et al. 2012, Herchenhan et al. 2013). However it is unknown whether tendon 
or ligament cells retain the specific identifiable characteristics of the original tissue. It is yet 
to be determined whether the analogous tendon and ligament constructs reproduce 
specific phenotypic, biochemical and proteomic characteristics of the tendinous and 
ligamentous tissue when cultured in vitro in 3D fibrin culture.  
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1.11 HYPOTHESIS AND AIMS  
 
This study will address the hypothesis that canine tendons and ligaments around the stifle 
joint will be different in terms of their cellular and ECM composition. This difference will be 
reflected in a distinct cellular morphology, structural arrangement, localisation of ECM 
molecules and proteome characteristics between tendons and ligaments. It is further 
hypothesised that canine tendon and ligament cells retain similar morphological, ECM 
composition and proteomic characteristics to the original tendon and ligament tissue when 
cultured in 3D fibrin culture.  
 
To answer our hypothesis the aims and objectives of this study are to: 
1. Determine measurable differences in cellular and ECM macromolecular composition 
between canine tendons and ligaments with regard to the location and function of 
the tissue  
2. Identify structural and morphological tissue characteristics using a semi-objective 
histological scoring system and identify the distribution and localisation of the ECM 
components in both tissue types. 
3. Determine whether canine tendon/ligament cells are able to recapitulate the 
formation of tendinous or ligamentous tissue using 3D cultures and characterise 
whether 3D tendon and ligament constructs retain biochemical and morphological 
characteristic of the original tissue.  
4. Identify the differences between the proteomes of native tendon and ligament as 
well as engineered tendon and ligament 3D constructs. 
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2 CHAPTER 2 
GENERAL MATERIAL AND METHODS 
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2.1 TISSUE COLLECTION 
The canine cranial cruciate ligament (CCL), medial collateral ligament (MCL), long digital 
extensor tendon (LDET) and superficial flexor tendon (SDFT) (Figure 2.1) were harvested 
from disease-free cadaveric canine hindlimbs from skeletally mature Staffordshire bull 
terrier crossbreeds on the same day of euthanasia. The dogs were euthanased for purposes 
not related to this study and were clinical waste material donated to the University of 
Liverpool. Ethical approval was granted by the Veterinary Research Ethical committee 
(VREC64) to use material in this research project.  
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Figure 2.1. Anatomy of canine stifle or knee joint which is adapted from Evans et al. (1979). Locations of tissues collected are indicated by the 
green arrow. Figure A, B, C and D indicate the left and right stifle with the position of CCL, MCL and LDET.  Figure D indicates lateral view of 
pelvic limb, showing the position of LDET and SDFT.  Dashed images represent the location of division into proximal, middle and distal parts of 
ligaments and tendons.  
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Sample 
ID 
Tissues obtained  
Experimental testing protocol Left stifle Right stifle 
A 
 
 
 
 
B 
 
 
C 
 
 
 
D 
 
 
 
 
E 
CCL, MCL, 
LDET and 
SDFT 
 
CCL, MCL, 
LDET and 
SDFT 
 
CCL, MCL, 
LDET and 
SDFT 
 
CCL, MCL, 
LDET and 
SDFT 
 
 
CCL, MCL, 
LDET and 
SDFT 
CCL, MCL, 
LDET and SDFT 
 
 
CCL, MCL, 
LDET and SDFT 
 
 
CCL, MCL, 
LDET and SDFT 
 
 
CCL, MCL, 
LDET and SDFT 
 
 
 
CCL, MCL, 
LDET and SDFT 
 
 
 
Both left and right knee tissues  were used 
biochemical and histological analysis 
 
 
Samples A, B and C were used for tissue 
immunohistochemistry/ immunofluorescence 
 
 
 
F 
 
G 
 
H 
 
I 
 
J 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
 
CCL and LDET 
Left  stifle joint samples were used for cell 
isolation and creation tendon and ligament  
constructs for biochemical analysis, histology and 
mass spectrometry 
 
Right stifle joint tissues were only used for mass 
spectrometry 
 
TEM analysis was also performed with constructs 
created from isolated cells from samples F,G and 
H of left stifle joint 
Table 2.1.  Tissue collection and associated experimental testing purposes. All tissues were 
obtained from skeletally mature (<5 years) Staffordshire bull terrier crossbreeds with 
disease free stifle joints. 
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2.2 TISSUE PREPARATION  
2.2.1 Samples for biochemistry, histology and 
immunohistochemistry/immunofluorescence analysis (Chapters 3 and 4) 
CCL, MCL, LDET and SDFT were divided into proximal, middle and distal regions (Figure 2.1). 
In both LDET and SDFT any residual muscle was removed. The AM and PL bundles in CCL 
were not dissociated in this study. Further subdivision into thirds through each longitudinal 
section allowed one third to be snap frozen in liquid nitrogen and stored at -80°C for 
biochemical analysis and one third to be fixed in 4% paraformaldehyde for histological 
analysis. The remaining third was embedded on a cork disc in Tissue-TEK OCT (Sakura 
Finetek; Torrance, CA, USA), snap frozen in isopentane and stored at -80°C until required for 
analysis.  
 
2.2.2 Samples for cell culture, construct development and proteomics (Chapter 5 and 6) 
CCL and LDET were obtained for creation of tendon and ligament constructs and for 
proteomic analysis. The left stifle joint tissues were used for cell culture and development of 
tendon and ligament constructs, while the right stifle joint tissues were used for proteomic 
analysis (Table 2.1).   
For proteomics analysis native LDET and CCL tissues of the right stifle joint were prepared by 
firstly removing the LDET muscle and washing three times in PBS. Tissues were then 
transferred into clean eppendorf tubes, snap frozen in liquid nitrogen and stored at -80°C 
until further analysis (Section 2.8).   
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2.3 DEVELOPMENT OF TISSUE ENGINEERED LIGAMENT AND TENDON CONSTRUCTS 
2.3.1 Cell isolation and processing  
CCLs and LDETs were sectioned into small pieces of around 1 mm3 and placed in Dulbecco’s 
modified Eagle’s medium (DMEM, life technologies, MD, USA) containing 10% foetal bovine 
serum (Gibco, Paisley, UK), 100 units/ml penicillin/streptomycin (Penstrep, Life 
technologies, Paisley, UK), 500 ng/ml Amphotericin (Life technologies, Paisley, UK),  20mM 
L-glutamine (Life Techonologies, Paisley, UK) and 0.1% collagenase (Worthington, 
Lakewood, NJ). The solution was incubated at 37°C overnight and then filtered through a 70 
µm cell strainer (SLS, Yorkshire, UK). Following centrifugation at 1100 rpm for 4 minutes, 
cells were resuspended with 12 mls of DMEM, 10% FBS and antibiotics. Both ligamentocytes 
and tenocytes were grown to ~95-100% confluence at 37°C in 5% carbon dioxide. Tenocytes 
and ligamentocytes were split no further than the 3rd passage prior to being used in 
construct set up. 
 
2.3.2 Preparation of culture plates  
Each well of a six well plate was coated with a ~2 mm- thick layer (1.5 ml) of SYLGARD 
(SYLG184, WPI, Hertfordshire, UK) and incubated overnight at 55ºC to induce 
polymerisation. Next, two short silk sutures (0.8 cm) (W328H, sutures Ethicon, Bunzl 
Healthcare, London, UK) were pinned onto the coated plates with minutien insect pins  (0.1 
mm diameter) (Fine Science Tools, Interfocus Ltd, Cambridge, UK). Sutures were pinned at a 
distance of 1 cm. Prior to cell seeding each six well plate was sterilised by immersion in 
100% ethanol for 1 hour under UV light.  
 
2.3.3 Tendon and ligament construct development  
Both tenocytes and ligamentocytes were removed from tissue culture flasks using trypsin-
EDTA (Lonza, UK), centrifuged at 300 g for 10 min and re-suspended inculture medium 
containing DMEM supplemented with penicillin (100U/ml), streptomycin (100 µg/ml), L-
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glutamine (2 mM) and FCS (10%). The cell density was measured, where 10 µl of cell 
suspension was pipetted into a haemocytometer (Hawskley, Sussex, UK) and manually 
counted. For three technical replicates of fibrin constructs, 1.2 mls of 1.5x106 cells/ml were 
resuspended in 250 µl of 20 mg/ml fibrinogen (F8630, Sigma-Aldrich, UK) and 25 µl of 200  
U/ml thrombin (T4648, Sigma-Aldrich, UK), 480 µl of the mixture was immediately deposited 
in each well and vigorously shaken to ensure even mixing and formation of a flat layer of the 
fibrin gel. After the deposition of the mixture the plates were incubated for 30 minutes at 
37°C, 5% CO2 to allow the gels to set. Cell-fibrin layers were scored with a fine pipette tip to 
prevent adhesion to the side of the well, then incubated with 2 mL culture medium (as 
above) supplemented with L-ascorbic acid 2-phosphate (200 µM; Sigma-Aldrich, UK), non-
essential amino acids at 10 µl/ml (Sigma-Aldrich, UK) and aprotinin at 10 µl/ml. The gel was 
scored and media changed every two days until it had contracted to form a linear construct 
between the pinned sutures. All constructs were fully contracted between the fixed anchors 
at fourteen days.   
 
2.3.4 Harvesting of constructs 
Constructs formed were excised from the plates using a scalpel blade.  Both tendon and 
ligament constructs were washed for three times in PBS, snap frozen in liquid nitrogen and 
stored at -80ºC until ready for biochemical and proteomic analysis. Constructs were also 
fixed in 4% paraformaldehyde and 2.5% glutaraldehyde for histology staining and 
transmission electron microscopy (Section 2.7) respectively.  
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2.4 BIOCHEMICAL ANALYSIS  
Double stranded DNA (dsDNA), total sulphated glycosaminoglycan (sGAG), total collagen 
and elastin content were measured. The details of each assay are provided below.  
 
2.4.1 Water content  
Samples were thawed at room temperature and wet weight measured. To obtain water 
content and dry weight samples were freeze dried overnight at -60°C and reweighed. 
 
2.4.2 Papain digestion  
A papain digest was performed to determine the dsDNA, total collagen and sulphated 
glycosaminoglycans (sGAG) content of ligament and tendon samples. Papain buffer (500 µl; 
10  unit/ml papain (P4762, Sigma-Aldrich, UK) in sterile phosphate buffered saline (PBS) with 
100mM sodium acetate, 2.4mM EDTA and 5mM cysteine HCL, pH 5.8) was added to the 
samples (5-20 mg dry weight) which were then incubated for 24hrs at 60°C (Farndale et al. 
1986). The samples were vortex mixed several times during digestion to ensure all tissue 
was solubilised. Once completely solubilised samples were stored at -20°C until used for 
analysis. 
 
2.4.3 Oxalic acid digestion  
Oxalic acid digestion was performed to extract the insoluble elastin from the tissue in the 
form of soluble cross-linked polypeptide elastin fragments; α-elastin. This was done by 
adding 750 µl of 0.25 M oxalic acid (35295, Sigma-Aldrich, UK) and by heating samples to 
95°C. They were centrifuged at 3000g for 10 minutes and the supernatant extracted. This 
process was repeated 5 times for all tissues to extract all elastin.   
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2.4.4 Cellular content  
2.4.4.1 Double stranded DNA content   
Total DNA was measured using Quant-iTTM Picogreen ® dsDNA reagent and kits (P7589, 
Invitrogen, UK). Quant-iTTM PicoGreen® dsDNA reagent is an ultrasensitive fluorescent 
nucleic acid stain for quantitating double stranded DNA in solution (Singer et al. 1997). 
Triplicate aliquots of 100 µl of pre-diluted papain-digested ligament and tendon samples 
were incubated with 100 µl Quant-iTTM Picogreen® dsDNA reagent for 5 minutes at room 
temperature, protected from the light. Fluorescence was read on fluorescence microplate 
reader (Bio-Tek FLX800) at wavelength 480 nm excitation and 520 nm emission. DNA 
concentration was calculated by comparing to a standard curve constructed using 
bacteriophage lambda DNA standards from 0-1000 ng/ml. DNA content was expressed as µg 
per mg dry weight tissue.  
 
 
Figure 2.2. Typical standard curve for dsDNA quantification. Final concentrations of λDNA 
(100 µl) ranging from 1-1000 ng/ml were entered into wells of 96-well plate in triplicate and 
100 µl Quant-iTTM Reagent PicoGreen® reagent dye was added into each well. After 5 
minutes incubation the fluorescence value were read at 480 nm/520 nm excitation and 
emission. 
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2.4.5 Extracellular matrix composition 
2.4.5.1 Sulphated glycosaminoglycan content  
Total sulphated GAG was measured using the 1, 9-dimethlylmethylene blue (DMMB) dye 
binding assay, which forms a complex that absorbs light and is measured 
spectrophotometrically (Farndale et al. 1986). In brief, 40 μl aliquots of papain-digested 
ligaments and tendons samples were placed into a transparent flat bottomed 96-well plates. 
From the stock solution of DMMB dye (16 mg 1-9 dimethyl methylene blue, 2 g sodium 
formate, 2 ml formic acid; made up to 1 litre dH20, pH 3.5), 250 µl was pipetted into each 
sample and standard.  Absorbance was immediately read on the spectrophotometer at a 
wavelength of 570 nm. The assay was calibrated by the use of standards of shark 
chondroitin sulphate (C4384, Sigma-Aldrich, UK) up to 70 μg/ml, and sGAG concentration 
obtained by comparison with the standard curve. sGAG concentration was expressed as μg 
per mg dry weight tissue. 
 
Figure 2.3.Typical standard curve for sGAG quantification.  Final concentrations of 
chondroitin sulphate (40 µl) ranging from 0-70 µg/ml were entered into wells of 96 well 
plate in triplicate and 250 µl DMMB assay dye added into each well. Absorbance was 
immediately read on a spectrophotometer  at an absorbance of 570 nm. 
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2.4.5.2 Collagen content 
Collagen content was calculated by measuring the concentration of the imino acid 
hydroxyproline (Bergman and Loxley 1963). This assay involves the oxidation by chloramine 
T, coupled with dimethylaminobenzaldehyde (DMBA) resulting in a coloured product which 
can be visualised at 550 nm using a spectrophotometer. Aliquots of papain digested tissue 
(100 μl) were hydrolysed with 100 µl of concentrated (12 M) hydrochloric acid (HCL), dried 
and re-dissolved in 10 ml deionised water. Samples (1 ml) were then mixed with 1 ml diluent 
(2 parts propan-2-ol to 1 part deionised water), 1 ml of oxidant was added (0.42 g 
chloroamine T, 5 ml deionised water. water, 25 ml stock buffer) and the samples left to 
stand for 20 minutes. Colour reagent (1 ml; 3 g DMBA, 4.5 ml 70% percholoric acid, 25 ml 
propan-2-ol) was then added and the samples left for 14 minutes before heating (70°C, 20 
minutes). Absorbance was read on a spectrophotometer (CECIL CE2040, CECIL instrument 
limited) after allowing the samples to cool for 10 minutes. Concentration was calculated by 
comparison to a standard curve prepared using L-hydroxyproline standards (56250, Sigma-
Aldrich, UK) from 0-10 μg/ml (final concentration). Collagen content was calculated 
assuming hydroxyproline to be present at 14%. The total collagen content was then 
expressed as a percentage of dry tissue weight (Rumian et al. 2007). 
 
Figure 2.4. Typical standard curve for hydroxproline quantification. Final concentrations of 
hydroxyproline (1 ml) ranging from (0-10 µg/ml) were mixed with 1 ml diluent and 1 ml of 
oxidant. Colour reagent was added and samples incubated at 70°C for 20 minutes. 
Absorbance was read on a spectrophotometer at an absorbance of 550 nm.  
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2.4.5.3 Elastin content 
Elastin was measured using the FastinTM dye-binding assay (Biocolor Ltd, N. Ireland) 
previously described by Smith et al. (2013). The average dry weight of samples used for the 
elastin assay was 14.3mg. Oxalic acid extracts were pooled together and were precipitated 
with elastin precipitation reagent (trichloroacetic acid and hydrochloric acid). Following 
centrifugation (10000g) for 10 minutes, the precipitate was incubated on a mechanical 
shaker with 1ml of elastin fastin dye reagent (5,10,15,20-tetraphenyl-21,23-porphine 
tetrasulphonate) for 90 minutes to allow reaction between α-elastin and the dye. Following 
centrifugation (1000g) for 10 minutes, the bound dye was suspended in a 250 µl of 
dissociation agent (guanidine HCl and propan-1-ol) and transferred to a 96 well plate after 
10 minutes to ensure that all bound dye had passed into solution.  Absorbance was 
measured on the plate reader (Mulltiskan EX, Therma) at 550nm and compared to a 
standard curve generated from known concentrations of alpha-elastin. Elastin concentration 
was expressed as a percentage of dry weight. 
 
 
Figure 2.5. Typical standard curve for elastin quantification.  Final concentrations of α- 
elastin (0-100 µl) ranging from (0-100 µg) were entered into 1.5 ml eppendorf tubes, 
precipitated with an equal volume of elastin precipitation reagent and incubated with 
elastin bind dye complex. The bound dye was suspended with 250µl of dissociation reagent 
and transferred into duplicate wells of a 96 well plate. Absorbance was read on a 
spectrophotometer at an absorbance of 550 nm. 
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2.5 HISTOLOGY STAINING AND SCORING 
2.5.1 Sample preparation  
Tendon and ligament native samples (Table 2.1: Samples A-E) and constructs created from 
isolated cell samples (Table 2.1: Samples F-J) were fixed in 4% neutral buffered 
paraformaldehyde (PFA) and further processed by the Division of Veterinary Pathology, 
School of Veterinary Science, where samples were longitudinally embedded in paraffin, cut 
in 4 µm sections and mounted on polylysine slides  
 
2.5.2 Histology staining  
Histological sections were stained with Hematoxilin and Eosin (H&E), Alcian blue periodic 
acid Schiff (PAS) and Miller’s stain. In addition to the above mentioned stains, tendon and 
ligament constructs were also stained with Masson's trichrome. All histological sections 
were visualised using a Nikon eclipse 80i microscope and pictures were acquired with Nikon 
DS-L2 standalone control unit.  
 
2.5.2.1  Alcian blue and periodic acid Schiff (AB-PAS) stain 
The AB-PAS was used for the detection of the areas rich in GAGs (John and Bancroft 1996). 
Sections were deparaffinised and rehydrated in two washes of xylene, 100% and 95% 
ethanol for 10 minutes and two washes of ultrapure water for 5 minutes. Once rehydrated, 
the slides were stained in 1x Alcian blue (1 g Alcian blue, 3ml glacial acetic acid, 97 mls of 
distilled water) for 3 minutes.  The slides were then washed in running water for 2 minutes, 
rinsed in distilled water and treated with 0.5% periodic acid (HC6405, TCS Biosciences Ltd, 
Buckingham, UK) for 10 minutes. The slides were then further washed in running tap water 
for 5 minutes, rinsed in distilled water, treated with Schiff's reagent (3952016, Sigma-
Aldrich, UK) for 15 minutes and washed in running tap water for 5 minutes. The nuclei were 
stained with Mayer Haemalum for 2 minutes and washed in tap water for 5 minutes. The 
slides were then dehydrated in two washes of 95% ethanol, 100% ethanol, and xylene for 10 
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seconds in the first wash and 5 minutes in the second. Once dehydrated, the slides were 
coverslipped with D.P.X. (Di-n-butyl phthalate in xylene, Sigma-Aldrich, UK) mounting media. 
 
2.5.2.2  Miller’s stain  
Miller’s stain was used to stain for elastic fibres (Miller 1971). In brief, sections were 
deparaffinised and rehydrated, treated with 1% potassium permanganate for 5 minutes and 
rinsed in distilled water. The slides were then decolourised in 1% oxalic acid for 10 minutes 
followed by a brief wash in running water and a rinse in 95% ethanol untill the colour 
disappeared. The slides were stained with Miller’s stain (HS235, TCS Biosciences Ltd, 
Buckingham, UK) for 3 hours, rinsed in 95% alcohol to remove the excess stain and washed 
in running tap water for 3 minutes. Slides were counter stained with Van Gieson (HS780, 
TCS, Biosciences LtD, Buckingham, UK) for 4 minutes followed by dehydration and mounted 
with D.P.X. 
 
2.5.3 Histology scoring methods  
Histological sections of the CCL, MCL, LDET and SDFT were scored by a three part scoring 
system to assess the cells and extracellular matrix of the tissues. All sections were read by 
two observers blinded to section location and tissue type on two separate occasions at least 
two weeks apart.  
H&E- H&E sections were assessed to determine differences in terms of tissue architecture, 
cell morphology, cell distribution, vascularization and inflammation. The scoring system was 
modified from Stoll, John et al (2011), whereby each parameter was numerically graded 
from  0-2  based on changes seen for each parameter listed (Table 2.2). For each parameter 
the average score between inter and intra-observers was converted into percentage 
distribution by counting the occurrence of the graded numerical scores. This was multiplied 
by 100% and then divided by the number of biological replicates. For instance for ECM 
organisation parameter, the presence of grade 2 and 1 and 0 score was counted, the 
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number of occurrence of each grade was then converted to percentage score as explained 
above.  
Miller’s stain- A modified scoring system from Smith (2010) was used to quantify the 
differences in term of elastin and microfibril staining. In brief, the distribution and increased 
staining in interfascicular, interbundle and ligament substance regions, as well as the extent 
and degree of pericellular staining was scored.   For the general distribution and presence of 
pericellular staining a score between 0-1 was given. For the interfascicular, interbundle, 
intrabundle and pericellular staining a score from 0-3 was awarded based on the extent of 
staining 0%= 0, absent, 0-25%= 1, staining percent in up to 25% of tissue, 25-50%=2, staining 
present in 25-50 percent of tissue, >50%= 3, marked staining in above 50% of the tissue.  
The overall score was added up for each sample, giving a range of 0-14.  The average scores 
within and between observers was calculated (Table 2.3).  
AB-PAS stain- a similar scoring system like the Miller’s score was self-developed based on 
Smith (2010) to quantify differences in GAGs staining. For general GAG distribution and 
chondrocytic cell change shape a score between 0-1 was given. For more detailed location 
of staining i.e. interfascicular, interbundle, substance and cellular staining, a score from 0-3 
was awarded based on the extent of positive staining, The overall score was added up for 
each sample, giving a range of 0-14.  The average scores between inter- and intra-observers 
were calculated (Table 2.4). 
Each parameter of H&E scoring, Miller’s scoring and AB-PAS scoring were assessed for 
agreement between inter and intra-observer scorings results using a Kendall’s coefficient 
concordance. 
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1) Extracellular matrix organization of the whole ligament or tendon                                 
Score      
 Wavy,  compact and parallel arranged collagen fibre    2                                       
            (Normal collagen architecture and density) 
 In part compact, in part loose or not orderly      1 
               (Reduced density) 
 Loosely composed, not orderly                                                  0 
           (Absent, minimal density)                  
 
2) Cellular shape, distribution and alignment                            
a) Shape                                                                         
 Spindle shape (normal)                                                 2 
 Mixed                                                                                  1 
 Oval to round shape                                                             0 
 
b) Distribution                                                                                            
 Normal distribution of cells                                                  1                                                 
  focal areas of elevated cell density                                       0 
   (Cell clustering or formation of cell chains) 
 
c) Alignment                                                                                                        
 Uniaxial                                                                                   2                                           
 Areas of irregular arranged cells                                         1 
 More than 50% of cell with no uniaxial alignment         0  
 
3) Vascularity of the whole ligament and/or tendon                                                                                                               
 hypo-vascularised                                                          1 
 hyper-vascularised  (increased number                     0 
 of smaller or larger capillaries) 
Table 2.2. H&E scoring sheet adapted from Stoll, John et al (2011)  
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1) Distribution and location of Microfibril staining                                Score  
a) Distribution                                                                                               
 Normal (sparse fibres throughout)                                                      0  
 Increased                                                                                                  1 
 
b) Location    
 >50% 25-50% 0-25% 0% 
 Interfascicular     
 >50% 25-50% 0-25% 0% 
 Interbundle      
 >50% 25-50% 0-25% 0% 
 Substance      
           
2) Pericellular staining 
a) Pericellular deposition                                                      
 not present                                                                                              0                                                               
 present                                                                                                     1  
 
b) Degree of pericellular deposition  
                                
 >50% 25-50% 0-25% 0% 
     
Table 2.3. Miller’s scoring sheet adapted from Smith, Clegg et al. (2013). 
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1) Glycosaminoglycans distribution and location                                                                                 
a) Overall                                                                                
 normal (absent)                                                             0              
 Increased (focal or generalised)                                 1 
 
b) location  
 >50% 25-50% 0-25% 0% 
 Interfascicular      
 >50% 25-50% 0-25% 0% 
 Interbundle           
 >50% 25-50% 0-25% 0% 
 Substance      
 
2) Cell with ‘chondroid’ change  
a) Cell shape                                                                                  
 No change  (well-spaced, spindle shaped)                            0 
 Oval to rounding of nuclei (halos around them)                  1 
 
b) Location of stain with cells  
 Around the cells  
  
 
>50% 25-50% 0-25% 0% 
    
Table 2.4. Alcian-blue-PAS scoring sheet. 
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2.6 TISSUE IMMUNOSTAINING  
 
2.6.1 Immunohistochemistry for collagens and proteoglycans staining  
For collagen type I, III. VI, asporin, decorin, biglycan, keratocan, agreccan, and versican 
immunostaining (Table 2.5) sequential sections of 4 μm from paraffin-embedded samples 
(Table 2.1: Samples A-C) were deparaffinised and rehydrated in two washes of xylene, 100% 
and 95% ethanol solution for 10 minutes and in two washes of ultrapure water for 5 
minutes.   
Endogenous peroxidase activity was blocked by incubating the tissue sections with 3% H2O2 
for 10 minutes. After endogenous peroxidase block, the slides were washed two times for 5 
minutes in water and then in Tris buffered saline (TBS) for an additional 5 minutes. Sections 
for decorin, biglycan, asporin, keratocan and versican immunostaining were pre-digested 
with chondroitinase ABC (Sigma) (0.5 U/ml) in 100 mM Tris-HCL pH 7.2-7.4 for 30 minutes at 
room temperature followed by two washes of 5 minutes in TBS.  
Each section was subsequently blocked with 200 µl of 10% normal goat serum (PCN500, 
Invitrogen, CA, USA) for 1 hour at room temperature to prevent non-specific antibody 
binding. The solution was replaced with 100µl of primary antibody diluted in TBS (Table 2.5). 
The slides were incubated overnight at 4°C. After incubation, the sections were washed for 
three times for 5 minutes in TBS and incubated with appropriate of secondary antibody for 1 
hour at room temperature.  For the primary antibodies that were raised in rabbit, 100µl of 
Zytochem Plus HRP polymer goat antirabbit was used as secondary antibody (ZUC032), 
Zytomed system, DE). For the primary antibodies that were raised in mouse, 100µl goat 
antimouse was used (A0545, Sigma-Aldrich, UK) as secondary antibody.  
Following incubation with secondary antibody, the slides were washed three times in TBS 
before adding 400µl of 3,3- diaminonemzidine  (Sigmafast DAB, Sigma Aldrich, UK) for 1 
minute. The slides were immersed in ultrapure water for 5 minutes, counterstained with 
Mayer's Haemalum for 1 minute and washed in tap water. The sections were then 
dehydrated and mounted with D.P.X.  
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As control, non-immune polyclonal rabbit or mouse IgG (isotope control) (Abcam, 
Cambridge, UK) and buffer were used instead of the primary antibodies.  
Every collagen and proteoglycan antibody has been validated using western blot analysis.  
All immunohistological sections were examined using a Nikon eclipse 80i microscope and 
images were acquired with a Nikon DS-L2 standalone control unit. 
 
2.6.2 Immunofluorescence for elastic fibre staining 
Elastic fibre immunostaining were assessed using sections stained with elastin, fibrillin 1 and 
fibrillin 2 antibodies (Table 2.5), previously described by  Smith et al. (2011). (Table 2.1, 
Samples A-C). Elastin was dual stained with fibrillin 1 or fibrillin 2 together (Table 2.5).  
Longitudinal sections (5 µm) of OCT-embedded samples were cut on a cryostat (Leica CM 
1900), adhered to poly-L-lysine slide (polysine, VWR, UK), allowed to dry and stored at -20°C 
until required.  
Tissue sections were fixed for 20 minutes in 100% methanol at -20°C and then rinsed three 
times for 5 minutes in PBS. This was followed by an overnight incubation at room 
temperature with hyaluronidase (4800 IU/ml in PBS, H3884) solution containing a protease 
inhibitor cocktail (complete mini, Roche). Sections were rinsed three times for 5 minutes 
with PBS, and then blocked with 200 µl of 10% normal goat serum (PCN5000, Invitrogen, CA, 
USA) in PBS for 1 hour at room temperature.  After blocking the goat serum was drained off 
and the tissue sections were incubated overnight at 4°C with 100 µl of primary elastin 
antibody diluted in PBS. The sections were washed three times for 5 minutes in PBS and 
followed by a second overnight incubation at 4°C with 100µl of fibrillin 1 or 2 antibody. 
Slides were rinsed in three times in PBS for 5 minutes, followed by secondary antibody 
incubation (100ul) (antimouse IgG or antirabbit IgG) for 1 hour at room temperature and 
rinsed in PBS.  
After washing, all section were incubated with DAPI (1:1000 diluted in PBS) (Invitrogen, USA) 
for 5 minutes at room temperature, rinsed with PBS and mounted with mounting media (H-
1400, Vector Laboratories, UK).  
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Negative controls were included with rabbit and mouse Isotope IgG and normal serum in 
place of primary antibody.  Elastin and fibrillin antibodies have previously been validated in 
canine connective tissue (Smith et al. 2011). 
Sections were examined with confocal microscope (Nikon Ti Eclipse) and images were 
captured with Nikon EZ-C1 free viewer (version 3.90, Nikon corporation).  
Primary antibody Manufacturer  Secondary antibody  
Collagen I (1:100) Abcam (ab292) ZytoChemPlus (HRP) Polymer anti-Rabbit 
(ZUC032) 
Collagen III (1:100) Abcam (ab7778) ZytoChemPlus (HRP) Polymer anti-Rabbit 
(ZUC032) 
Collagen VI (1:100) Abcam (ab6588) ZytoChemPlus (HRP) Polymer anti-Rabbit 
(ZUC032) 
Asporin (1:100) Abcam (ab58741) ZytoChemPlus (HRP) Polymer anti-Rabbit 
(ZUC032) 
Decorin (70.6) (1:50) Donated by B.Caterson/ C 
Hughes (Cardif university) 
Anti-Mouse IgG  (1:50)  (A4416, Sigma, UK) 
Biglycan (PR8A4) 
(1:50) 
Donated by 
B.Caterson/C.Hughes 
Anti-Mouse IgG  (1:50) (A4416, Sigma, UK) 
Keratocan (KER-1) 
(1:50) 
Donated by B.Caterson/ C. 
Hughes 
Anti-Mouse IgG  (1:50) (A4416, Sigma, UK) 
Agreccan (7D1) (1:50) Donated by B.Caterson/C. 
Hughes 
Anti-Mouse IgG  (1:50) (A4416, Sigma, UK) 
Versican (1:100) Hybridoma (12C5) Anti-Mouse IgG  (1:50) (A4416, Sigma, UK) 
Elastin  (1:100) Abcam (ab9519) Anti-Mouse IgG  (1:500) (A11001, 
Invitrogen, USA) 
Fibrillin 1 (1:50) Donated by B. Mecham 
(Washington University) 
Anti-Rabbit IgG (1:500) ( A11011, 
Invitrogen, USA) 
Fibrillin 2 (1:50) Donated by Tim Ritty (Penn 
State University) 
Anti-Rabbit IgG (1:500) ( A11011, 
Invitrogen, USA) 
Table 2.5. Primary and secondary antibodies used in tissue immunostaining for detection 
ECM macromolecules. 
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2.7 TRANSMISSION ELECTRON MICROSCOPY 
Transmission electron microscopy (TEM) of LDET and CCL constructs (Table 2.1: Samples F-
H) was performed by Marion Pope in the School of Veterinary Science, Division of Veterinary 
Pathology. In brief, constructs were fixed in 2.5% glutaraldehyde in 0.1M sodium cacodylate 
buffer for about 8 hours. After three times washing, this was followed by a secondary 
fixation and contrast stain with 1% osmium tetroxide for 90 minutes. Samples were stained 
with 8% uranyl acetate in 0.69% maleic acid for 90 minutes, dehydrated in ascending 
ethanol concentrations (50,70, 90,95%) and embedded in epoxy resin. Ultrathin cross-
sections (60-90 nm) were cut with a Reichert- Jung Ultracut on an ultramicrotome using a 
diamond knife. Cut cross sections were then mounted on 200 mesh copper grids and 
stained with ‘Reynold’s Lead citrate’ stain for 4 minutes. Images were viewed in Philips 
EM208S Transmission Electron Microscope at 80kV.   
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2.8 PROTEOMIC ANALYSIS 
2.8.1 Sample preparation 
Both native  LDET, CCL and harvested  tendon and ligament constructs samples (Table 2.1, 
Samples F-J) were first washed with PBS, snap frozen in liquid nitrogen and stored at -80°C 
until required. Prior to protein extraction all samples were freeze dried overnight and dry 
weight was measured.   
 
2.8.2 Protein extraction  
All lyophilised samples were disrupted using a micro-Dismembrator U (B.Braun Biotech. 
International, Germany). 200 µl of chondroitinase buffer (100 mM Trisacetate, mini 
protease inhibitor cocktail with EDA (Roche, UK ) containing 1 unit/ml chondroitinase ABC 
(C2905-10 UN , Sigma-Aldrich, St Louise, MO) was added to approximately 3 mg of 
dismembranated lyophilised tissue. Samples were then placed in hybridizer roller tube at 
37°C and incubated for 6 hours. After chondroitinase treatment, samples were centrifuged 
at 15000 rpm for 15 minutes and media was removed. 500 µl of GnHCL extraction buffer (4 
M guanidine HCL, 50 mM sodium acetate, 65 mM DTT with mini protease inhibitor cocktail 
tablet) was added to the media removed from the samples and incubated for 48 hours at 
4°C on a shaker. The samples were then centrifuged at 15000 rpm at 4°C for 15 minutes and 
the soluble fraction removed. Both the soluble and insoluble fractions were stored at -20°C. 
The soluble fraction was used for in-solution trypsin digestion and analysed by liquid 
chromatography tandem mass spectrometry (LC-MS/MS) (see Section 2.8.5), but prior to 
that protein concentration was measured and an  aliquot of each sample run on a 4-12% 
Tris-Bris SDS-PAGE gel (section 2.8.4).   
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2.8.3 Protein concentration  
The protein concentration of the samples was measured with the PierceTM 660nm protein 
assay (Thermo scientific, Hertfordshire, UK.). Samples were diluted with water and 50µl of 
each sample was added to a 96-well plate with 150 µl of the protein assay reagent. The 
plate was shaken for 1 minutes and left to incubate at room temperature for 5 minutes. 
Absorbance was measured on a plate reader at 650 nm (Mulltiskan EX, Therma). 
Concentration are calculated by comparison to a standard curve (Figure 2.6) prepared using 
BSA (0-2 mg/ml).  
 
 
 
 
Figure 2.6. Typical standard curve for PIERCETM protein assay.  Final concentrations of BSA 
(50 µl) ranging from (0-2 µg/ml) were measured in a 96-well-plate with 150 µl of protein 
assay reagent. Absorbance was read on a spectrophotometer at an absorbance of 650nm. 
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2.8.4 SDS-PAGE and Silver stain 
A 50µl (~50 µg) aliquot of the GnHCL soluble fraction was precipitated overnight with 100% 
cold ethanol, centrifuged for 15 minutes at 1200 rpm speed at 4°C and washed with 90% 
cold ethanol. Samples were re-centrifuged for 15 minutes at maximum speed at 4°C. The 
ethanol was discarded and the pellet air dried for 3 hours. The air dried pellet was then 
resuspended in 20 µl of 7 M Urea, 2 M Thiourea, 4% Chap and 3 mM Tris at pH 8. Once 
mixed, 10 µl of 2x SDS loading buffer containing 8% mercaptoethanol was added to the 
samples.  
 
2.8.5 In-solution tryptic digestion and LC-MS/MS 
The soluble 4M GnHCL extracted proteins were send to the University of Liverpool Centre 
for Proteome Research facility. In-solution tryptic digestion was performed by one of the 
technical team, Dr Deborah Simpson, who also ran the samples on liquid chromatography 
tandem mass spectrometry.  
For tryptic digestion, the samples were 8-fold diluted to 0.5 M with 100 mM ammonium 
bicarbonate (AMBIC) and normalised to the sample that had lowest protein concentration. 
This gave about 18.5 µg of protein from each sample which were diluted to a volume of 
160uL with AMBIC. Each protein sample was supplemented with digestion enhancer; 10 µl 
Rapigest for 10 minutes at 80°C (Waters, Manchester, UK). Protein samples were reduced 
and alkylated with DTT (10 µl of 9.2 mg/ml at 60°C for 10minutes) and then IAA added (10 µl 
of 33mg/ml for 30min in the dark room temperature). Trypsin (10 µl) was added and 
incubated overnight at 37°C and inactivated with 0.5% trifluoroacetic acid for 30 minutes. A 
desalting procedure (Zip-tip) on trypsin digested samples was performed.  About ~93 ng 
protein per each sample was loaded on liquid chromatography and mass spectrometry.  
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2.8.6 Liquid chromatography and tandem mass spectrometry  
Liquid chromatography separation All peptide separations were carried out using an 
Ultimate 3000 nano system (Dionex/Thermo Fisher Scientific). For each analysis the sample 
was loaded onto a trap column (Acclaim PepMap 100, 2 cm x 75 µm inner diameter, C18, 3 
µm, 100Å) at 5 µL/min with an aqueous solution containing 0.1% (v/v) TFA and 2%(v/v) 
acetonitrile. After 3 min, the trap column was set in-line with an analytical column (Easy-
Spray PepMap® RSLC 15cm x 75 µm inner diameter, C18, 2 µm, 100Å) (Dionex). Peptide 
elution was performed by applying a mixture of solvents A and B. Solvent A was HPLC grade 
water with 0.1%(v/v) formic acid, and solvent B was HPLC grade acetonitrile 80%(v/v) with 
0.1%(v/v) formic acid. Separations were performed by applying a linear gradient of 3.8% to 
50% solvent B over 30 minutes at 300 nL/min followed by a washing step (5 minutes at 99% 
solvent B) and an equilibration step (10 minutes at 3.8% solvent B).  
 
Q Exactive set-up- The Q Exactive instrument was operated in data dependent positive 
(ESI+) mode to automatically switch between full scan MS and MS/MS acquisition. Survey 
full scan MS spectra (m/z 300-2000) were acquired in the Orbitrap with 70,000 resolution 
(m/z 200) after accumulation of ions to 1x106 target value based on predictive automatic 
gain control (AGC) values from the previous full scan. Dynamic exclusion was set to 20s. The 
10 most intense multiply charged ions (z ≥ 2) were sequentially isolated and fragmented in 
the octopole collision cell by higher energy collisional dissociation (HCD) with a fixed 
injection time of 100ms and 35,000 resolution. Typical mass spectrometric conditions were 
as follows: spray voltage, 1.9kV, no sheath or auxillary gas flow; heated capillary 
temperature, 250C; normalised HCD collision energy 30%. The MS/MS ion selection 
threshold was set to 1 x 104 counts and a 2 m/z isolation width was set. 
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2.8.7 Proteomic data analysis  
Proteomic data was analysed for protein identification, label-free quantification, and post 
translation modifications. PEAKS® software (Version 6, Bioinformatics Solutions, Waterloo, 
Canada) and Progenesis™ LC-MS software (Nonlinear dynamics) were used for data analysis.  
Raw MS/MS data were imported into PEAKS® where the peptides and proteins were 
identified. PEAKS®searches were performed against the canine taxonomy in which protein 
sequence database was imported from ensemble 
(http://www.ensembl.org/info/data/ftp/index.html). Details of PEAKS® search parameters, 
filter parameter and classification of protein categories is described in Chapter 6 (Section 
6.3.5a).  
For label free quantitative analysis PEAKS® data search results were imported into 
Progenesis™ LC-MS software, where statistical significant differentially abundant proteins 
were identified between group comparisons (Chapter 6, section 6.3.5c).  
Post-translational modifications were assessed using the PEAKS® PTM finder algorithm 
(Chapter 6, Section 6.3.5c). 
 
2.9 GENERAL STATISTICAL ANALYSIS 
Statistical analysis was performed on biochemical assays data and histology scoring results.  
A one-way of analysis of variance (ANOVA) with Bonferroni post-hoc test was performed 
using Graphpad Prism (version 6, GraphPad Software, La Jolla California, USA). A Univariate 
analysis was also performed using SPSS (IBM SPSS Statistics, Version 20.0, and Chicago). The 
significance level was set at p<0.05 and exact p-values are presented for all data sets as 
appropriate. 
For proteomic label free quantification data sets, one-way ANOVA was performed by 
Progenesis™ LC-MS software. Identified proteins were regarded as significant, with adjusted 
p-value to false discovery (FDR) rate to be <0.05, at greater than 2 fold change and when 
two or more peptides were identified. 
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3 CHAPTER 3 
A BIOCHEMICAL COMPARISON OF THE EXTRACELLULAR MATRIX 
COMPOSITION OF TENDONS AND LIGAMENTS AROUND THE CANINE 
STIFLE JOINT 
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3.1 INTRODUCTION 
The macromolecular extracellular matrix composition of tendons and ligaments are similar, 
however the precise matrix components, cellular morphology and arrangement and 
mechanical properties are specialised for the efficient functioning of each tissue type and 
for tissues within each type e.g. SDFT vs CDET tissue (Rumian et al. 2007, Mienaltowski and 
Birk 2014). In general both tissues consist of cells and extracellular matrix (ECM), where 
ECM has been reported to contain collagens (70-80% of dry weight) and non-collagenous 
proteins including glycoproteins, proteoglycans and elastin. The water content of tendons 
and ligaments ranges from 55 to 70% and a substantial part of this is associated with 
proteoglycans in the ECM (Benjamin and Ralphs 1997, Frank 2004, Kjaer 2004, Rumian et al. 
2007). 
The composition of tendon and ligaments is related to their specific function and 
mechanical properties  (Mienaltowski and Birk 2014). Composition and cellular 
arrangements alters with different tendon and ligament types, locations and regions 
(Mienaltowski and Birk 2014). This has been shown between different tendons and 
ligaments in rabbit (Amiel et al. 1984) and sheep (Rumian et al. 2007), where altered 
proportions of molecular components and a different collagen organisational structure was 
found between tendons and ligaments  (Rumian et al. 2007). Specialised tendon types such 
as the energy storing SDFT and positional CDET have also been shown to have structural and 
compositional differences, which relate to differing function of these tendons (Birch 2007, 
Birch et al. 2008, Franchi et al. 2009, Thorpe et al. 2010, Thorpe et al. 2012). While 
ligaments at different locations around the knee joint such as the inter-articular anterior 
cruciate ligament (ACL) and extra-articular medial collateral ligament (MCL) have been 
reported to have different collagen content (Fujii et al. 1994), ultrastructural morphometry 
(Hart et al. 1992) and cellular morphology (Newton et al. 1990). Other ligaments with 
discrete biomechanical properties including the ACL, the ligamentum teres of the hip (LT), 
and the iliofemoral ligament (IL) have been found to have differences in collagen type I, 
elastin, fibromodulin and biglycan expression indicating molecular heterogeneity between 
anatomically distinct ligaments with differing biomechanical demands (Lorda-Diez et al. 
2013). Regional variation of tendons and ligaments can occur as a result of changes in 
mechanical loading, where regions under mechanical compression can exhibit increased 
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fibrocartilaginous matrix composition (Benjamin and Ralphs 1998). Alterations in 
hydroxyproline and collagen crosslinks, at different locations (femoral and tibial insertions 
and the midsubstance) within the ligaments and a tendon of the human knee (Hanada et al. 
2014) have been reported. Vogel et al. (1993) demonstrated different cell morphology and 
increased glycosaminoglycan (GAG) content in human posterior tibialis tendon at the 
compressed regions where it is subjected to more compressive forces. This phenomenon 
has also been identified in tendons of other species such as the dog (Okuda et al. 1987), cow 
(Koob and Vogel 1987) and rabbit (Daniel and Mills 1988). Heterogeneity in cell morphology 
at different regions in canine cranial cruciate ligament (CCL) has also been reported, 
indicating the adaptation of ligament to mechanical or physiological environment and 
reflects variation in stresses and strains (Smith et al. 2012).  
The CCL is comparable to human ACL (Arnoczky 1983) and is prone to cranial cruciate 
ligament disease (CCLD), where degenerative changes occur and result in altered 
extracellular matrix (ECM) and cellular metabolism, eventually leading to a non-contact 
injury (Comerford et al. 2011). This situation is closely analogous to that in man where non-
contact ACL rupture has been reported (Serpell et al. 2012). Risk factors such as age, 
hormonal influence and exercise have been reported for both human and dogs with non-
contact ACL injury (Comerford et al. 2011, Serpell et al. 2012). An additional risk factor in 
dogs for non-contact injury is the genetic or breed predisposition, where non-diseased CCLs 
from dogs at high risk dogs to CCLD (Labradors retriever) have an increased ECM 
degeneration and collagen turnover compared to low risk dog breeds (Greyhounds) 
(Comerford et al. 2005). Ultrastructural differences with increased collagen fibril diameters 
and a fibrocartilaginous appearance of the ligaments were identified in low risk dogs, 
reflecting the higher maturation levels of collagen at the slower turnover rate and greater 
adaptability to mechanical loading (Comerford et al. 2006).  
The distribution of ECM macromolecules have previously been identified in CCL (Smith et al. 
2013), however it remains unknown whether canine ligaments and tendons with different 
functions around the canine stifle joint have similar or different compositions. Increased 
knowledge of the normal composition of these structures will aid in our understanding of 
the pathology of these tissues with regard to function related injury and in the future 
development of tendon and ligament tissue-engineered structures.  
 
 
68 
 
3.2 HYPOTHESIS & AIM 
The hypothesis in this study was that canine inter-and extra- articular ligaments and flexor 
and extensor tendons have a different cellular and biochemical composition. The aim was to 
use the dog as the animal model for investigation and comparison of different tendons and 
ligaments, due to its comparable nature to man and because of the species predisposition 
to ligament disease and rupture. Normal (non-diseased) tendons and ligaments tissues were 
used from a breed with moderate risk (Staffordshire bull terrier cross) to CCLD (Whitehair et 
al. 1993). The objective was to measure the biochemical ECM composition of ligaments and 
tendons with regard to location (extra- and intra-articular), function (extensor and flexor) 
and region (origin, middle, insertion). 
Our aim was to use the dog as our animal model for investigation and comparison of 
different tendons and ligaments, due to its comparable nature to man and because of the 
species predisposition to ligament disease and rupture. Normal (non-diseased) tendons and 
ligaments tissues were used from a breed with moderate risk (Staffordshire bull terrier 
cross) to CCLD (Whitehair et al. 1993). The objective was to measure the biochemical ECM 
composition of ligaments and tendons with regard to location (extra- and intra-articular), 
function (extensor and flexor) and region (origin, middle, insertion). 
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3.3 EXPERIMENTAL PROCEDURE 
The methods described below are those pertinent to this chapter. More general detail is 
described in Chapter 2; General Material and Methods.   
 
3.3.1 Tissue extraction and preparation  
Cranial cruciate ligament (CCL), medial collateral ligament (MCL), long digital extensor 
tendon (LDET) and superficial extensor tendon (SDFT) were harvested from five paired 
disease free cadaveric canine hindlimbs from Staffordshire bull terrier cross dogs on the day 
of euthanasia. All harvested tissues (Chapter 2, table 2.2) were sectioned into proximal, 
middle and distal sections. Sections that were previously snap frozen and stored -80°C were 
used for biochemical analysis. Two of the animals were female and three were male. All 
animals were skeletally mature,age ranging between 2-5 years old and body score between 
2 and 3. 
 
3.3.2 Water content 
The water content was calculated as described in Chapter 2, Section 2.4.1. The water 
content was calculated and expressed as % of wet weight.  
 
3.3.3 Biochemical analysis  
Biochemical analysis was performed on lyophilised tendon and ligament tissues from the 
different regions, relevant to Chapter 2, Section 2.4. 
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3.3.4 Cellular content 
3.3.4.1 dsDNA content  
Total dsDNA content was measured using the Quant-iTTM Picogreen ® dsDNA reagent and kit  
(Singer et al. 1997), relevant to Chapter 2, section 2.4.4.1). DNA concentrations were 
determined by comparing to a standard curve using bacteriophage lambda DNA standards 
and expressed as µg per mg dry weight tissue. 
 
3.3.5 Extracellular matrix composition 
3.3.5.1 Collagen content  
Total collagen content was indirectly determined by measuring the imino acid, 
hydroxyproline (Bergman and Loxley 1963), as described in Chapter 2, Section 2.4.5.2. The 
hydroxyproline concentrations were calculated by comparison against hydroxyproline 
standard curve and collagen content was  calculated assuming hydroxyproline to be present 
at 14% (Rumian et al. 2007). 
 
3.3.5.2 Elastin content  
and elastin content was measured on pooled oxalic acid digested extracts using Fastin dye-
binding assay (Biocolor) (Chapter 2, Section, 2.5.3). Elastin concentrations were determined 
by comparing against the alpha-elastin generated standard curve were expressed as a 
percentage of dry weight (Smith et al. 2013). 
 
3.3.5.3  sGAG content 
Total sulphated glycosaminoglycan (sGAG) concentrations were measured using  the 
dimethylene blue (DMMB) dye binding assay (Farndale et al. 1986), relevant to Chapter 2, 
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Section 2.4.5.1. sGAG concentrations  were measured against shark chondroitin sulphate 
and were expressed as µg per mg dry weight tissue. 
 
3.3.6 Statistical analysis  
Data are presented as means + standard error of the mean. For comparison between the 
different locations statistical analysis using One-way ANOVA with Bonferroni post-hoc test 
was performed using Graphpad Prism (version 6). The significant differences between 
tissues was statistically analysed with SPSS (version 20) using a Univariate analysis with 
Bonferroni post-hoc test. For both analyses the significance level was set at p<0.05. 
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3.4 RESULTS 
3.4.1 Water content  
The average water content was 60.7% + 0.7 in CCL, 57% + 1.4 in MCL, 56.8% + 0.9 LDET and 
58.9% + 0.6 in SDFT (Table 3.1). No statistically significant differences were found in water 
content between proximal, middle and distal regions or between different tissues (Figure 
3.1).  
 
 
 
Figure 3.1. Box plot summaries of CCL, MCL, LDET and SDFT (n=5 paired) water content (%). 
No statistically significant differences were between the different locations or between 
tissues.   
  
 
 
73 
 
3.4.2 DNA content  
The mean dsDNA content was 2.9 + 0.3 µg per mg dry weight tissue in CCL, 5.2 + 0.8 µg/ mg in 
MCL, 3.8 + 0.3 µg/ mg in LDET and 3 + 0.3 µg/ mg in SDFT (Table 3.1). Between the proximal, 
middle and distal regions of tissues no statistically significant difference was found. 
Significantly greater DNA content was found in the MCL compared to CCL (p=0.012) and 
SDFT (p=0.017) (Figure 3.2).  
 
Figure 3.2. DNA content (µg DNA/ mg dry weight) of the proximal, middle and distal regions 
of CCL, MCL, LDET and SDFT. n = 5 paired. Values are mean and error bars represent SEM.  
DNA content was significantly higher in MCL in comparison to CCL (p=0.012) and SDFT 
(p=0.017). No statistically significant differences were found between different locations. * 
indicates p=<0.05.  
 
  
 
 
* 
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3.4.3 Collagen content  
The average collagen as a percentage of dry weight was 65.6% + 1.8 in CCL, 70.4% + 2.6 in 
MCL, 71.2% + 1.4 in LDET and 50.8% + 1.2 in SDFT (Table 3.1). There were no statistically 
significant differences in collagen content between the proximal, middle and distal location 
in each tissue. However, the SDFT had statistically significantly less collagen compared to 
CCL (p=0.0001), MCL (p=0.0001) and LDET (p=0.0001) (Figure 3.3).  
 
 
Figure 3.3. Total collagen content (% /mg dry weight) of proximal, middle and distal regions of CCL, 
MCL, LDET and SDFT. n = 5 paired. Values are mean and error bars represent SEM. No variation was 
found between locations, but SDFT was significantly lower (p=0.0001) than ACL, MCL and LDET. * 
indicates p=<0.05.  
 
  
 
 * 
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3.4.4 Elastin content  
Elastin content (percentage of dry weight) was 4.6 % + 0.3 in CCL, 1.9 + 0.2 in MCL, 2.4 + 0.2 
in LDET and 2.9 + 0.2 in SDFT (Table 3.1). There was no statistically significant variation 
between proximal, middle and distal regions with the tissues. CCL contained significantly 
higher elastin content when compared to MCL (p=0.0001), LDET (p=0.0001) and SDFT 
(p=0.0001) (Figure 3.4).  
 
 
 
Figure 3.4. Elastin content (% /mg dry weight) of the proximal middle, distal regions of CCL, 
MCL, LDET and SDFT. n= 5 paired. Values are mean and error bars represent SEM. No 
variation was found between the different locations within tissues, but CCL was significantly 
higher than MCL (p=0.0001), LDET (p=0.0001) and SDFT (p=0.0001). * indicates p=<0.05. 
  
* 
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3.4.5 sGAG content 
The median sGAG content as µg/mg dry weight was 15.5 + 1.1 in CCL, 9.9 + 0.7 in MCL, 8.3 + 
0.7 in LDET and 11.1 + 0.8 in SDFT. There was no statistically significant difference found 
between proximal, middle and distal locations. CCL had statistically greater sGAG content 
compared to MCL (p=0.0001), LDET (p=0.0001) and SDFT (p=0.01) (Figure 3.5). 
 
 
 
Figure 3.5. sGAG content (µg sGAG/ mg dry weight) of the proximal, middle and distal 
regions of CCL, MCL, LDET and SDFT. n = 5 paired. Values are mean and error bars represent 
SEM. No significant variation was found between proximal, middle and distal locations 
within tissues, but CCL was significantly higher than MCL, LDET and SDFT. * indicates 
p=<0.05. 
 
* 
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Table 3.1. Water content and tissue concentration of DNA, collagen, elastin and sGAG of CCL, MCL, LDET and SDFT at proximal, middle and 
distal regions. Values are mean (n = 5 paired) + SEM. 
 
 Water  
(% per wet weight) 
dsDNA 
(µg/ mg dry weight) 
Collagen  
(%/mg dry weight) 
Elastin  
(%/mg dry weight) 
sGAG 
(µg/ mg dry weight) 
ACL proximal  61.1 + 1.2 2.6 + 0.3 67.1 + 2.5 5.1 + 0.4 15.1 + 2.2 
ACL middle  59.5 + 1.4 2.6 + 0.4 68.1 + 2.9 4.5 + 0.6 15.7 + 1.1 
ACL distal 61.7 + 1.4 3.6 + 0.7 61.9 + 3.8 4.3 + 0.7 15.7 + 1.9 
MCL proximal  58.1 + 2.1 3.6 + 0.9 70.3 + 3.3 1.8 + 0.3 10.1 + 1.2 
MCL middle  57.1 + 2.9 6.7 + 1.5 76.6 + 3.2 1.5 + 0.2 11.1 + 1.7 
MCL distal  55.9 ± 2.6 5.4 + 1.6 64.4 + 5.9 2.2 + 0.6 8.4 + 0.7 
LDET proximal 60.3 ± 1.2 2.8 + 0.6 71.5 + 1.8 2.4 + 0.4 10.2 + 1.3 
LDET middle  55.9 ± 1.6 4.6 + 0.3 72.5 + 2.4 2.5 + 0.4 8.1 + 1.1 
LDET distal  54.3 ± 1.6 3.9 + 0.9 69.5 + 2.8 2.3 + 0.5 6.6 + 1.2 
SDFT proximal 58.1 ±1.2 3.5 + 0. 7 49.5 + 1.6 2.5 + 0.3 10.4 + 1.3 
SDFT middle   59.2 ± 0.5 2.8 + 0.5 54.1 + 1.9 2.8 + 0.4 11.9 + 1.5 
SDFT distal  59.3 ± 1.2 2.7 + 0.5 48.8  + 2.5 3.3 + 0.3 10.7 + 1.2 
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3.5 DISCUSSION 
Determination of the content of ECM macromolecules between different functional tendons 
and ligaments will aid in finding tissue specific characteristics, which is vital for 
understanding the pathology of these tissues and for future development of regeneration 
and reparative strategies. In this study we have demonstrated a different ECM composition 
between inter- and extra-articular ligament and tendon, but no variation was identified at 
different regions in each tissue. CCL had significantly greater GAG and elastin content 
compared to the MCL, LDET and SDFT.  Significantly higher DNA content was measured in 
MCL, while SDFT had the lowest collagen content. The higher sGAG content in CCL in our 
study corresponds with previous comparison of the knee joint ligaments and tendons in 
sheep (Rumian et al. 2007) and rabbit (Amiel et al. 1984), where intra-articular ligaments 
had greater sGAG measurement than tendons and the extra-articular ligaments. Together 
the increased sGAG and elastin content in CCL may be due to a greater requirement for 
viscoelastic properties and elastic recoil mechanisms in CCL.  
 In this study, DNA concentration was measured to assess the tissue cellularity. Generally 
tendons and ligaments have relatively few cells and have been documented as hypo-cellular 
structures (Lo et al. 2002, Yin et al. 2010) with the vast majority of tendon and ligament cells 
being tenocytes and ligamentocytes, respectively (Hoffmann and Gross 2007). Cells in 
tendons communicate by intercellular communication sites known as gap junctions, 
necessary for strain-induced collagen synthesis (McNeilly et al. 1996). This finding has also 
been reported in meniscus, intervertebral disc (Bruehlmann et al. 2002) and in the ovine 
ACL and MCL (Lo et al. 2002). In this study a greater DNA content in MCL indicated a higher 
cellularity in MCL in comparison to CCL and SDFT. Although no correlation has been found 
between high cell content and intercellular communication, this result might indicate a 
better cell-cell communication in the MCL. This result supports a previous study, which 
demonstrated that human MCL contained higher cell numbers compared to ACL (Yoshida 
and Fujii 1999). The same group identified different cellular properties including slower 
growth rates and a lower response to growth factors in the ACL compared to the MCL 
(Yoshida and Fujii 1999). A comparison study of the human ACL and MCL stem cells 
demonstrated differential properties, with ACL stem cells exhibiting a lower capacity of 
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colony formation, slower proliferation and shorter period of self-renewal capability (Zhang 
et al. 2011). Together, these cellular differences between MCL and ACL may be indicative of 
a different healing capacity between the two tissue types.   
Collagens provide major tensile strength and are the abundant proteins in tendons and 
ligaments by contributing to 70-80% of their dry weight (Provenzano and Vanderby 2006, 
Mienaltowski and Birk 2014). In general both tendons and ligaments have been reported to 
contain collagen types I, II, III, V, VI and XI, XIV (Frank 2004, Franchi et al. 2007, 
Mienaltowski and Birk 2014). By measuring the hydroxyproline content, of which 14% is 
present in collagen (Bergman and Loxley 1963), total collagen can be quantified. The 
collagen content in canine CCL, MCL, LDET were not significantly different and ranged 
between 65-71% of dry weight tissues. Canine SDFT on the other had significantly less 
collagen (p=0.0001) compared to the other three tissues, representing 50.8% of the dry 
weight of the tissue. This finding does not correspond with a study comparing ovine tendons 
(patellar, LDET and SDFT) and ligaments (cruciate ligaments, MCL and LCL) (Rumian et al. 
2007), and may be explained by the species differences. The ovine SDFT had a collagen 
content of 78.8% of the dry weight and cruciate ligament contained 55-58% collagen per dry 
weight (Rumian et al. 2007). A similar concentration of collagen in equine SDFT (75.8% of 
dry weight) has been reported, while the positional CDET has been documented to contain a 
significantly higher collagen content (80.4%) than the energy storing SDFT (Thorpe 2010). 
The different collagen content between the energy storing SDFT and positional LDET in this 
study is similar to that found in the horse energy storing SDFT and positional CDET (Thorpe 
2010). The finding might indicate that the canine LDET is stiffer than SDFT, however the 
ultimate tensile strength of each of these tendons has yet to be determined.  
Elastic fibres are present in elastic connective tissues such as aorta and large arteries, skin, 
lung, and ligaments (Kielty 2006). A network of elastic fibres in the ECM of these tissues 
gives a required resilience that is needed for recoil after transient stretch (Alberts et al. 
2002). Other reported functions of elastic fibres include imparting mechanical properties 
(Butler et al. 1978, Eriksen et al. 2001) and cell-regulatory functions (Ito et al. 1997, Wendel 
et al. 2000). The presence of elastic fibres has been demonstrated in canine cruciate 
ligament (Smith et al. 2011) and in bovine tendon (Grant et al. 2013). A general estimate of 
elastin in human tendon is 1-2% of the total dry weight tissue (Kannus 2000), but in the 
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human ligament it can range from 5%, in the ACL (Dodds and Arnoczky 1994), 7.3% in the 
posterior longitudinal ligament (Nakagawa et al. 1994) and 1.7% in the intervertebral disc 
(Mikawa et al. 1986). The measurement of elastin content in the present study was similar 
to that (Fastin assay) previously used in canine cruciate ligament (Smith et al. 2013), but also 
has been measured in a number of other tissues and species (Isayama et al. 2014, Latimer et 
al. 2014). This method measures all of the elastin including elastin precursor and degraded 
elastin peptides in the tissue. The previous study in canine cruciate ligament indicated an 
average elastin content of 9.87% (Smith et al. 2013), which is higher than the measured 
elastin content of 4.64%  in this study. This may be as result of the different used dog breed 
or exercise background of the animals as compared to the greyhounds dogs from a racing 
background used by Smith et al. (2013). Although we did not have any information about 
dogs’ exercise history, the elastin content in the CCL was found to be similar to the 
estimated reported human ACL elastin content. Further work is required to identify whether 
exercise plays an important factor role and is associated with the increase of elastin 
content. The higher elastin content in CCL compared to the other three tissues may be due 
to greater requirement for a stretch and recoil mechanism of this tissue(Rumian et al. 2007).   
Proteoglycans consist of a core protein with one or more covalently attached GAGs, where 
the function of different proteoglycans is determined by structure of the protein core and 
GAG chains (Parkinson et al. 2011). In tendon and ligament, proteoglycans are reported to 
comprise about 1% of dry weight tissue, were they are likely to contribute to the 
biomechanical and structural properties of the tissues (Frank 2004, Yoon and Halper 2005, 
Halper 2014). Proteoglycans play a role in collagen fibrillogenesis and the organisation of 
collagen fibrils (Zhang et al. 2005, Franchi et al. 2007). They also interact with collagen fibres 
to yield viscoelastic properties (Rees et al. 2000, Woo et al. 2006, Franchi et al. 2007) in 
tendon and/or ligament.  In the present study, the total sGAG content was measured to 
estimate the proteoglycan content of each tissue. The CCL resulted in 15.48 µg /mg (0.15%) 
dry weight of sGAG content, which was significantly more than the MCL, LDET and SDFT. 
This value was slightly higher than the sGAG content previously measured in greyhound CCL 
(0.081%/dry weight) (Smith et al. 2013), which may be again as a result of breed differences. 
These results support previous findings in a ligament and tendons comparison study in 
sheep (Rumian et al. 2007) and rabbit  (Amiel et al. 1984), where higher GAG content was 
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found in cruciate ligaments compared to extra-articular collateral ligaments and several 
tendons. The greater proteoglycans in CCL may allow for more slippage between collagen 
fibrils and fibres, allowing a greater degree of deformation (Rumian et al. 2007). This altered 
viscoelastic property of CCL may signify an additional “shock absorbing” feature of this 
tissue.  Together, the greater elastin and proteoglycan content in CCL may be important 
contributors to mechanical specialisation of the CCL.  
Studies have shown variances of morphology and composition at different regions of 
ligaments and tendons (Vogel et al. 1993, Benjamin and Ralphs 1998, Waggett et al. 1998, 
Vogel and Peters 2005). The most proximal region of the human ACL contains round and 
ovoid cells, whereas the middle region contains more spindle shaped cells with higher 
collagen density and distal part is mainly rich in chondroblasts and ovoid fibroblasts (Duthon 
et al. 2006). The human ACL interface at the femoral origin and tibial insertion sites has 
been found to differ in collagen fibre orientation and has more sulphated GAGs and 
different collagen types such type II and X (Wang et al. 2006). A similar variation in cell 
morphology, collagen fibre arrangement and GAG content also been reported in at the 
different regions of human posterior tibialis tendon (Vogel et al. 1993). In human Achilles 
mid-tendon and insertion, Waggett et al. (1998) found more mRNA expression of collagen 
type II and aggrecan in the fibrocartilaginous regions and more versican in the midsubstance 
(Waggett et al. 1998). This was supported by a more recent study, where it was 
demonstrated that the distal region of rabbit Achilles tendon, which was closer to the bone 
had a more fibrocartiliginous tissue phenotype, with increased aggrecan expression 
(Huisman et al. 2014). In the present study, no statistically significant variation was found in 
ECM macromolecules at different regions of ligaments and tendons. This might indicate that 
there is no difference between compressed and tensile regions in canine ligaments and 
tendons or it could be that these differences cannot be detected when measuring the total 
content of main ECM macromolecules.  
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3.6 CONCLUSION 
The results of this study demonstrated no significant differences between proximal, middle 
and distal regions of inter- and extra-articular ligament, and flexor and extensor tendons 
around the canine stifle joint. However, a significantly higher sGAG and elastin content in 
canine CCL was measured in comparison to MCL, LDET and SDFT, which may indicate that  
there is more of a stretch and recoil mechanism and a greater degree of deformation 
required in the inter-articular CCL (Rumian et al. 2007). These findings may be as result of 
specific tissue physiology, location and adaptation to mechanical loading.  
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4 CHAPTER 4 
THE MORPHOLOGICAL AND STRUCTURAL DIFFERENCES AND 
EXTRACELLULAR MACROMOLECULES DISTRIBUTION BETWEEN TENDONS 
AND LIGAMENTS AROUND THE CANINE STIFLE JOINT  
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4.1 INTRODUCTION  
The collagen-rich composition of ligament and tendon is arranged in a hierarchical structure, 
where collagen molecules are grouped together in a highly ordered fashion, forming fibrils, 
fibres and fascicles (Kastelic et al. 1978, Clark and Sidles 1990, Thorpe et al. 2012). A group 
of collagen fibres are referred to as bundles, divided by interbundle (IB) regions, and 
bundles are grouped together as fascicles, separated by a surrounding loose connective 
tissue septa referred to as endotenon in tendon and endoligament in ligament or known as 
the interfascicular matrix (IFM) (Clark and Sidles 1990, Smith et al. 2012). The IFM has been 
suggested to have a specialised structure that plays a role in facilitating sliding between 
fascicles within tendon (Thorpe et al. 2012).   
Collagens fibrils confer the principal tensile strength to mammalian connective tissues and 
define the shape and form of tissues in which they occur (Canty and Kadler 2005). Tendons 
and ligaments mainly consists of type I collagen, but other collagens types including II, III, 
V,VI, IX and XI are also present (Frank 2004, Benjamin et al. 2008).   
Besides collagens, tendon and ligaments contain other non-collagenous extracellular matrix 
(ECM) components such as proteoglycans and elastic fibres (Benjamin and Ralphs 1997, 
Frank 2004, Kjaer 2004, Thorpe et al. 2013).  Proteoglycans (PGs) in tendons and ligament 
are primarily responsible for their viscoelastic behaviour (Benjamin and Ralphs 1997, 
Benjamin et al. 2008). They are composed of a protein core with one or more covalently 
attached glycosaminoglycans (GAG) side chains (Yoon and Halper 2005). In the tendon the 
majority of PGs are small leucine proteoglycans (SLRPS) with smaller amount of large 
aggregating PGs such as aggrecan and versican (Yoon and Halper 2005, Parkinson et al. 
2011). Decorin is the most common SLRP in tendon, where it constitutes 80% of the overall 
proteoglycan content (Samiric et al. 2004). Other SLRPS found in tendon include biglycan, 
lumican, fibromodulin and keratocan (Rees et al. 2009). In the ligament, decorin is also the 
major constituent of proteoglycans, with the remainder also including biglycan, aggrecan 
and versican (Ilic et al. 2005). Furthermore, in the canine cruciate ligament the presence of 
other SLRPS including lumican, fibromodulin, prolargin and osteoglycin has been 
demonstrated (Yang et al. 2012).  
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Elastic fibres are composed of an elastin core covered with sheath of fibrillin-rich 
microfibrils, which acts as a scaffold on which the secreted elastin molecules are deposited 
(Kielty et al. 2002, Kielty 2006). Elastic fibres are considered to have a structural role in 
tendon and ligament, where the distribution in canine cruciate ligament (Smith et al. 2011) 
and bovine flexor tendon (Grant et al. 2013) has been demonstrated.  
As mentioned previously in Chapter 1 (Section 1.10), a  different ECM composition between 
tendon and ligament has been demonstrated in rabbit (Amiel et al. 1984) and in sheep 
(Rumian et al. 2007). In this study, similar findings have already been observed between 
canine tendons and ligaments around the stifle (knee) joint, where the canine cruciate 
ligament (CCL) contained elevated proteoglycans (based on sGAG measurement) and elastin 
content (Chapter 3).  
To date there are little data regarding the distinct structural and morphological 
characteristics of different ligaments and tendons around the knee stifle joint in human/ 
dog and how they are related to the ligament and tendon functional role. Furthermore, the 
distribution and localisation of ECM macromolecules in the ligament and tendon in man and 
human has been not fully explored. These data will provide essential information on the 
fundamental structure of tendon and ligament tissues leading to increased understanding of 
the function relationship between these tissues types and will underpin future tissue 
engineering and regeneration strategies.   
 
 
4.2 HYPOTHESIS AND AIMS 
In this study, the canine intra-articular cranial cruciate ligament (CCL) has already been 
shown to have a different ECM composition when compared to the extra- articular medial 
collateral ligament (MCL), the positional long digital extensor tendon (LDET) and the energy 
storing superficial digital flexor tendon (SDFT) (Chapter 3). This finding might indicate how 
each tissue type functions in a distinct manner. However, the morphological differences and 
arrangement of ECM macromolecules between tendons and ligaments around the knee 
stifle joint has yet to be fully investigated. 
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In this study it was hypothesised that: 
1. Canine CCL has a diverse structural property, with a greater abundance of 
proteoglycan and elastic fibres in comparison to MCL, LDET and SDFT.  
2. Canine tendon and ligament have a different distribution in ECM collagens, 
proteoglycans and elastic fibres molecules and that there will be more proteoglycans 
and elastic fibres present at the IFM in ligament than tendon. 
The aim was to use tendons and ligaments around the canine stifle joint, due to the 
comparable nature of the dog’s stifle joint to the human knee joint (Cook et al. 2010). The 
canine stifle is an interesting model as it is predisposed to non-contact CCL injury 
(Comerford et al. 2011), which is analogous to the reported human ACL non-contact injuries 
(Serpell et al. 2012). Furthermore, there is a breed variation in ligament disease and rupture 
(Whitehair et al. 1993). In this study normal non- diseased tendons and ligaments were 
obtained from a breed with moderate risk (Staffordshire bull terrier cross) to cranial cruciate 
ligament disease (see Chapter 3). 
The objectives in this study were 
1. To identify the differential structural characteristics of ligaments (CCL and MCL) and 
tendons (flexor and extensor) at the different regions (proximal, middle, and distal) 
through semi-objective histological scoring analysis. 
2. To determine tendon-ligament differences in the distribution and organisation of 
collagens, proteoglycans and elastic fibre proteins using immunostaining 
techniques.   
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4.3 EXPERIMENTAL PROCEDURES  
The procedures written below are an outline of the performed experiments.  More detail of 
the materials and methods of this section are described in Chapter 2.  
 
4.3.1 Sample collection, tissue extraction and preparation  
Harvested cranial cruciate ligament (CCL), medial collateral ligament (MCL), long digital 
extensor tendon (LDET), and superficial digital flexor tendon (SDFT) tissues (n=5 paired) 
(Table 2.1) were sectioned into proximal, middle and distal sections. Divided sections were 
fixed in 4% paraformaldehyde or embedded in OCT. Two of the animals were female and 
three were male.  All animals were skeletally mature, age ranging between 2-5 years old and 
body score between 2-3. 
 
4.3.2 Determination of morphological differences based on histology staining  
4.3.2.1 Tissue preparation and histology staining 
Fixed tissues in 4% paraformaldehyde were paraffin embedded and cut into 4µm sections. 
Sections were stained with haematoxylin and eosin (H&E) for general observation of tissue, 
Alcian blue/PAS (AB-PAS) for detection of GAGs (Bancroft et al. 1996) and Miller’s stain for 
elastic fibres (Miller 1971).  
 
4.3.2.2 Objective measurements of histological parameters 
A three part scoring system was used to assess the cells and extracellular matrix of the 
tissues (Chapter 2, Table 2.1, 2.2 and 2.3). The scoring system used for H&E staining was 
modified from Stoll et al. (2011) and for Miller’s elastic stain from Smith (2010). Scoring of 
AB-PAS staining was developed in house, based on that of Smith (2010). All sections were 
read by two observers blinded to the section location and tissue type on two separate 
occasions at least two weeks apart.  
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4.3.3 Distribution of ECM macromolecules using immunostaining  
Distributions of the main ECM components were assessed on the mid-substance of CCL and 
LDET (n=3) using immunohistochemistry and immunofluorescence staining for different 
collagen types, proteoglycans and elastic fibres. The antibodies used were reactive against 
collagen type I, III, VI, aggrecan, versican, decorin, biglycan, keratocan and asporin, elastin, 
fibrillin 1 and fibrillin 2 (Chapter 2, Table 2.5 for manufacturer, concentration and secondary 
antibodies used). All antibodies (apart from elastin, fibrillin 1 and fibrillin 2) were assessed 
using immunohistochemistry methodology as described previously (Chapter 2, section 
2.6.1), using 4µm paraffin embedded sections. Frozen sections of 5 µm were used for 
immunostaining of elastin, fibrillin 1 and fibrillin 2 (Chapter 2, section 2.6.2). The distribution 
and arrangement of the selected collagens and proteoglycans were visualised with a Nikon 
DS-L2 standalone control unit, while elastic fibres were assessed with the confocal 
microscope ((Nikon Ti Eclipse). 
 
4.3.4 Statistical analysis  
Hematoxillin and eosin histological scoring were individually assessed for each parameter 
and presented as an average % score. For AB-PAS and Miller’s analysis the scores were 
accumulated together and the total score was presented with means ± standard error of the 
mean. Each histological parameter was assessed for statistical significance and integrity of 
agreement. Statistical analysis included comparison between the different locations 
(proximal, middle, distal) and between different tissue types (intra- and extra-articular 
tendon and ligament). Normal distribution for each data set was assessed with Graphpad 
Prism (Version 6) using Kolmogorov-Smirnov test.  
For comparison between the different locations statistical analysis using one-way ANOVA 
with Bonferroni post-hoc test was performed using Graphpad Prism. The significant 
differences between tissues was statistically analysed with SPSS (Version 20) using a 
univariate analysis with a Bonferroni post-hoc test. For both analyses the significance level 
was set at p<0.05. The integrity of agreement was calculated for intra- and inter-observer 
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concordance between and within both observers respectively using the Kendall’s coefficient 
of concordance for each histological parameter.  
 
4.4 RESULTS 
4.4.1 Morphological characteristics of intra- and extra-articular tendons and ligaments  
4.4.1.1 Histology H&E staining  
ECM organisation - The general architecture of collagen fibres bundles of both ACL and MCL 
ligament was less tightly packed than both LDET and SDFT tissue (Figure 4.1A and 4.1B). In 
both the LDET and SDFT tendon the collagen fibres were more dense and compact with 
parallel collagen fibres (Figures 4.2A and 4.2B,). The IF region in CCL appeared to be thicker 
than in the LDET and SDFT, where the IF region appeared narrower and the cells in this 
region were closer to each other (Figure 4.2B). Histological scoring of ECM architecture 
resulted in no statistically significant differences between different regions of either 
ligaments or tendons. However, CCL was significantly different in its architecture compared 
to LDET (p=0.0001) and SDFT (p=0.036), where a more wavy, compact and parallel aligned 
collagen architecture was observed on both the tendons (Figure 4.3A). This difference was 
also observed when MCL, was compared with LDET (p=0.0001)(Figure 4.3A).  
Cell shape - In general, heterogeneous cell nuclei phenotype was seen in all tissue samples 
with a mixed population of rounded and spindle cell nuclei morphologies. It was notable 
however that there were more rounded and elliptical cell nuclei in the CCL in comparison to 
the other three tissues (Figure 4.1A). The MCL, LDET and SDFT substance cell nuclei were 
more spindle-shaped and also more elongated in the LDET and SDFT (Figure 4.1B, 4.2A and 
B). This observation was found to be statistically significant between LDET and ACL 
(p=0.003), with the ACL having a more mixed cell shape population (Figure 4.3B). No 
statistically significant difference was found between different locations within both 
tendons and ligaments.  
Cellular distribution - Assessment of cellular distribution in the different tendons and 
ligaments were considered normal if cells were not focally increased. This increased cell 
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density was often seen at the IF regions in both tendons and ligaments, with cells showing a 
variation in length and orientation located at this region (4.1B and 4.2A and B). Statistical 
analysis of cellular distribution showed no significant differences either between different 
regions or between the tissues (p>0.05) (Figure 4.3C).  
Cell alignment - Alignment of cells was assessed based on orientation of cells along the 
collagen fibre bundles. In tendons, in particular the LDET, the cells were mostly uniaxial and 
parallel to collagen fibres bundles (Figure 4.2A). This finding was seen less frequently in 
ligaments; the MCL and ACL cells were at times found to be more irregularly aligned (Figure 
4.1A and 4.1B). Histological scoring of cell alignment demonstrated statistically significant 
differences in LDET than MCL (p=0.034), indicating a more uniaxial alignment of cells in LDET 
(Figure 4.3D). No statistical significant differences in cell alignment were found between 
different regions in both tendons and ligaments tissues.  
Vascularisation - Blood vessels were observed in both intra- and extra-articular tendons and 
ligaments, however they were mainly found in the tendons, localised in the IF regions 
(Figure 4.2B). Histological scoring results demonstrated significantly more blood vessels in 
SDFT compared to ACL (p=0.0001), MCL (p=0.001) and LDET (p=0.0001) (Figure 4.3E).  No 
statistically significant differences were found at the different regions in tendons and 
ligaments with regard to their vascularisation.  
Inflammation - The presence of Inflammation in the tissues was assessed based on the 
presence of infiltrates of cells, such as neutrophils, lymphocytes and macrophages. These 
cells were occasionally present in the epitenon of tendons and surrounding blood vessels in 
the interfasicular regions in tendon or ligament. Statistical analysis of histological 
inflammation score resulted in significantly more infiltrate cells in SDFT compared to ACL 
(p=0.0001), MCL (p=0.0001) and LDET (p=0.032). No statistically significant differences were 
found between the different locations in both intra- and extra-articular tendon and ligament 
tissues (Figure 4.3F).  
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Figure 4.1. Representative images of histological staining of the mid-region of CCL and MCL. H&E staining of 
CCL (A) and MCL (D). (Bar 100µm, 10X and 40X magnifications). Ligaments were found to have less tightly 
packed collagen fibre bundles. This was observed more in CCL, where IF regions seemed more spacious (black 
arrow in A) and fascicles had less compact collagen fibres (orange arrow in A). Heterogeneous cell morphology 
was found in both CCL and MCL, but cell nuclei morphology was primarily more rounded and more elliptical 
shaped in CCL (white arrow in A), while MCL cell nuclei were more spindle shaped (white arrows in D and E). 
Alcian blue-PAS staining of CCL (B) and MCL (E). (Bar 100µm, 40x magnification). Glycosaminoglycans were 
mainly present at IF and at interbundle regions (black arrows in B and E). Increased staining of GAGs in CCL was 
observed with pericellular staining (white arrow B). Miller’s staining of CCL (C) and MCL (F). (Bar 100µm, 40X 
magnifications). Elastic fibres were located mainly in IF and interbundle regions (black arrows in C and F) and 
orientated parallel aligned on collagen fibres (white arrows in C and F). 
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Figure 4.2. Representative images of histological staining of the mid-region of LDET and SDFT. H&E staining of 
LDET (A) and SDFT (D). (Bar 100µm, 10X and 40X magnifications). Both tendons appeared wavy and with 
generally compact collagen fibres architecture (black arrow in A and D).  Heterogeneous cell nuclei 
morphology were present in LDET and SDFT, where cells in the IF regions were more rounded and seemed to 
be increased in number (white arrow in D).  Cell nuclei morphology in the IF region was mainly spindle shaped 
in both tendons, but in LDET it also seemed more elongated (white arrow in A). Blood vessels were primarily 
seen in SDFT at IF regions (orange arrow in D). Alcian blue-PAS staining of LDET (B) and SDFT (E). (Bar 100 µm, 
40x magnification). GAGs were mainly present in IF and at IB regions (black arrows in B and E). No pericellular 
GAG staining was identified in tendons. Miller’s staining of LDET (C) and SDFT (F). (Bar 100µm, 40X 
magnifications).  The presence of elastic fibres was identified in LDET and SDFT located in IF and IB regions 
(white arrow in F) and parallel aligned on collagen fibres (black arrows in F). 
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Figure 4.3. Histology scoring results of ECM organisation, cell shape, cell distribution, cell alignment, vascularisation and inflammation.  (A) ECM 
organisation: Both ACL and MCL collagen fibre architecture was less dense compared to tendons. *p<0.05 vs ACL, • p<0.05 vs MCL. (B) Cell shape:  A 
more heterogeneous mix cell shape population was seen in ACL compared to LDET, which had more spindle shaped cell nuclei. *p<0.05 vs ACL.  (C) Cell 
distribution was not significantly different. (D) Cell alignment: LDET cells were significantly more uniaxial aligned along the collagen fibres compared to 
MCL, • p<0.05 vs MCL (E) Vascularisation: SDFT was statistically more vascularised compared to the other three tissues. *p<0.05 vs ACL, • p<0.05 vs 
MCL, +p<0.05 vs LDET. (F) Inflammation: SDFT had statistically more infiltrating inflammatory cells compared to the other three tissues. *p<0.05 vs 
ACL, • p<0.05 vs MCL, +p<0.05 vs LDET. 
+ 
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4.4.1.2 Histological staining for glycosaminoglycans 
Glycosaminoglycans (GAGs) were distributed mainly in IF and IB regions in both tendon and 
ligaments.  In the CCL, GAGs seemed to have a mesh-like structure with increased staining 
subjectively noted at IF/IB regions and surrounding the cells (Figure 4.1C). Compared with 
the CCL, in the MCL (Figure 4.1D) the LDET (Figure 4.2C) and SDFT (Figure 4.2D) less staining 
for GAGs were was seen in the IF and occasionally in IB region, with no staining for GAGs 
surroundings the cells. Statistical analysis of the histological scoring for differential GAG 
staining between ligaments and tendons, resulted in statistically higher AB-PAS score in the 
CCL than MCL (p=0.0001), LDET (p=0.0001) and SDFT (p=0.001)(Figure 4.4).  
 
 
Figure 4.4. Alcian blue-PAS score for CCL, MCL, LDET and SDFT. Increased staining was noted 
in CCL which was statistically significant compared to MCL (p=0.0001), LDET (p=0.0001) and 
SDFT (p=0.001). No statistically significant differences were found between the different 
regions. Values are average of accumulated score, error bars represent SEM. *p<0.05 
 
* 
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4.4.1.3  Histological staining for elastic fibres  
Subjectively histological staining showed more elastic fibres in CCL compared to the other 
three tissues. Elastic fibres were mainly located between fascicles and fibre bundles, but 
were also found aligned parallel to the collagen fibres and pericellularly (Figure 4.2F). 
Further description of the arrangement of the elastin and microfibrillar glycoproteins 
fibrillin-1 and fibrillin 2 within the tendon and ligament tissues is described in Section 4.5.2. 
Histological scoring demonstrated statistically more elastic fibres in CCL compared to MCL 
(p=0.0001), LDET (p=0.0001) and SDFT (p=0.0001) (Figure 4.5).  
 
 
Figure 4.5. Miller’s stain score for CCL, MCL, LDET and SDFT. More elastic fibres were 
identified in CCL compared to the other three tissues.  Statistical analysis showed 
significantly more elastin fibres in CCL than MCL (p=0.0001), LDET (p=0.0001) and SDFT 
(p=0.0001). No statistically significant differences were found between the different regions. 
Values average of the accumulated score and error bars represents SEM. *p<0.05 
 
* 
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4.4.1.4 Inter- and intra-observer agreement Histology scoring system 
The integrity of agreement for both intra and inter-observer for each histology scoring 
parameter was assessed using Kendal coefficient of concordance analysis (Table 4.1). A 
Kendal coefficient values ranges from 0 to 1 with values closer to 1 suggestion a high degree 
of agreement.  
 
 
 Intra-observer 
variation 
Inter-observer 
variation  
Observers  Ob1  Ob2 Ob1 and Ob2 
ECM 
organisation 
 
 
ACL 0.72 0.57 0.79 
MCL  0.7 0.83 0.83 
LDET 0.89 0.65 0.85 
SDFT  0.68 0.59 0.64 
Cell 
morphology  
 
 
ACL 0.65 0.66 0.77 
MCL  0.81 0.86 0.88 
LDET 0.71 0.54 0.72 
SDFT  0.62 0.74 0.79 
Cell 
distribution  
 
 
ACL 0.82 0.66 0.8 
MCL  0.67 0.62 0.78 
LDET 0.78 0.56 0.79 
SDFT  0.58 0.45 0.54 
 
Cell alignment  
 
 
ACL 0.71 0.43 0.74 
MCL  0.78 0.73 0.89 
LDET  0.81 0.61 0.74 
SDFT 0.65 0.63 0.8 
 
Vascularity 
 
 
ACL 0.92 0.57 0.79 
MCL  0.65 0.49 0.77 
LDET  0.91 0.73 0.9 
SDFT 0.76 0.72 0.67 
Inflammation  
 
 
ACL 0.63 0.61 0.61 
MCL  0.64 0.58 0.77 
LDET  0.79 0.87 0.79 
SDFT 0.67 0.53 0.7 
Table 4.1. H&E scoring Kendall’s coefficient of concordance results. 
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 Intra-observer 
variation 
Inter-observer 
variation  
Observers  Ob1 Ob2 Ob1 and Ob2 
Alcian blue-PAS 
score  
 
ACL 0.55 0.59 0.69 
MCL  0.58 0.63 0.66 
LDET  0.64 0.61 0.65 
SDFT 0.62 0.69 0.84 
Millers score   
 
 
ACL 0.68 0.61 0.69 
MCL  0.62 0.69 0.58 
LDET  0.71 0.73 0.83 
SDFT 0.76 0.65 0.82 
Table 4.2. Kendall’s coefficients of concordance for Alcian blue-PAS and Miller’s histology 
score.  
 
Kendall’s coefficient concordance gave an average 0.71 and 0.64 for ob1 and ob2 intra-
observer variation, while inter-observer variation an average value of 0.75 was measured. 
These indicated a good strength agreement between intra- and inter- observers.  
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4.4.2 Distribution of ECM macromolecules in CCL and LDET 
4.4.2.1 Negative controls  
Negative controls were included for every antibody immunostaining. Primary 
antibodies were raised either in rabbit or mouse.  No immunostaining were detected 
with negative controls of non-specific rabbit and mouse IgG or in the absence of 
primary antibodies (Figure 4.6)  
 
4.4.2.2 Collagens  
 Collagen type I immunostaining was intense in both CCL and LDET and had a similar 
pattern distribution in both CCL and LDET. Although the most marked 
immunostaining of collagen type I was present in fascicular regions and was aligned 
along the fibres, the presence of collagen type I was also found between collagen 
fibre bundles in both CCL and LDET (Figure 4.7A and 4.7B).  
 
 Collagen type III was mainly present in IF and IB regions of LDET, whilst in CCL 
collagen type III was more widespread and was found to be present in CCL 
substance, between collagen fascicles and fibre bundles (Figure 4.7C and 4.7D).  
 
 Collagen type VI was mainly presented at the IF regions in both CCL and LDET (Figure 
4.8A and 4.8B). Collagen type VI was found in close association with both CCL and 
LDET cells being localised at the pericellular regions of CCL and LDET, where they 
formed a dense mesh around groups of cells (Figure 4.8B and 4.8D).  
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Figure 4.6. Representative immunostaining pictures of negative controls. Bar 100µm and 40X magnifications. No immunostaining was detected 
in the absence of primary antibody with addition of secondary goat antirabbit (A), secondary goat antimouse (B), rabbit IgG (C) and mouse IgG 
(D). 
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Figure 4.7. Immunostaining of collagen I and III.  Microscopic longitudinal sections of canine CCL (A and B) and LDET (C and D). (Bar 100µm and 40X 
magnifications). Collagen type I immunostaining was mainly present in the aligned fibres (black arrows in A and C).  Collagen type III 
immunostaining of CCL was present at both fascicular regions (black arrow in B) and between IF regions (white arrow in B), while in LDET collagen 
type III was primarily found at IF regions (black arrow in D).  
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Figure 4.8. Immunostaining of collagen type VI. Microscopic longitudinal sections of canine CCL (A, B) and LDET (C,D). (Bar 100µm and 40X 
magnifications). Immunohistochemical localisation of type VI collagen.  A marked immunostaining of type collagen VI was present at the IF regions 
(black arrows in A and B). Collagen VI was also localised in close proximity to tendon and ligament cells (B and D).  
C 
D 
A B 
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4.4.2.3 Proteoglycans 
Large aggregating proteoglycans  
 Aggrecan was mostly found at the interfascicular and interbundle regions of CCL and 
LDET. Marked immunostaining of aggreccan was observed in at IF regions of CCL 
compared to LDET. Aggrecan was highly localised around ligamentocytes (Figure 
4.9A and 4.9B). This pericellular immunostaining of aggrecan was not observed in 
tendon and could be a key feature characteristic of ligament cells. 
 
 Versican was found to be distributed between collagen fascicles and collagen fibre 
bundles in both CCL and LDET (Figure 4.8C and 4.8D). A noticeable immunostaining 
of versican was noted in CCL in comparison to LDET. Versican was not present on the 
aligned fibres throughout tendon and ligament tissue and was not found to be 
localised around ligament and tendon cells (Figure 4.9C and 4.9D).  
Small leucine rich proteoglycans  
  Decorin demonstrated marked immunostaining in both CCL and LDET and was 
present on the aligned collagen fibres at both fascicular and IF/IB regions (Figure 
4.10A and 4.10B). 
 
 Biglycan was present at the IF region of LDET with a minor immunoreactivity and no 
pericellular staining. However in the CCL biglycan was only found occasionally 
surrounding rounded cells (Figure 4.10C and 4.10D).   
 
 Keratocan was only observed in the IF regions of both CCL and LDET although there 
was noticeable more immunoreactivity in the LDET (4.11A and 4.11B).  
 
 Asporin immunostaining in LDET was in the IF region and surrounding tenocytes. In 
the CCL, whilst asporin immunostaining was localised to the pericellular region 
around most of ligament cells, no IF staining of asporin was found (Figure 4.11C and 
4.11D).
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Figure 4.9. Immunostaining of aggrecan and versican. Microscopic longitudinal sections of canine CCL (A, C) and LDET (B,D). (Bar 100µm. 10X 
and 40X magnifications). Aggrecan was mainly present between collagen fascicles and fibre bundles in both CCL and LDET (black arrow in A and 
B), though this was noticeably higher in CCL. Immunostaining of aggrecan was also noted surrounding ligament cells (white arrows in A). 
Similar to aggrecan, a marked immunostaining of versican was found at IF and IB regions of CCL and LDET (black arrow in C and D), though 
greater immunostaining was observed in CCL in comparison LDET. No pericellular staining of versican was observed in either CCL or LDET. 
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Figure 4.10. Immunostaining of decorin and biglycan.  Microscopic longitudinal sections of canine CCL (A, B) and LDET (C, D). (Bar 100µm. 40X 
magnifications). Decorin immunostaining was present on the aligned collagen fibres (black arrows in A and C) and at the IF regions in both CCL 
and LDET (white arrow in A). Minor immunostaining of biglycan was detected in both tissues, where biglycan was only occasionally present 
pericellularly in CCL (black arrow B) and at the IF region in LDET (black arrow D).  
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Figure 4.11. Immunostaining of keratocan and asporin. Microscopic longitudinal sections of canine CCL (A, B) and LDET (C, D). (Bar 100µm. 40X 
magnifications). Keratocan was present at the IF regions in both CCL and LDET (black arrows in A and C). Asporin immunostaining was found at 
the IF region (white arrow in D) in LDET and surrounding tenocytes (black arrow in D). In CCL, asporin was only present pericellularly (black 
arrow in B 
A B 
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4.4.2.4 Elastic fibres  
 Fibrillin 1 and fibrillin 2  
Fibrillin 1 localised to the interfascicular region, running longitudinally along the CCL and 
LDET in parallel alignment to collagen fibres and was highly localised around ligament and 
tendon cells. Stronger immunofluorescence was observed at interfascicular regions in both 
CCL and LDET, where the fibres formed a fine irregular meshwork (Figure 4.12A and C). The 
pattern of fibrillin 2 distribution was similar to fibrillin 1. Fibrillin 2 was broadly orientated 
parallel to collagen bundles with pericellular staining in both CCL and LDET.  Fibrillin 2 
immunostaining was also found to be more marked between fibres bundles and fascicles 
(Figure 4.12 B and D). No difference in the distribution of fibrillin 1 and fibrillin 2 was 
observed between CCL and LDET. Fibrillin 1 and 2 were unaffected following hyaluronidase 
enzymatic treatment.  
 
 Elastin fibres and co-localisation with fibrillin 1 and fibrillin 2 
Elastin fibres were sparse in comparison to the fibrillin 1 and fibrillin 2. Immuno-detection of 
elastin fibres was enhanced following treatment with hyaluronidase. In both CCL and LDET 
elastin fibres were found to be predominantly present at the interfascicular or interbundle 
regions and arranged in a fine, twisting meshwork either parallel or perpendicular to the 
long-axis of the tissue (Figure 4.13, white arrows in elastin images). All elastin fibres at this 
region were co-localised with either fibrillin 1 and 2 in both CCL and LDET (Figure 4.13 white 
arrows in elastin + fibrillin 1 images).  Elastin fibres were also found at CCL and LDET 
substance where they were mostly oriented parallel to collagen bundles (Figure 4.13 orange 
arrows in elastin images). At this region elastin fibres were commonly co-localised with both 
fibrillin 1 and fibrillin 2, where they were in close conjunction to the cells (Figure 4.13 
orange arrows elastin + fibrillin 1 and 2 images). In LDET it was occasionally noted that 
fibrillin 1 and 2 were independent, as elastin was occasionally not found to co-localise with 
fibrillin 1 and 2 (Figure 4.13 blue arrows in elastin+ fibrillin 1 and 2 images). 
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Figure 4.12. Immunostaining of fibrillin 1 (A, B) and fibrillin 2 (C, D). Microscopic longitudinal 
sections of canine CCL (A, C) and LDET (B,D).  (Bar 50µm. 40X and 60X magnifications). 
Fibrillin 1 and fibrillin 2 (red) were found to be localised between collagen fascicles and 
bundles (orange arrows in A, B and D) with a parallel alignment to the long-axis of the tissue 
mainly surrounding the ligament and tendon cells (nuclei in blue) (white arrows in A, B, C 
and D).   
  
 
 
 
 
Fibrillin 1 Fibrillin 1 
Fibrillin 2 Fibrillin 2 
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Figure 4.13. Immunostaining of elastic fibres with fibrillin 1 and 2. Microscopic longitudinal 
sections of canine CCL (A, B) and LDET (C, D). (Bar 50µm. 40X magnifications). Elastin fibre 
(green) distribution was sparse in comparison to fibrillin 1 and fibrillin 2 (red). In both CCL and 
LDET, elastin fibres were mainly distributed in IF regions and co-localised with fibrillin 1 and 2 at 
this region (white arrows A, B, C and D). Elastin fibres were also found within the CCL and LDET 
fascicles  mostly parrallel aligned and co-localised to fibrillin 1 and 2 (orange arrows and A, B, C, 
D). Occasionally in LDET not all elastin fibres were found to co-localise with  fibrillin 1 and 2 (blue 
arrows in C and D).  
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4.5 DISCUSSION 
This study has demonstrated different morphological characteristics between the ligament 
and tendons that are in and around the canine stifle joint. However no significant regional 
differences within each tissue were found. A differential distribution of several ECM 
proteins between tendon and ligament was observed, which supports the second 
hypothesis, that canine tendon and ligament have distinct distributions of ECM 
macromolecules. Analysis of histological sections of ligaments (MCL and CCL) showed that 
they have a more loosely aligned collagen fibre bundle architecture and different cellular 
alignment compared to LDET. Ligaments such as the CCL were also found to have a more 
mixed population of cell morphologies than LDET. Vascularity was significantly more 
abundant in SDFT than both CCL and MCL. Similarly for inflammation, SDFT was found to 
have the highest number of infiltrative cells present compared to all three tissues. 
Immunostaining of the ECM macromolecules in CCL and LDET demonstrated a diverse 
distribution in collagen type III, aggrecan and asporin between the two tissue types.  A more 
marked intensity of aggrecan and versican staining was observed in CCL.  An altered 
distribution of collagens, proteoglycan and elastic fibres was observed at the fascicular 
regions, interfasicular and pericellular regions between and within tendons and ligaments, 
which may indicates the important role of ECM macromolecules for cellular function, 
regulation of the collagenous components viscoelasticity and elastic recoil mechanism. 
 
4.5.1 Morphological and structural comparison of the different tendons and ligaments  
4.5.2 Histological findings  
ECM organisation- The overall architecture of intra- and extra-articular ligaments and 
extensor and flexor tendons was assessed based on the alignment of collagen fibres and 
spacing between fibre bundles and fascicles. The CCL and MCL had loosely arranged and less 
compact collagen fibres in comparison to LDET. This was more prominent in particular in the 
CCL where more spacing between collagen fibre bundles was observed and was statistically 
significant when compared to both LDET and SDFT. This finding might indicate a more 
complex structure of collagen fibre arrangement with regards to the IFM in CCL.  Zhu et al. 
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(2012) demonstrated with scanning electron microscopy an undulating wave pattern known 
as crimp, in the human ACL, semitendinous and gracilis tendons. In addition, an helical wave 
pattern was also found in the ACL, indicating a more complex arrangement of collagen fibres 
in ACL, where tissue must resist multidirectional or unpredictable loading (Zhu et al. 2012). 
In the dog, both patellar tendon and CCL have been found to have crimp and a helical wave 
pattern of collagen fibres (Yahia and Drouin 1989). Crimp is involved in both 
transferring/absorbing forces and recoiling of tendon and ligaments (Franchi et al. 2009), 
and different crimp patterns may reflect different mechanical role of ligaments (Franchi et 
al. 2010).  Franchi et al. (2009) demonstrated that the energy storing human vastus 
intermedius tendon required greater elastic recoil and therefore has larger crimp angles 
than that of both the positional rectus femoris and patellar tendon. Similar results have 
been found comparing the energy storing equine SDFT and positional CDET (Birch et al. 
2013). In this study the different collagen structural architecture between tendon and 
ligament may be as result of the different axial forces applied in these structures. Forces are 
generally applied in a uniaxial direction in tendon resulting in parallel alignment collagen 
fibrils, whereas in the ligament collagen fibrils are not as uniformly aligned due to a 
multiaxial loading pattern (Amis 1998, Rumian et al. 2007). Further investigation with regard 
to crimp pattern and collagen fibril diameter between canine inter- and extra-articular 
ligament and extensor and flexor tendons in relation to functional and mechanical 
properties of these tissues is required.   
Cellular morphology- Histological analysis showed different cellular morphologies in all 
ligament and tendon tissues throughout the different regions, indicating a heterogeneous 
cellularity among these tissues which is likely to be an adaptation to tissue mechanics or 
physiology (Benjamin and Ralphs 1998). This finding supports the variation in cell 
morphology previously reported in canine cruciate ligament (Smith et al. 2012). The 
majority of tendon and ligament cells are fibroblasts (Benjamin and Ralphs 1997), which are 
referred to as tenocytes in tendon and ligamentocytes in ligament (Hoffmann and Gross 
2007). Apart from tenocytes, progenitor stem cells have been identified in human hamstring 
tendon (Bi et al. 2007) and in human ACL and MCL (Zhang et al. 2011). Furthermore more 
recently it has been shown that in mice Achilles tendon the epitenon and tendon substance 
have different populations of progenitors cells (Mienaltowski et al. 2013), with a unique 
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tenogenic differentiation (Mienaltowski et al. 2014). The presence of heterogeneous cell 
morphology in the ligament and tendons in this study may also be due to the occurrence of 
stem cell or progenitors cells. Though whether these stem cells reside in canine tendons and 
ligaments yet needs to be identified.   
The scoring analysis result for cellular morphology demonstrated more spindle shaped cell 
nuclei in LDET in comparison to CCL which had more rounded and epileptically shaped cell 
nuclei (p=0.003). The spindle shaped cell nuclei morphology of tenoctyes in the canine 
tendons from the current study corresponds with other tendons from different species such 
as the horse (Clegg et al. 2007) and rabbit (Amiel et al. 1984). Similar to the present findings, 
Amiel et al. (1984) also found rabbit ACL contained more round and ovoid cells when 
compared to MCL, patellar and Achilles tendon. Murray et al. (2004) reported a majority of 
fusiform and rounded cell nuclei in normal human ACL which were also  found in the canine 
CCL using histological analysis, indicating similar intrinsic properties of the fibroblasts 
between two species. The rounding and ovoid cell phenotype (chondrocytic) in tendon and 
ligament becomes more prominent where it approaches close to the bone (origin and 
insertion regions) in ligament (Duthon et al. 2006) and at the osteotendinous junction in 
tendon (Docking et al. 2013), and is likely to be as a result of compressive forces. In the 
human ACL a chondrocytic cell phenotype along with GAG accumulation, disorientation of 
collagen fibres and inflammation has been reported to be associated with degeneration and 
ageing (Hasegawa et al. 2012). The human ACL has also been shown to have different 
cellular changes with degeneration and ageing, where a decrease in the total cell number, 
MMP-1, 3 and 13 expression was found in normal ACL ageing but was increased in 
degenerated ACL (Hasegawa et al. 2013). In the canine CCL, a chondrocytic cell phenotype 
has been found in breeds with both a low (greyhound) and high risk (Labradors) of ligament 
rupture (Comerford et al. 2006). The low risk CCLs also had a fibrocartilaginous appearance 
with increased collagen fibril diameters, whereas the high risk breed had marked chondroid 
changes similar to what has been reported in human ACL with ageing and degeneration 
(Hasegawa et al. 2012). In this study, the CCLs were normal (disease free) and from young 
skeletally mature  dogs (less than 5 years of age) at a moderate risk (Staffordshire bull 
terrier cross), to ligament rupture. It was found that the CCL ligamentocytes throughout the 
different regions to have a more epiliptical and round shaped cell nuclei being mostly 
 112 
 
surrounded by GAGs as stained with Alcian blue-PAS. The “chondrocytic” appearance of 
ligamentocyte nuclei in cell chains and lacunae were also noted at the proximal, middle and 
distal regions of CCL. These findings particularly in the low and moderate risk dog breeds to 
ligament rupture may indicate that chondroid change may be a normal finding and a 
physical adaptation of CCL, rather than pathological degeneration. Nonetheless, further 
studies are required to identify cells type ontogeny and the effect of ageing and 
degeneratiion on canine CCL structure and whether this matches to the results reported in 
human ACL ageing and degeneration (Hasegawa et al. 2013).  
Cellular distribution and alignment- In all tissues we found an increased cellular density in 
the interfasicular regions, with cells displaying rounded nuclei morphology with no 
particular orientation at this region. Although there was not any statistically significant 
differences for cellular distribution between different tissues, the CCL cells were more 
clustered and aligned in chains corresponding to the chondrocytic appearance as discussed 
earlier. Alignment of cells was assessed based on orientation of cells along the collagen fibre 
bundles. The tendon cells were more uniaxial and parallel to collagen fibres, while not all 
ligament cells were aligned in the same direction. This finding was statistically significant 
between MCL and LDET, which may be as result of different axial forces applied between 
these tissues.  
Vascularity- Tendons and ligaments generally have a poor blood supply (Benjamin et al. 
2008). Fibrocartilaginous regions of tendon and ligament are avascular, but there is some 
indirect anastomosis between the vessels (Petersen and Tillmann 1999, Fenwick et al. 2002, 
O’Brien 2005, Benjamin et al. 2008). Several tendons including the Achilles tendon, patella 
tendon and supraspinatus tendon appear to have regions of reduced vascularity, where 
avascular zones can be associated with degeneration and rupture (Fenwick et al. 2002). In 
human ACL non-homogenous vascularity and areas of hypovascularity have also been 
reported, which are within the core region of the ACL (Petersen and Tillmann 1999, Duthon 
et al. 2006). This has also been reported in the dog, with the proximal region containing a 
greater number of vessels, although a normal canine CCL is considered to be relatively 
hypovascular (Vasseur et al. 1985, Hayashi et al. 2011). This corresponds to our findings of 
low blood vascularity in non-diseased CCL. Blood vessels, when present, were found to be 
mainly located in the interfascicular regions of the different tendons and ligaments. 
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Histological scoring analysis demonstrated SDFT to be statistically more vascular in 
comparison to LDET, MCL and CCL, indicative of a better blood supply in canine SDFT. 
Inflammation- In this study few inflammatory cells were found to be present in the tendon 
and ligaments examined. Occasionally infiltrating cell, which were primarily mononuclear-
type cells where found at the epitenon and close to blood vessels. This finding was most 
evident in SDFT, which also had the highest number of blood vessels being statistically 
higher in comparison to LDET, MCL and CCL. The role of vascularity and inflammation in 
canine SDFT needs to be further explored with a focus on whether is it associated with 
disease or normal physiology.   
Pathological tendons do not generally show signs of inflammation, however it may play a 
role in early initiation of the disease (Legerlotz et al. 2012). Studies have suggested that 
inflammatory cytokines and mediators may play a role contributing to disease as they have 
also been detected in painful posterior tibialis tendon and Achilles and rotator cuff tendons 
(Nakama et al. 2006, Legerlotz et al. 2012).  
GAGs histological analysis- The accumulation of GAGs have been found to be associated 
with human ACL degeneration (Hasegawa et al. 2012), Achilles tendinopathy (Riley 2008), 
and supraspinatus tendinosis (Riley et al. 1994), although it has been shown to decrease in 
supraspinatus tendon with age (Riley et al. 1994). This has also been found in dog, where 
ruptured CCLs contained significantly higher GAG content when compared to intact CCLs 
from the same breed (Comerford et al. 2004). In the present study, the GAGs were mainly 
found at the IF and IB regions in all tissue, but also pericellularly in CCL. LDET, SDFT and MCL 
displayed relatively little GAG staining in comparison to CCL, which had significantly higher 
scores than the other three tissues (p=0.001). This finding corresponds with the increased 
GAG content found in CCL in comparison to MCL, LDET and SDFT (Chapter 3). Hasegawa et 
al. (2012) found an increased deposition of GAGs in the human ACL with the development of 
cartilage lesions, though no correlation was found between ACL ageing and mucoid 
degeneration, as they indicated that a relatively high percentage of young donors already 
had mucoid degeneration. This might also explain the high GAG content in our CCLs that 
were obtained from young skeletally mature donors. The high GAG content in CCL is most 
likely not as result of pathological degeneration, but is possibly related due to the physical 
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adaption of the tissue to different mechanical loading, which subsequently can lead to 
altered viscoelastic properties.  
Elastic fibres-  Histological staining of elastic fibres has previously been reported in canine 
CCL, demonstrating an increased quantity of staining and elastin content reported in a 
breed (greyhound) which has a low-risk of ligament rupture (Smith et al. 2013). These 
greyhounds were all exercised animals being ex-racing dogs (Smith et al. 2013). Although 
the exact effect of exercise on elastin content in canine cranial cruciate ligament has not 
been determined. A further study of the comparison between dog breeds demonstrated 
much less elastic staining in similarly aged moderate (beagle) and high risk breeds (Labrador 
retriever) (Smith 2010). This finding may be suggestive of a fundamental difference between 
breeds and may be due to the reduced production or increased destruction of elastic fibres 
(Smith 2010). In this study the elastic fibre intensity staining in the CCL was found to be 
similar to the previously described moderate risk breed (beagle) (Smith 2010). In both 
tendons and ligaments tissues elastic fibres were mainly present at the interfascicular and 
interbundle regions, but also found parallel aligned to collagen fibres. Comparison of the 
total Miller’s score between the different tissues found a significantly higher score in the 
CCL than MCL, LDET and SDFT (p=0.001). This finding supports previous biochemical results 
showing a higher elastin content in CCL (Chapter 3) compared to other tendons and 
ligaments. Overall the higher elastin content in the CCL may be due to greater requirement 
for a stretch and recoil mechanism in this tissue.  
Differences between regions- Regional variation of tendons and ligaments can alter as a 
result of changes in mechanical loading, where regions under mechanical stress can exhibit 
an increased fibrocartilaginous matrix composition (Benjamin and Ralphs 1998). The human 
ACL has been reported to have a different cellular morphology and collagen content at the 
proximal, middle and distal regions (Duthon et al. 2006). Ralphs et al. (1998) demonstrated 
altered cellular morphology in rat Achilles tendon at different regions, while Waggett et al. 
(1998) found more mRNA expression of aggrecan and versican in fibrocartilaginous regions 
compare to the mid-substance of the human Achilles tendon. However, no differences were 
found between the regional variances of the levels of matrix constituents in tendons and 
ligaments using either histological analysis or biochemical assays (Chapter 3). One possible 
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explanation could be that during dissection only a fragment of each proximal and distal 
region was analysed which may mask localised differences between the regions.  
 
4.5.3 Distribution and organisation of collagens, proteoglycans and elastic fibres in CCL 
and LDET     
In this study the distribution of the ECM macromolecules were assessed between CCL and 
LDET as representative ligaments and tendons respectively. Both CCL and LDET were 
primarily chosen based on the findings of a different ECM composition in these tissues 
(Chapter 3) and morphological and/or structural differences (as discussed above) in CCL. In 
comparison to CCL, LDET has been found to differ in terms of ECM content, structure and 
cellular morphology. As this positional tendon is also located in intra-articular in canine stifle 
joint it was therefore considered to be more comparable to the CCL. The distribution and 
organisation of ECM macromolecules were assessed on the middle region of the tissues as 
no regional difference were found (Chapter 3 and as discussed above), but also to avoid any 
of the fibrocartilage regions in both tissues.    
Collagens 
Distribution of collagen types I, III and VI- in both tendon and ligament- Collagens type I and 
III have been documented to be the major collagens in both tendon and ligament 
(Mienaltowski and Birk 2014). In the current study type I collagen immunostaining was 
found to be intense and mainly present in the fascicular regions in both LDET and CCL. 
Collagen type III was primarily located along the interfascicular and interbundle regions in 
LDET, similar to that previously reported for normal equine SDFT (Sodersten et al. 2013) and 
human extensor carpi radialis brevis tendon (Duance et al. 1977). In CCL, collagen type III 
displayed increased immunostaining and it was found to be located not only between 
collagen fibre bundles but also aligned on the fibre bundles. This finding agrees with 
previous reports comparing rabbit cruciate ligament with patellar tendon (Amiel et al. 1984) 
and human ACL with patellar tendon (Little et al. 2014). A quantitative study Wan et al. 
(2014) which used picrosirius red staining and tensile testing demonstrated that altered 
collagen type I and III ratio during ligament ageing is correlated with the mechanical 
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properties of ligaments, as the different type I and III ratios were found to be strongly 
related to the Young’s modulus in the linear region of the stress-strain curve. This finding 
may indicate that different distribution of collagen type I and III in CCL and LDET in the 
current study may result in different mechanical behaviour in the two tissue types, yet this 
needs to be further elucidated.  
Collagen type VI has a non-fibrillar organisation and is widely expressed in most tissues, 
including skeletal muscle, tendons and ligaments (Keene et al. 1988). It has been shown that 
collagen type VI interacts with many ECM molecules, including collagen I, II, and XIV, 
microfibril associated glycoprotein (MAGP-1), perlecan, decorin, biglycan, chondroitin 
sulphate, heparin and hyaluronan (Mienaltowski and Birk 2014). In this study collagen type 
VI immunostaining was mainly found between fascicles and bundles, but also localised 
around the CCL and LDET fascicular fibroblasts. No differences in distribution were noted 
between CCL and LDET. Pericellular localisation of collagen type VI in both canine CCL and 
LDET were also found, which supports previous findings in human ACL (Sardone et al. 2014) 
and human supraspinatus tendon (Thakkar et al. 2014). The absence of collagen type VI in 
knockout mice has been shown to result in dysfunctional tendon collagen fibrillogenesis (Izu 
et al. 2011) and points to a critical role of collagen VI in both tendons and ligaments. 
Proteoglycans 
Distribution of large aggregating and small leucine rich proteoglycans- The major 
proteoglycan in tendons and ligament are the small leucine proteoglycan (SLRPS) decorin,  
biglycan, fibromodulin and lumican (Rees et al. 2009, Parkinson et al. 2011, Yang et al. 
2012). To date, other SLRPS are less well characterised, in these tissues. For instance the 
distribution of keratocan has only been determined in bovine digital flexor tendon (Rees et 
al. 2009), while the distribution of asporin has not been previously elucidated in either 
tendon or ligament. Large aggregating proteoglycans aggrecan and versican have also been 
found at the tensional region of bovine deep digital flexor tendon (Rees et al. 2000, Rees et 
al. 2009) and human ACL (Little et al. 2014). In this study the presence and distribution of 
aggrecan, versican, decorin, biglycan, keratocan and asporin was demonstrated with 
immunostaining in both CCL and LDET. An increased immunostaining of both aggrecan and 
versican was found in the midsubstance region of CCL compared to the midsubstance region 
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in LDET. Both aggrecan and versican were localised mainly between fascicular and bundle 
regions, however aggrecan was also found to be pericellularly located only in CCL. Both 
aggrecan and versican are large proteoglycans that bind to hyaluron (Halper 2014). 
Aggrecan is highly glycolysated with numerous chondroitin and keratan sulphate GAG 
chains, which attracts counter-ions and functions to hold water within the tissue, resulting 
in high tissue hydration that renders the tissue resistant to compressive loading (Riley 2005, 
Halper 2014). The structure of versican is similar to aggrecan, but lacks in one of the 
globular domain and contains much less GAGs (CS) (Riley 2005). An increase in versican 
content leads to expansion of ECM and a greater viscoelasticity of pericellular matrix, 
supporting cell-shape changes required for cell proliferation and migration (Halper 2014). In 
the human Achilles tendon, a higher expression of aggrecan has been found at the 
fibrocartilaginous regions where it is more associated with compressive forces, while 
versican mRNA was more expressed in mid-substance regions when compared to the 
insertion region (Waggett et al. 1998). Together the increase of aggrecan and versican 
immunostaining in this study may indicate higher tissue hydration and viscoelastic 
properties of CCL. In addition the increased pericellular location of aggrecan may also 
indicate that the CCL is subjected to more compressive forces throughout the tissue, which 
could be due to its functional adaption to protect the tissue from damage (Riley 2005).  
SLRPs have regulatory roles in collagen fibrillogenesis during tendon development (Zhang et 
al. 2005, Chen and Birk 2013). In the current work a panel of SLRPS that are well described 
(decorin and biglycan) and less described (keratocan and asporin) were analysed. Asporin 
was also examined based on our proteomic finding between CCL and LDET (Chapter 6). 
Decorin acts to modulate collagen fibrillogenesis by binding to collagen fibres (Hedbom and 
Heinegard 1993, Parkinson et al. 2011). It can bind to several or several collagen types 
including type I, II, III, and VI (Halper 2014). In the present study the distribution of decorin 
in both CCL and LDET was found to be similarly intense, as it was found in both fascicular 
and between interfascicular regions, indicative of binding to collagen type I, III and VI. In 
contrast to decorin, biglycan immunostaining was present in LDET interfasicular regions and 
occasionally pericellulary in CCL. This finding supports studies where low mRNA expression 
and immunostaining of biglycan was observed in canine CCL (Yang et al. 2012). Asporin is 
the third member of class I SLRPs that lacks GAGs chains. It competes for type I collagen 
 118 
 
binding with decorin via its leucine rich repeat domain with high affinity (Kalamajski and 
Oldberg 2010). To date asporin has only been identified thorough proteomic analysis in 
human ACL and patellar tendon (Little et al. 2014). Here, asporin was found in the LDET at 
interfascicular regions and pericellularly, whereas in CCL, asporin was only found 
pericellularly. Asporin has been found to bind to calcium and induces collagen 
mineralization (Kalamajski et al. 2009), but is a negative regulator of BMP-2 or TGF-β activity 
and could therefor play a factor in OA progression as well as susceptibility to the disease 
(Ikegawa 2008). In tendon and ligament the mechanism and role of asporin still needs to be 
explored.  Keratocan is a member of the class II family of SLRPS and has been identified at 
both tensional and fibrocartilagenous regions in bovine deep digital flexor tendon (Rees et 
al. 2009). The tendon keratocan is poorly sulphated, in contrast to corneal keratocan, which 
is highly glycosylated possibly reflecting differences in function between these two tissues 
(Rees et al. 2009). Here, low intensity immunostaining of keratocan in both CCL and LDET 
was found, present only between fascicles and fibre bundles. This finding corresponds with 
a similar distribution of keratocan in bovine tendon endotenon (Rees et al. 2009). In 
addition Rees et al. (2009) also demonstrated co-localisation of keratocan with collagen 
type I at the endotenon indicating a role in the regulation of the collagenous components 
within this loose matrix in both tendon and ligament.  
 
Elastin/Elastic fibres 
Distribution of Elastic fibres- Elastic fibres are composed of an elastin core and microfibrils 
(fibrillin 1 and 2) (Mithieux and Weiss 2005). Previous studies have demonstrated the 
distribution of elastin, fibrillin 1, and fibrillin 2 in canine cruciate ligament (Smith et al. 2011) 
and bovine flexor tendon (Grant et al. 2013). Through the use of our histological analysis an 
increase in elastic fibres in CCL using the Miller’s stain was demonstrated (section 4.4.1.2). 
The next aim was to identify the differences in distribution of elastic fibres between CCL and 
LDET using specific antibody staining. In this part of the study, the objective was to 
determine whether tendon and ligament from the same species and breed have a different 
or similar distribution of elastic fibres. Fibrillin 1 and 2 was found to be aligned along the 
long axis of the tissue and surrounding ligament and tendon cells. An increased intensity of 
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staining was also noted at the interfascicular regions. The similar distribution of both 
fibrillins may indicate co-localisation of both fibrillin-1 and fibrillin-2, which has been 
previously shown in bovine tendon (Grant et al. 2013).  In comparison to fibrillin-1 and 
fibrillin-2, elastin fibres were sparse and were more located at the interfascicular and 
interbundle regions, but also found on CCL and LDET within fascicles. When elastin was 
present either in between collagen fibre bundles or orientated along the fibres, it was found 
to co-localise with both fibrillin-1 and fibrillin-2, where it was also in close conjunction to 
cells. These findings supports the previously demonstrated elastic fibre distribution in 
bovine tendon (Grant et al. 2013), but was slightly different to that previously reported for 
canine CCL, where elastin was found to co-localise with fibrillin-2, but not fibrillin-1 (Smith 
2010). As discussed earlier, elastin content was also found be different between in this 
study and Smith et al. (2013) and these findings may be due to breed differences. One 
limitation of this part of the study was that the overall distribution of elastic fibres 
throughout the depth of the tissue was not presented due to software limitations in 
creating 3D images of different stack, as a result only representative 2D images were 
presented.  
Studies have shown that type VI collagen and elastic fibres are in close conjunction with 
tendon cells (Thakkar et al. 2014) and ligament cells (Sardone et al. 2014) and are localised 
at the pericellular matrix. Finding in the current work are consistent with these studies, and 
may indicate a link between elastic fibres and collagen type VI. Apart from collagen type VI 
and elastic fibres, asporin (in both CCL and LDET) and aggrecan (only in CCL) were also found 
to be distributed pericellularly. Future work may address whether these protein are co-
localised around the same cell. Together, these proteins may play an important role in the 
microenvironment of both LDET and CCL cells.  The increased distribution of elastic fibres at 
interfascicular and interbundle regions may provide elastic recoil and offer stress protection 
of blood vessels and nerves at this region (Grant et al. 2013). 
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4.6 CONCLUSION 
This study has demonstrated statistically significant structural and morphological 
differences between inter- and extra-articular ligaments and flexor and extensor tendons 
around the canine stifle joint. By using established and newly adapted scoring systems we 
have for the first time demonstrated semi-quantitative morphological and structural 
differences between the CCL and the other tendon and ligament tissues examined. These 
differences include a less compact collagen architecture, differences in cell nuclei 
phenotype, and increased staining for GAGs and elastic fibres in CCL. These findings may be 
a normal and a physical adaptation of CCL to mechanical loading, rather than pathological 
degeneration as suggested by the author Hasegawa et al. (2013) .  
A different distribution of was also found for collagen type III, aggrecan, versican, asporin of 
CCL in comparison to LDET. While different collagen ratios may lead to different mechanical 
properties, the increase distribution of aggrecan and versican may result to increase the 
hydration and viscoelastic properties of CCL. Together, these finding may relate to different 
functioning of CCL and LDET and indicate that CCL is subjected to more compressive forces, 
resulting in different ECM composition and arrangement to protect the tissue from damage.  
In both LDET and CCL collagens, proteoglycans and elastic fibres were either fascicular, 
interfascicular and pericellularly located. In particular ECM proteins including collagen type 
VI, elastic fibres, asporin and aggrecan (only in CCL) may play an important role in the 
cellular function and microenvironment of both LDET and CCL as these proteins were closely 
located adjacent to cells. Differences in the distribution and arrangement of ECM collagen, 
proteoglycans and elastic fibres between fascicular and interfascicular and/or interbundle 
regions in both LDET and CCL is suggestive of different shear forces between regions during 
deformation. Proteoglycans and elastic fibres in the interfascicle or interbundle matrix may 
be involved in the regulation collagenous matrix and could enhance the lubrication of 
collagen bundles and elastic recoil mechanism at this site.  
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5 CHAPTER 5 
A COMPARISON OF THE EXTRACELLULAR MATRIX COMPOSITION OF 
NATIVE TENDON/LIGAMENT AND 3D TENDON/LIGAMENT CONSTRUCTS 
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5.1 INTRODUCTION 
Tendon and ligament injuries can cause significant joint instability, which may lead to injury 
of other tissues and the development of degenerative joint disease (Woo et al. 1999). 
Depending on whether tendon and ligament injury has resulted in partial or complete tear a 
nonsurgical or surgical intervention is required for treatment. For instance, in nonsurgical 
treatment of human Achilles tendon progressive physical therapy and rehabilitation is often 
required (Soroceanu et al. 2012) and is usually also performed for pre- and post- operative 
ACL reconstruction (Adams et al. 2012). Strategies such as delivery of growth factors (Molloy 
et al. 2003, Thomopoulos et al. 2005) or cell therapy (Alves et al. 2011) have been 
considered to alter tendon and ligament repair and accelerate the healing process. With a 
complete tendon or ligament tear a surgical intervention is often necessary. At present both 
autologous and allogenic surgical treatments are used to treat tendon and ligament injuries, 
but are associated with complications such as infection (Robertson et al. 2006), chronic pain 
(Spindler et al. 2004), decreased muscle strength (Beynnon et al. 2002) and, donor site 
morbidity (Mastrokalos et al. 2005).  
Tissue engineering can offer great potential in the treatment of tendon and ligament injury 
by seeking a biological replacement with a fully regenerated autologenous tissue that 
mimics the natural structure and function and has long term availability (Rodrigues et al. 
2013). The engineering approach involves the acquisition and cultivation of adequate cells, 
growth-inducing stimuli and an artificial extracellular matrix (scaffold) in which cells can 
proliferate and differentiate with subsequent new tissue generation (Ahmed et al. 2008).  
Fibrin is a natural scaffold with no toxic degradation or inflammatory reaction and can be 
used as an autologous scaffold for fibroblasts from connective tissue to create a three-
dimensional (3D) structure (Ye et al. 2000). Use of this biological material in tissue 
engineering is advantageous compared to synthetic polymers and collagen gels where cost, 
inflammation, immune response and toxicity may be significant drawback (Ahmed et al. 
2008). The generation of 3D tendon constructs using a fibrin gel from embryonic tendon 
cells has been described by Kapacee et al. (2008). This method was adapted from those 
used previously by Hecker et al. (2005) and Huang et al. (2005) to successfully culture 
smooth muscle and skeletal muscle cells in vitro. Kalson et al. (2010) demonstrated that 
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tendon constructs produced with embryonic chicken tendon cells are able to form after 10 
days under static conditions and produce mechanical properties similar to 14- day- old chick 
embryonic tendon. 3D constructs made with human adult tendon fibroblasts revealed the 
cells to have the potential to produce a tendon-like structure in vitro with aligned collagen 
fibrils along the axis of tension (Bayer et al. 2010). 3D tendon constructs from adult cells 
have also been shown to develop larger collagen fibrils with increasing diameter resulting in 
an increasing resistance toward tensile mechanical forces (Herchenhan et al. 2013). Human 
adult ACL fibroblasts have also been used in vitro for creation of a ligament construct which 
demonstrated an increasing collagen content for maximal tensile load following the addition 
of transforming growth factor 1 (TGFβ1) and insulin-like growth factor (IGF) (Hagerty et al. 
2012). Overall, it appears that these constructs have the potential to be used in studies of 
ligament and tendon regeneration and replacement. However it remains unknown to what 
extent 3D tendon and ligament constructs formed from tendon and ligament fibroblasts in 
3D culture are able to recapitulate native tendon/ligamentous tissue characteristics.  
 
5.2 HYPOTHESIS & AIMS  
Previously we have identified biochemical and structural differences between canine intra- 
and extra- articular ligaments and tendons and identified tissue specific characteristics 
(Chapter 3 and 4). 3D constructs could provide an important role in tendon and ligament 
repair and replacement, but can also provide insight on whether cells derived from 
tendinous and ligamentous tissues have similar characteristics to original tissue when grown 
in a 3D culture system. Cells grown in 3D fibrin cultures have been reported to produce their 
own ECM system (Hecker et al. 2005). Therefore the biochemical characteristics of 3D 
tendon and ligament constructs can be measured and compared to native tendon and 
ligament tissue. We hypothesised that there are that there are differences in ECM 
macromolecules between native tendon and ligament tissue and 3D tendon and ligament 
constructs. The aims of this study were to identify whether canine isolated tendon/ligament 
cells are able to form in vitro 3D cultures and characterise the extent to which isolated 
tendon/ligament cells are able to recapitulate the formation of tendon/ligamentous tissue.   
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5.3 EXPERIMENTAL PROCEDURES 
An overview of the performed experiments is highlighted below. More detail on the 
methods is described in the general material and methods Chapter 2. 
 
5.3.1 Tissue extraction  
Cranial cruciate ligament (CCL) and long digital extensor tendons (LDET) were harvested 
from five disease free skeletally mature Staffordshire bull terrier cross dogs cadaveric canine 
hindlimbs on the day of euthanasia (Table 2.1). Tissues were enzymatically digested 
overnight. Cells were isolated, cultured and split at no further than the 3rd passage.   
 
5.3.2 Creation of 3D tendon and ligament constructs 
Tendon and ligament 3D constructs were created as described in Chapter 2, section 2.3 3. 
All constructs were fully contracted between the anchored points and were harvested at 14 
days post-seeding. 
 
5.3.3 Histology staining 
Tissue engineered constructs were fixed in 4% paraformaldehyde, paraffin embedded and   
4 µm section cut. Sections were stained for hematoxilin and eosin (H&E) for general 
observation of tissue structure, alcian blue/PAS (AB-PAS) for detection of GAGs,  Masson’s 
trichrome for collagen staining (Bancroft et al. 1996) and Miller’s stain for elastic fibres 
(Miller 1971).The methodology of these stains are explained in detail in Chapter 2, Section 
2.5.2. 
 
 
 
 125 
 
5.3.4 Transmission electron microscopy (TEM)  
Transmission electron microscopy was performed by Marion Pope, technician, Division of 
Veterinary Pathology, School of the Veterinary Science (Chapter two, section 2.7). Ultra-thin 
transverse-sections were cut with a Reichert- Jung Ultracut on ultramicrotome with a 
diamond knife. Images were acquired in a Philips EM208S Transmission Electron Microscope 
at 80kV. 
  
5.3.5 Biochemical analysis  
Prior to biochemical analysis, tissue samples were freeze dried overnight and their dry 
weight was determined. For the measurement of sulphated glycosaminoglycan (sGAG), 
collagen and DNA content, samples were  papain digested, whilst for elastin content 
measurement tissue samples were digested with 0.25M oxalic acid (Chapter 2, Section 2.4). 
 
5.3.5.1 dsDNA 
Quant-iTTM Picogreen ® dsDNA reagent was used to measured DNA content in the papain 
digested samples (Singer et al. 1997)(Chapter 2, Section 2.4.4.1). DNA concentrations were 
determined by comparing to a standard curve constructed using bacteriophage lambda DNA 
standards and expressed as µg per mg dry weight tissue.  
 
5.3.5.2 Collagen  
Total collagen content was determined by measuring the amino acid of hydroxyproline 
(Bergman and Loxley 1963)(Chapter 2, Section 2.4.5.2). The hydroxyproline concentrations 
were calculated by comparison against a hydroxyproline standard curve and collagen 
content calculated assuming hydroxyproline to be present at 14% (Rumian et al. 2007). 
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5.3.5.3 sGAG 
The dimethylmethylene blue (DMMB) dye binding assay (Farndale et al. 1986) was used to 
assess (Chapter 2, Section 2.4.5.1) the concentration of sulphated glycosaminoglycan (sGAG) 
in the samples. Concentrations were determined using sGAG calibration curves and 
chondroitin sulphate as a standard. sGAG concentrations were expressed as µg per mg dry 
weight tissue. 
 
5.3.5.4 Elastin 
Elastin content was measured using the FastinTM dye-binding assay on the pooled oxalic acid 
extracts (Chapter 2, Section 2.4.5.3). Unknown elastin concentration in the samples were 
compared to a standard curve generated from known concentrations of alpha-elastin. 
Elastin concentration was expressed as a percentage of dry weight(Smith et al. 2013). 
 
5.3.5.5 Statistical analysis  
Data are presented as means + standard error of the mean (SEM) and statistically analysed 
using One-way ANOVA with a Bonferroni post-hoc correction using Graphpad Prism (Version 
6). The significance level was set at p<0.05.  
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5.4 RESULTS 
5.4.1 Formation of 3D tendon and ligament constructs 
CCL and LDET fibroblasts within 3D ligament and tendon constructs displayed a rounded 
morphology following seeding (Figure 5.1A and 5.1B), but began to form cellular extensions 
1 day after being embedded into the fibrin matrix. Cellular arrangements inside the 
constructs were more ordered and displayed elongated cell body extension after three days 
of construct formation (Figure 5.1C and 5.1D). In both 3D constructs fibroblasts became 
more organised forming a parallel arrangement during ECM formation (Figure 5.1E and 
5.1F). Cells were initially seeded in a circular fibrin matrix which became fully contracted 
being at least partially replaced with collagen fibrils. A continuous tendon or ligament-like 
tissue was formed between the sutures after 14 days post seeding (Figure 5.1G and 5.1H).   
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Figure 5.1. Canine CCL and LDET cells embedded in a 3D fibrin gel. Shortly after embedding in fibrin CCL (A) and LDET (B) fibroblasts displayed a 
rounded cell morphology. (10x magnification. Bar; 100µm). After 3 day of construct formation both CCL (C) and LDET (D) fibroblast displayed 
elongated cell bodies and long cellular extensions. (4x magnification Bar: 1mm). After 10 days of incubation of CCL (E) and LDET (F) fibroblast 
were located between ordered aligned matrix. (4x magnification. Bar; 1mm). At day 14 constructs were fully contracted and engineered tissues 
were formed (G and H). (4X magnification Bar; 1mm). 
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5.4.2 Ultrastructure of 3D tendon and ligament constructs 
5.4.2.1 Histology 
H&E staining displayed a general loose and not orderly architecture of both 3D ligament and 
tendon constructs with a high degree of cellularity that had no particular alignment. 
Towards the edge of the constructs, cell nuclei had more fibroblastic morphology, whereas 
in the centre of the constructs the cell nuclei had more rounded morphology. (Figure 5.2A 
and 5.3A).  
AB-PAS staining displayed areas of blue staining indicating the presence of GAGs, which 
were mainly found next to collagen fibres. No pericellular staining was observed (Figure 
5.2B and 5.3B).  
Miller’s staining- Both 3D tendon and ligament constructs demonstrated no elastic fibres, 
though intriguingly some structures which strongly resembled blood vessels were found in 
several tendons and ligaments constructs (Figure 5.2C and 5.3C).  
Masson’s trichrome indicated the presence of collagen (stained blue) in both 3D tendon and 
ligament constructs. Collagen fibres had a generally loose architecture and did not appear to 
be compact or dense with no particular orientation. Some areas of the fibrin matrix was 
stained red in several 3D tendon and ligament constructs, indicating that the fibrin matrix 
was not fully degraded (Figure 5.2D and 5.2E).  
 
5.4.2.2 TEM 
The presences of collagen fibrils were further confirmed with TEM, whereby close-packed 
narrow diameter collagen fibrils were visible in the extracellular space. Collagen fibrils were 
also found to be located in collagen fibripositors (Figure 5.4 and 5.5), which are actin rich 
plasma membrane protrusions that mediate collagen fibril organisation in embryonic 
tendon (Canty et al. 2004).  
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Figure 5.2. Representative histology staining pictures of 3D LDET construct. (A) – (D) longitudinally sectioned micrographs. (A) H&E staining 
indicated highly cellular structure of LDET construct. (10X magnification. Bar: 100µm). (B) AB-PAS staining. Areas of with GAGs were observed 
(black arrow). (40X magnification. Bar: 100µm). (C) Millers staining. No Elastic fibres were found, though a possible blood vessel was found 
within the construct (black arrow). (40X magnification. Bar: 100µm). (D) Masson’s trichome staining. Collagen fibres were stained blue and 
cells were stained dark blue. Collagen fibres appeared loosely composed with minimal density. (40X magnification. Bar: 100µm). 
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Figure 5.3. Representative histology staining pictures of 3D CCL construct. (A)–(D) longitudinally sectioned micrographs. (A) H&E staining 
demonstrated highly cellular structure of CCL construct. (10x magnification. Bar: 100µM). (B) AB-PAS staining. GAGs were identified (black 
arrow) magnification (40x Bar: 100µM) (C) Miller’s staining. No Elastic fibres were found. Blood vessel-like structure was found (black arrow) 
magnification (40x Bar: 100µM) (D) Masson’s trichome staining. Collagen fibres were stained blue and were general loose, but at some areas 
collagen fibres seemed more dense (white arrow).  Areas of red staining indicated the presence of fibrin matrix (black arrow). (40x 
magnification. Bar: 100µM). 
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Figure 5.4. Representative pictures of transmission electron analysis of 3D CCL construct. (A) 2200x, (B) 24000x and (C) 28000x magnification. 
(A)-(C) transverse sectioned micrographs. (Bar: 0.5µm). Collagen fibrils were identified and appeared to be of a narrow diameter (~46nm). 
Collagen fibrils were located in extracellular space (black arrow). Collagen fibrils were also found with plasma membrane protrusions  known 
as collagen fibripositors (white arrows).  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AA BA CA 
ECM ECM 
 133 
 
 
Figure 5.5. Representative transmission electron pictures of 3D LDET constructs. (A) 18000x , (B) 22000x, (C) 36000x transverse sectioned 
micrographs. (Bar 0.5µm).  Collagen fibrils with uniformity can be seen being mainly identified in extracellular space (black arrow), but also in 
fibripositors (white arrow). 
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5.4.3 Biochemical comparison between native tissues and 3D tendon and ligament 
constructs 
 
5.4.3.1  DNA content 
3D tendon and ligament constructs were found to have significantly higher DNA content 
than both native tendon and ligament tissues (p=0.0157 and p=0.015) (Figure 5.6). DNA 
averaged 2.92 + 0.32 mg/dry weight in native CCL and 3.94 + 1.1 mg/dry weight in native 
tendon. 3D CCL and LDET constructs had an average of 10.6 + 1.57 and 9.82 + 1.46 DNA 
mg/dry weight, respectively. No significant differences were found between the native 
tendon and ligament or and between 3D tendon constructs compared to ligament 
construct.  
 
 
 
 
 
 
 
 
 
 
Figure 5.6. DNA content (µg/ mg dry weight). Values are mean and error bars represent 
SEM.  Ligament construct had significantly higher DNA content than both native tendon and 
ligament tissues (p=0.0046, p=0.015). The DNA content in tendon constructs was also 
statistically significantly higher than native tendon (p=0.0157) and native ligament (p=0.012) 
tissues. There were not any statistically significant differences between native tissues types 
and 3D tendon and ligament constructs. * indicates p<0.05.   
* 
* 
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5.4.3.2 Collagen content 
The total collagen content showed statistically significant differences between native 
tendon/ligament tissue and 3D tendon and ligament constructs (Figure 5.7). Both LDET and 
CCL constructs had significantly lower collagen content than native tissues (p=0.0001). The 
CCL and LDET had average values of 65.1% + 1.02 and 70.4% + 2.8 of dry weight tissue, while 
3D CCL and 3D LDET had average values of 3.61 + 0.9 and 2.89 + 0.71 of dry weight. No 
significant variations were found between the two native tissues and between engineered 
tissue types.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7. Collagen content/ mg % dry weight.  Values are mean and error bars represent  
SEM. Collagen content in ligament and tendon constructs were both significantly lower than 
native tendon (p=0.0001) and ligament (p=0.0001). No significant differences were observed 
between native tendon and ligament and between 3D tendon and ligament construct. 
 * indicates p<0.05.   
 
 
* 
* 
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5.4.3.3 Total sulphated GAG content  
sGAG content (as µg/mg dry weight) was an average of 15.1 + 0.74 in native CCL, 8.29 + 1.03 
in native LDET, 14.4 + 1.97 in 3D CCL and 11.1 + 0.76 in 3D LDET. Native CCL contained 
significantly more sGAG than LDET (p=0.008). Only the 3D CCL construct had statistically 
higher sGAG than native LDET (p=0.028) (Figure 5.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8. sGAG content (µg/ mg dry weight). Values are mean and error bars represent 
SEM. Ligament constructs had significantly higher than native tendon (p=0.028). Significant 
differences were found between native ligament and tendon tissues types (p=0.008), but 
not between engineered tissues. * and +  indicates p<0.05. 
 
 
 
 
 
 
* 
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5.4.3.4 Elastin content  
Elastin content was 5.52 % + 0.58 in native CCL, 2.42 % + 0.18 in native LDET, 9.47% + 1.39 in 
3D CCL and 14.26% + 0.49 in 3D LDET. Both 3D tendon and ligament constructs had higher 
elastin content than both native tendon and ligament tissue (p=0.0001). Statistically 
significant differences between native CCL and LDET were found (p=0.0038), with CCL 
containing significantly higher elastin. Between tissue engineered CCL and LDET constructs, 
the LDET constructs contained significantly more elastin (p=0.0026) (Figure 5.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9. Elastin content (% mg dry weight). Values are mean and error bars represent 
SEM.  Native tendon ligament tissues were significantly lower in elastin content than both 
native LDET (p=0.0001) and CCL (p=0.0001) 3D constructs. Statistically significant differences 
were found between native tendon and ligament (p=0.0038) and 3D tendon and ligament 
constructs (p=0.0026). *, + and • indicates p<0.05. 
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5.5 DISCUSSION 
This study has demonstrated that 3D tendon and ligament fibrin constructs are able to 
produce ECM macromolecules. The constructs had a resemblance of an embryonic tendon 
or ligament, containing high cellular content and collagen fibripositors. Collagen content in 
both 3D tendon and ligament constructs was significantly lower compared to what was 
measured in native tendon and ligament tissue. A high content of non-collagenous ECM 
macromolecules including sGAGs and elastin were measured in both types of 3D constructs, 
indicating that these components mature faster than collagen and might play an important 
role in the development of 3D tendon and ligament constructs.  
 
5.5.1 Tendon and ligament construct ultrastructure  
Linear 3D tendon and ligament construct were created from mature canine long digital 
extensor tendon (LDET) and canine cranial cruciate ligament (CCL) fibroblasts using in vitro 
3D cell fibrin cultures. Constructs from both tissues displayed a high degree of cellularity 
with collagen fibrils present and glycosaminoglycans identified in histological sections. The 
high degree of cellularity also corresponds to higher DNA content in both 3D tendon and 
ligament constructs compared to mature native tendon and ligament tissue, indicative of a 
high cell-to-matrix ratio in both 3D constructs. A high cell number could stimulate 
embryonic fibrillogenesis which have been identified in neonatal rat tendon (Calve et al. 
2004), but also in human embryonic tendon (Chaplin and Greenlee 1975) using electron 
microscopy, Chaplin and Greenlee (1975) previously demonstrated that human digital 
embryonic tendon being as a  highly cellular structure with few small diameter collagen 
fibrils.  After 6 days, collagen fibrils developed in close proximity to the cells, whilst after 95 
days, the extracellular space was filled with longitudinal aligned collagen fibrils containing a 
relatively high cell volume fraction and loose collagen packing density (Chaplin and Greenlee 
1975). Comparing these electron microscopy pictures with our developed tendon and 
ligament construct at 14 days post-seeding, a resemblance is seen with the human 
embryonic digital tendon until about 60 days of gestation. The shorter period time for our 
constructs may be explained by the fact that cells are derived from mature adult tissue and 
ready to form ECM, whereas in the embryonic tendon the cells need to differentiate.    
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Transmission electron microscopy results in this study showed that collagen fibrils in the 
tendon and ligament constructs were mainly located in extracellular space, but also 
occasionally found in carriers, known as collagen fibripositors. Collagen fibripositors are 
plasma membrane protrusions that contain narrow diameter fibrils and have only been 
found in embryonic tendon (Canty et al. 2004). Despite active procollagen synthesis, 
fibripositors are absent in postnatal stages when fibrils increase in diameter by accretion of 
extracellular collagen (Canty et al. 2004). Fibripositors have been found to be associated 
with actin bundles suggesting cytoskeletal involvement in fibril assembly and coordination 
of collagen fibril alignment in tendon (Canty et al. 2006). Previous studies have identified 
collagen fibripositors in embryonic tendon fibroblasts, which are actin rich plasma 
membrane protrusions containing narrow collagen fibrils and occurring in tendon only 
during embryonic development when seeding of the ECM occurs (Canty et al. 2004, Canty et 
al. 2006). Together, the high cellularity and presence of collagen fibripositors reflect the 
immature state of the constructs in this study. This finding correlates with observations in 
rat tendon constructs obtained from postnatal tissue (Calve et al. 2004), chick embryo 
tendon constructs (Kapacee et al. 2008), and adult human tendon constructs (Bayer et al. 
2010, Herchenhan et al. 2013), where the structural characteristics were similar to 
developing embryonic tendon.  
 
5.5.2 Tendon and ligament construct ECM composition 
Collagen content- The function of collagen content of the tissue is to withstand tensile 
forces (Canty and Kadler 2005), and it may be assumed that in vitro generated tissues with 
greater collagen concentration would be superior by providing more resistance to 
mechanical forces.  Here, a low collagen content in 3D tendon and ligament constructs was 
found with only an average of 3.2% collagen in 3D tendon and ligament, whereas native 
tissues had an average 67.7% collagen. This may be explained by the immature state of 
constructs whereby collagen fibrillogenesis may still be in progress. The maturation of 
human Achilles tendon is associated with an increase of collagen fibril concentration and 
diameter as well as the presence of fewer cells that display altered cell morphology 
(Strocchi et al. 1991). An increase in ECM, decrease in cellularity and different morphological 
cell structure were also found with sheep tendon and ligament maturation, although 
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ligament cell morphology remained the same during postnatal development (Meller et al. 
2009). To what extent 3D tissue engineered ligament and tendon are able to mature is not 
fully known. However, Paxton et al. (2012) demonstrated a more dense structure and an 
improved collagen content with chick embryonic construct when cultured over period of 5-
weeks. This improvement was also observed in adult human constructs in terms of 
mechanical strength, stiffness, increase of collagen fibril diameter and density when 
subjected to static tension for 5 weeks (Herchenhan et al. 2013). Other studies have 
identified that factors such as loading (Paxton et al. 2012) and addition of growth factors 
such as TGFβ1 or insulin growth factor 1(IGF 1) (Paxton et al. 2010, Hagerty et al. 2012) can 
increase collagen content in 3D fibrin constructs. For instance, TGFβ is known to play role in 
tendon development (Pryce et al. 2009) and is thought to activate early growth response 
(EGR) 1 and 2 (Chen et al. 2006). TGFβ has been demonstrated to increase the collagen 
expression in invertebrate tendon by binding to Col1a1 promoter (Lejard et al. 2011). A 
significant decrease in collagen content of tendon and ligament has been detected in the 
absence of EGR 1/2 (Lejard et al. 2011). In addition to TGFβ1, Hagerty et al. (2012) found an 
additive effect with IGF1 on the collagen content and maximal tensile load in human adult 
ACL fibrin constructs. This was supported by the work of Herchenhan et al. (2014) in human 
adult tendon constructs, where IGF1 increased collagen fibril diameter, overall collagen 
content and mRNA gene expression of collagen type I and III, tenomodulin and scleraxis 
(Herchenhan et al. 2014). Paxton et al. (2012) measured the effect of loading on tendon-like 
constructs derived from chick embryonic tendon and demonstrated that short cyclical 
loading with diverse strain rates and amplitudes resulted in an increase in collagen content 
within the engineered graft. Together, these variations and factors can be considered in 
future studies to get a better understanding of the development tendon and ligaments in 
vivo.  
GAG and elastin content- In this study other non-collagenous ECM matrix components 
including sulphated glycosaminoglycan (sGAG) and elastin in 3D tendon and ligament 
constructs were measured. Significantly more sGAG and elastin were found, in native CCL 
and as compared to native LDET, indicative of greater viscoelastic properties and a stretch 
and recoil mechanism in CCL (also described in Chapter 3 and 4).  Similar sGAG content was 
identified in both 3D tendon constructs compared to native tissues. Significantly higher 
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elastin content was found in both 3D constructs compared to native tissues. The high sGAG 
and elastin content in both 3D constructs suggest that these ECM components are rapidly 
acquired and mature much faster than the collagen matrix. Proteoglycans have been known 
to play role in the regulation of tendon collagen fibrillogenesis (Zhang et al. 2005). During 
tendon development the absence of several small leucine-rich proteoglycans causes distinct 
abnormalities, where different fibril diameter distributions with irregular profiles were 
observed in mice tendons with deficient lumican and fibromodulin in postnatal period 
(Ezura et al. 2000). Small leucine-rich proteoglycans have also been shown to prevent later 
fusion of collagen fibrils (Danielson et al. 1997, Raspanti et al. 2007). The data in the present 
study might indicate that the high GAG content might play an important role in the 
organisation of the collagen fibrils and the development of 3D tendon and 3D ligament 
constructs.  
Elastic fibres have previously been identified in canine cruciate ligaments (Smith et al. 2011) 
and bovine flexor tendon (Grant et al. 2013). Elastic fibres have important mechanical 
(Butler et al. 1978, Eriksen et al. 2001), cell-regulatory (Ito et al. 1997, Wendel et al. 2000) 
and, recoil functions in tissue (Ritty et al. 2002). Elastic fibres are composed of an elastin 
core covered with a sheath of fibrillin- rich microfibrils, which acts as a scaffold onto which 
the secreted elastin molecules are deposited (Kielty et al. 2002, Kielty 2006). Although 
higher elastin content was identified in both 3D tendon and ligament constructs, no elastic 
fibres were detected in histological and TEM sections. Again this may be explained by the 
embryonic state of the constructs and agrees with the work of Brown et al. (2012), where 
elastic fibers were only detected at postnatal stage, while fibrillin-1 and tropoelastin were 
found to be present during embryonic development in the spinal ligament. Moreover, the 
elastin assay does not distinguish between tropoelastin precursor, insoluble elastin and 
degraded peptides, which could mean that higher elastin content in 3D tendon and ligament 
constructs may be the tropoelastin precursor.   
Elastic fibres are also major component of blood vessels (Davis 1993) and are therefore 
stained with the Miller’s stain. In this study the presence of blood vessel-like structures 
were also shown in both 3D tendon and ligament constructs with the Miller’s stain. This 
might indicate that the endothelial cells from the native tendon and ligament tissue are able 
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actively remodel once placed in 3D culture. However, further validations through antibody 
immunostaining are required to verify the presence of blood vessels.  
 
5.6 CONCLUSION 
The results of this study shows that 3D tendon and ligament constructs have similar ECM 
matrix composition and are composed of different proportions of ECM proteins in 
comparison to the native tendon and ligament tissue. The low concentration of collagen and 
high cellularity of the construct might be explained by the embryonic nature of the tendon 
or ligament constructs. The increased sGAG and elastin content in the engineered 
constructs might indicate that these components mature faster than collagen matrix, as in 
particular sGAGs are important for collagen fibrillogenesis and might play an important role 
in the development of engineered connective tissue constructs.  
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6 CHAPTER 6 
PROTEOMIC COMPARISON OF TENDON, LIGAMENT AND 3D 
TENDON/LIGAMENT CONSTRUCTS 
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6.1 INTRODUCTION  
Proteomics is relatively a new technology that has been used widely in cancer, cartilage 
biology (Polacek et al. 2010) and osteoarthritis research (Ruiz-Romero and Blanco 2010), but 
also in several tendon and ligament studies (Johnson 2009, Little et al. 2014, Peffers et al. 
2014)  .  
The concept of the proteome was first described by Wilkins et al. (1996) as "the entire set of 
proteins produced by the genome, or by a cell or tissue type". The functional proteome is 
the physiological state of a tissue represented by the protein complement of a given cell at a 
given time, including the set of all proteins isoforms and modifications (de Hoog 2004). 
Proteomics seeks to determine protein structure, modifications, localisation, and protein-
protein interactions as well as protein expression levels (de Hoog 2004). Mass spectrometry 
(MS) is currently the most versatile technology in achieving these objectives (Aebersold and 
Mann 2003). MS allows identification and characterisation of thousands of proteins in a 
complex mixture by performing chromatographic separation prior to MS detection 
(Aebersold and Mann 2003, Domon and Aebersold 2006).  
 
6.1.1 Mass spectrometry 
Separation of proteins and peptides- Prior to MS separation of protein/peptides is required 
and achieved by gel electrophoresis or gel free techniques which normally involve liquid 
chromatography (LC).  
Two dimensional gel electrophoresis (2DE) is an example of gel- based separation, where 
proteins are separated by isoelectric point and by molecular weight (Gorg et al. 2000, Gygi 
et al. 2000). Subsequently proteins can be visualised by staining techniques, excised from 
the gel and proteins can be identified by MS techniques.  
Gel free separation involves the use of high performance liquid chromatography (HPLC) with 
reverse phase C18 column, where peptides are separated according to hydrophobicity 
(Wang et al. 2003). This is coupled to a mass spectrometer for online MS analysis and is 
therefore high throughput method.  
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The mass spectrometer- it consists of three main parts; the ion source, mass analyser, and 
detector. After LC, peptides enter the mass spectrometer and are ionised. The most 
commonly used ionisation is electrospray ionisation (ESI) and matrix-assisted laser 
desorption ionization (MALDI). The produced ions are transferred to a mass analyser where 
the mass-to-charge ratio (m/z) ratio is detected (Aebersold and Mann 2003, Matthiesen and 
Jensen 2008). In tandem mass spectrometry (MS/MS), the ions of particular interest m/z 
ratio are first selected in the mass analyser and are then fragmented in the second 
dimension of MS by collision induced dissociation (CID). The peptide CID spectra are more 
specific by mass mapping only as, in addition to the peptide mass, the peak pattern in the 
CID spectrum also delivers information about peptide sequence (Aebersold and Mann 
2003). Examples of commonly used mass analysers are quadrupole, ion traps (IT), time of 
flight (TOF) and Fourier transform ion cyclotron (FT-MS)(Aebersold and Mann 2003). The 
detector is final part of the mass spectrometer, where the m/z vs intensity plot or a mass 
spectrum output is visualised (Matthiesen and Jensen 2008) 
 
   
 
Figure 6.1. Outline diagram of mass spectrometer adapted from Matthiesen and Jensen 
(2008) 
 
6.1.2 Protein quantification 
Protein identification can be achieved by comparing the peptide profile of the unknown 
protein in comparison to theoretical peptide libraries generated from the sequences in the 
different databases (Barrett et al. 2005). Proteins can be quantified through absolute or 
relative quantification using either label-based or label-free methods. Absolute 
quantification is a targeted approach, where MS peptide peaks are compared alongside 
known internal standard concentrations (Kirkpatrick et al. 2005, Bantscheff et al. 2007). This 
quantification is used to calculate copy number or concentration. On the other hand relative 
quantification is used to define relative changes of protein between samples. This 
quantification is based on spectral counting and by using a relative peak intensity approach 
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(Bantscheff et al. 2007, Zhu et al. 2010, Bantscheff et al. 2012). Spectral counting is only 
used with label-free quantification and involves data-dependent analysis such as 
‘exponentially modified protein abundance index’ (emPAI) (Ishihama et al. 2005, Zhu et al. 
2010). The relative intensity peak approach is also used to quantify protein or peptide 
abundance by calculating MS peak intensity (Zhu et al. 2010). The abundance of each 
peptide or protein is associated with the relative peak intensity (peak area) (Zhu et al. 2009).  
There is a growing interest in applying label-free LC-MS approaches. In comparison to the 
isotope label method, label-free methods have several advantages. These include higher 
dynamic range of quantification, reduced protein loading, fractionation, sample handling, 
and the ability to compare more conditions within one experiment (Bantscheff et al. 2007, 
Patel et al. 2009). However it must also be noted that with label-free quantification it is 
difficult to detect low-abundance peptides as there is less sensitivity (Zhu et al. 2010). 
Tendon and ligament 3D fibrin constructs have been created using cells from several species 
such as chick embryonic tendon (Kapacee et al. 2008, Kalson et al. 2010, Paxton et al. 2010, 
Herchenhan et al. 2012), human adult ACL (Hagerty et al. 2012) and human adult tendon 
cells (Bayer et al. 2010) and canine tendon and ligament cells in this thesis. With the 
collagen fibrils having the ability to grow in size  and with strength approaching that of adult 
human tendon (Herchenhan et al. 2013), these fibrin constructs have the potential for 
tendon and ligament replacement. However, to date an understanding of the proteome 
composition of these tendon and ligament-like structures is unknown. The ability of these 
structures to retain similar proteome characteristics to the original tissue and whether 
ligament and tendon fibroblasts have the ability to produce a distinct ligament and tendon 
proteome phenotype has yet to be identified. In this study a gel free separation technique 
with label free quantification was used to identify differences in protein abundances 
between samples.  
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6.2 HYPHOTHESIS & AIMS    
In the previous chapters (Chapter 3 and 4) a comparison between canine intra- and extra 
articular tendons and ligament was performed.  Through biochemical analysis and semi-
objective histological scoring, the canine cranial cruciate ligament (CCL) had significantly 
more elastin and sulphated glycosaminoglycan content in comparison to long digital 
extensor tendon (LDET), medial collateral ligament (MCL) and superficial digital flexor 
tendon (SDFT) (Chapter 3 and 4). We have also shown that isolated cells from tendon (LDET) 
and ligament (CCL) grown in 3D culture have been able to form 3D tissue engineered tendon 
and ligament constructs with specific extracellular matrix (ECM) macromolecules being 
present (Chapter 5). The hypothesis in this part of the study was that native tendon and 
ligament have differential structural protein expression and that 3D constructs formed from 
tendon and ligament cells retain the proteome characteristics of the original tissues. 
Therefore, the study aimed to identify the differences between the proteomes of native 
tendon and ligament as well as engineered tendon and ligament 3D constructs. These 
findings would represent a level of comparison between native and tissue engineered 
ligaments and tendons that has not been previously reported.  
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6.3 EXPERIMENTAL PROCEDURE 
An overview of experimental procedures is described below. For more detail of the 
procedures see general materials and methods (Chapter 2).  
 
6.3.1 Tissue collection and preparation 
The cranial cruciate ligament (CCL) and long digital extensor tendon (LDET) were harvested 
from five paired disease-free cadaveric canine hindlimbs from skeletally mature 
Staffordshire bull terrier dogs immediately after euthanasia. Tissues were used from both 
the right and left stifles joints (Chapter 2, table 2.1). The right stifle joint tissues were used 
for protein isolation and proteomic analysis of the native tissues. The left stifle joint tissues 
were used for cell isolation and creation of engineered tissues, which were subsequently 
used for protein isolation and proteomic analysis. All samples were snap frozen in liquid 
nitrogen and stored at-80°C until required for protein extraction.  
 
6.3.2 Tendon and ligament construct formation  
The isolation of cells and the generation of 3D constructs is described in detail in the general 
material and methods (Chapter 2, Section 2.3). All constructs were fully contracted between 
the anchored points and harvested at 14 days post-seeding. 
 
6.3.3  Protein extraction  
Prior to protein extraction all samples were lyophilised and then disrupted using a 
dismembrator. Approximately 3 mg of each dismembrenated sample were treated with 1 
unit/ml chondroitinase ABC (1 unit/ml) and protein was extracted with 4 M GnHCL 
extraction buffer. The soluble fraction was used for in-solution trypsin digestion and 
analysed by liquid chromatography tandem mass spectrometry (LC-MS/MS). Protein 
concentration was measured with the PierceTM 660 nm protein assay. For verification of 
isolated proteins an aliquot of each samples was run on a 4-12% Bis-Tris SDS-PAGE gel. 
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6.3.4 In-solution tryptic digestion and LC-MS/MS 
In-solution tryptic digestion and LC-MS/MS was performed with technical assistance by 
Deborah Simpson at the University of Liverpool Centre for Proteome Research facility 
(Chapter, section 2.8.5). In brief, samples were reduced, alkylated and in-solution tryptic 
digested.  Following desalting using procedure the digested peptide mixture was assessed 
using label-free identification and quantification on LC-MS/MS using Ultimate 3000 nano 
system for peptide separation which was coupled to Q Exactive instrument for tandem mass 
spectrometry.  
 
6.3.5 Proteomic data analysis  
a) Protein identification  
Data was analysed with a PEAKS® de novo and database search against the canine protein 
sequence database to identify the protein composition of each tissue. A separate run was 
performed for each group (native ligament, native tendon, 3D ligament and 3D tendon) to 
identify protein composition. Instrument configuration was set up as Orbitrap (Orbi-Orbi) 
and high collisional dissociation (HCD) fragmentation. The following parameters were used 
for the PEAKS® search; parent mass error tolerance, 10.0 ppm; fragment mass error 
tolerance, 0.1 Da, precursor mass search type, monoisotypic; enzyme, trypsin; max missed 
cleavage, 1; non specific cleavage, 1; fixed modification; carbamidomethylation, 57.02Da; 
variable modification; oxidation,  methionine, 15.99 Da, Hydroxylation, 15.99 Da; and 
variable  PTMs per peptide, 3. The results were filtered on the basis of the following 
parameters; de novo average local confidence score (ALC) %) threshold, 50; protein -10lgP> 
20; False discovery rate (FDR) at peptide spectrum matches (PSMs), 1%; and unique 
peptides > 2. The ensemble protein accessions were put into Ingenuity Pathway Analysis 
(IPA, Inguinity Systems, Redwood City, CA, USA) and gene symbol with protein description 
and protein subcellular locations were then mapped. Tendon and ligaments contain a wide 
variety of ‘matrisomal proteins’ (Hynes and Naba 2012, Little et al. 2014). The matrisome is 
a part of the proteome that exhibits the complete complement of ECM proteins (Hynes and 
Naba 2012). Matrisomal proteins include collagens, proteoglycans, glycoprotein and other 
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proteins associated with ECM. Therefore the ‘Matrisome Project’ has been used to classify 
proteins into ECM categories (Hynes and Naba 2012, Naba et al. 2012). The remaining 
proteins were categorised according to UNIPROT function description. Gene ontology (GO) 
and protein network analysis was carried out using the String bioinformatics tool.   
b) Quantification of differential expressed proteins 
Differentially expressed proteins were analysed using Progenesis™ LC-MS software 
(Nonlinear dynamics) with data searched for protein identification in PEAKS® with de novo 
and database search against the canine protein sequence database. After adjusting to 1% 
false discovery rate (FDR) and unique peptides > 2, the search hits were imported into 
Progenesis™ for label free quantification. Statistical analysis was performed on all detected 
features using transformed normalized abundances for one-way analysis of variance 
(ANOVA). Identification of proteins with two or more peptides, greater than 2 fold 
abundance and with a q value (p-value adjusted to FDR) <0.05 were considered significant. 
Quantitative analysis was initially performed by comparing the four groups of tissue samples 
together. After that pair-wise comparisons were performed between native ligament and 
tendon, native ligament and 3D ligament, native tendon and 3D tendon, and 3D ligament 
and 3D tendon.  
c) Comparison of post-translational modifications (PTMs) between native tendon and 
ligament  
Post-translational modification of protein (PTMs) can modulate the protein function as it 
can regulate numerous facets of a protein, including protein turnover and localisation, 
complex assembly, enzyme activity, protein-protein interactions and modulation of  various 
signalling cascades (Karve and Cheema 2011). The PEAKS® software includes the advanced 
PEAKS® PTM algorithm for identifying peptides with unspecified modifications (Han et al. 
2011). Using the parameters as detailed in Section 6.3.5a, a PEAKS PTM file for native 
tendon and ligament were used to compare PTMs of collagens, large proteoglycans and 
small leucine rich proteoglycans between the two tissue types.  
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6.4 RESULTS 
6.4.1.1 Qualitative proteomes of native and tissue engineered tissues 
A total of 3569, 3743, 4481 and 5790 peptides assigned to 167, 215, 442 and 561 proteins 
each with the presence of more than 2 unique peptides were identified in native ligament, 
native tendon, 3D ligament and 3D tendon respectively (Table 6.1). Between both native 
tissues and engineered tissues 93 proteins were common, which included both ECM and 
cellular proteins (Figure 6.2). The common matrisomal proteins between tendon and 
ligament native tissues and 3D constructs are highlighted in Table 6.2.  
Identified proteins for each tissue were classified into matrisomal proteins (Matrisome 
Project) and into the other categories based on their function (Supplementary data, Chapter 
8, Table S1).  
  
Native tissues (CCL and LDET) protein composition  
The native ligament proteome consisted of 50% matrisomal proteins, 10.3% nucleosome 
related protein, 8.5% cytoskeleton and related proteins, 8.5% metabolic enzymes, 7.9% 
proteins associated with translation and signalling, 4.8% proteins associated with immune 
and inflammatory response, 3.6% proteins associated with transport and membrane 
activity, 2.4% proteins associated with chaperone, stress, and protein folding, 2.4% proteins 
associated with detoxification, 1.2% proteins associated with development and 0.6%  
associated with proteolytic activity (Figure 6.3A). About 53% of native ligament proteins 
locations were annotated to extracellular space and the rest were distributed between the 
cytoplasm, nucleus and plasma membrane (Figure 6.3B). Ligament matrisomal proteins 
were annotated as collagens (11), glycoprotein (27), proteoglycans (13), ECM-regulators 
(10), ECM-affiliated (11), and ECM-secreted factors (9). Analysis for String protein network 
and gene ontology (GO) resulted in connected clusters around ECM proteins and matrisome 
associated proteins with the principal gene ontology processes identified as ECM 
organisation, wound healing and collagen fibril organisation  (FDR adjusted p-values of 
3.75e-27 and 1.85e-14, 1.19e-13 respectively) (Figure 6.4).  
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The native tendon proteome contained 39.7% matrisomal proteins, 13.1 % nucleosome 
related protein, 10.7% cytoskeleton and related protein, 9.3% metabolic enzymes, 8.4%  
protein associated with translation and signalling, 4.7% proteins associated immune and 
inflammatory response, 4.2% proteins associated with transport and membrane activity, 
4.2% proteins associated with chaperone, stress, and protein folding, 2.8% proteins 
associated with detoxification, 2.3% proteins associated with development and 0.5% 
associated with proteolytic activity (Figure 6.3C). About 45% of proteins locations were 
annotated to the extracellular space and the remainder to the cytoplasm, nucleus or plasma 
membrane (Figure 6.3D). Similar to ligament, the protein-protein interaction in tendon was 
mainly between ECM and other matrisome associated proteins, with similar ontology 
process identified such as extracellular matrix organisation, wound healing, collagen fibril 
organisation (FDR adjusted p-values 1.53e-26, 1.94e-14, 2.01e-21 respectively) (Figure 6.5). 
Based on matrisome annotations, in tendon there were collagens (11), proteoglycans (13), 
glycoproteins (30), ECM regulators (11), ECM-secreted factors (8) identified.  
 
Tissue engineered tendon and ligament 3D constructs protein compositions 
The ligament 3D construct proteome contained 23.1% proteins associated with translation 
and signalling, 15.2% as proteins associated with nucleosome, 14.3% matrisomal proteins, 
12.4% cytoskeletal proteins and related proteins, 12.2% metabolic enzymes, 7.5% proteins 
associated with transport and membrane activity, 6.6% chaperones, stress and protein 
folding, 3.6% proteins associated with detoxification, 2.0% proteins associated with immune 
and inflammatory response, 1.1% proteins associated with biodegradative metabolism and 
1.1%  associated proteolytic activity (Figure 6.6A). The tendon construct consisted of  20.5% 
proteins associated with translation and signalling, 16.6%  metabolic enzymes, 14.6% 
proteins associated with nucleosome, 11.9% matrisomal proteins, 10.7% cytoskeletal 
proteins and related proteins, 8.9%  proteins associated with transport and membrane 
activity, 6.1% chaperones, stress and folding domains, 3.2% proteins associated with 
detoxification, 2.7% proteins associated with biodegradative metabolism, 2.0% proteins 
associated with immune and inflammatory response, 1.6% as proteins associated with 
development and 1.2% as proteins associated proteolytic  activity (Figure 6.6C). In both 3D 
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constructs an average of 66.3% protein were associated with cytoplasmic location, 
indicating high cellularity of these tissues (Figure 6.6B and 6.6D). This was further confirmed 
with String analysis whereby the main connected cluster was between ribosomal proteins 
(Figure 6.7 and 6.8). There was also association between cytoskeletal proteins, metabolic 
enzymes and heatshock proteins. Principle ontology for 3D ligament and 3D tendon involved 
translational elongation (FDR adjusted p-values 3.71e-65, 2.3e-63), protein targeting to ER 
(FDR adjusted p-values 9.98e-64, 1.75e-65) (Figure 6.6 and 6.7). Matrisomal protein in 3D 
ligament and 3D tendon consisted of 10 collagens, 18 glycoproteins and 11 ECM-regulators 
in both, 8 and 9 proteoglycans, 11 and 13 ECM-affiliated, and 5 and 6 ECM-secreted factors 
respectively.   
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Tissues Identified 
PSM 
Peptide 
sequences 
Proteins Unique 
peptides  
Native ligament  14956 3569 167 
129 ≥2 
38= 2 
Native tendon  14587 3743 215 
156≥2 
59= 2 
 
3D ligament  13805 4481 442 
339≥2 
103=2 
 
3D tendon 17009 5790 561 
431>2 
130=2 
 
 
Table 6.1. Overview of PEAKS® database search results for native CCL and LDET tissue and 3D 
CCL and LDET construct. 
 
 
 
 
 
Figure 6.2. Venn diagram of native (CCL/LDET) and 3D tissues with the total number of 
proteins identified in each tissue as well as common proteins between the tissues.  
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Table 6.2.Matrisomal proteins in common between tendon and ligament native tissues and 3D constructs. Identified proteins had a -10lgP >20 
(p < 0.01) and unique proteins > 2. 
ECM collagens ECM proteoglycanS  ECM glycoproteins 
 
ECM affiliated proteins 
 
Secreted factors  
 
Collagen type III, alpha 1 
Collagen type V, alpha 1 
Collagen type VI, alpha 2 
Collagen, type I, alpha 1 
Collagen, type I, alpha 2 
Collagen, type I, alpha 2 
Collagen, type V, alpha 2 
Collagen, type VI, alpha 1 
Collagen, type VI, alpha 3 
Collagen, type XII, alpha 1 
 
Asporin 
Biglycan 
Decorin 
Heparan sulfate 
Proteoglycan 2 
Lumican 
Osteoglycin 
Proline/arginine-rich 
end leucine-rich 
repeat protein 
 
Dermatopontin 
Dlastin microfibril interfacer 1 
Fibrillin 1 
Fibrinogen alpha chain 
Fibrinogen beta chain 
Fibrinogen gamma chain 
Fibulin 1 
Microfibrillar-associated protein 2 
Milk fat globule-EGF factor 8 protein 
Tenascin C 
Thrombospondin 1 
Transforming growth factor, beta-
induced 
Vitronectin 
Annexin A1 
Annexin A2 
Annexin A4 
Annexin A5 
Lectin, galactoside-binding, 
soluble, 1 
Lectin, galactoside-binding, 
soluble, 3 
 
S100 calcium binding protein A10 
S100 calcium binding protein A11 
S100 calcium binding protein A4 
S100 calcium binding protein A6 
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Figure 6.3. Overview of native ligament and tendon proteomes which were subdivided based on 
matrisomal proteins and on function (A, C) with the associated subcellular locations of the 
proteins in both tissues (B,D). 
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Figure 6.4. String analysis of native canine CCL.  Stronger associations are represented by 
thicker lines. Two highly connected clusters were evident, with the first cluster between 
collagens, proteoglycans and elastin associated proteins (red circle) and second cluster 
between matrisome associated proteins (black circle). The main principal gene ontology 
processes were identified as ECM organisation (p=3.75e-27), wound healing (p=1.85e-14) and 
collagen fibril organisation (p=1.19e-13). 
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Figure 6.5. String analysis of native canine LDET. ECM proteins (red circle) and matrisome 
associated proteins (black circle) have the most evident protein-protein interaction. The main 
principal gene ontology processes were identified as ECM organisation (p=2.1e-28), wound healing   
(p=8.7e-15) and collagen fibril organisation (p=1.5e-13). 
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Figure 6.6. Overview of the proteomes of 3D ligament and 3D tendon constructs which were 
subdivided based on matrisomal proteins and on function (A,B) with the associated subcellular 
locations of the proteins in both tissues (C, D). 
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Figure 6.7. String analysis of 3D ligament construct. The strongest predicted protein-protein 
interaction is between the ribosomal proteins, which are mainly clustered together (red circle). The 
main principal gene ontology processes were identified as translational elongation (p=3.71e-65) and 
protein targeting to ER (p=9.98e-64). 
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Figure 6.8. String analysis of 3D tendon construct. The most connected cluster was between 
ribosomal proteins (red circle). The main principal gene ontology processes were identified as 
translational elongation (p=3.71e-65) and protein targeting to ER (p=9.98e-64). 
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6.4.2 Label free quantification  
Quantitative analysis was performed using Progenesis™ LC-MS software for group 
comparison between both native tissues and 3D constructs and pairwise comparisons as 
described earlier.  
 
6.4.2.1 Quantitative differences of all group comparisons  
Overall we identified 387 proteins that were different between the four tissue types, with 
38 proteins being abundant in native ligament, 26 in native tendon, 4 in 3D ligament 
construct and 361 in 3D tendon construct. (Supplementary data, Chapter 8, Table S2). 
Principle component analysis (PCA) of either the peptide or protein PCA plots revealed that 
native ligament and tendon are grouped together and are therefore distinct, whereas 3D 
ligament and tendon did not split into discrete groups (Figure 6.9A and 6.9B).  
 
6.4.2.2 Quantitative differences between native ligament and tendon 
There were a total of 45 proteins identified with 2 or more peptides and more than 2-fold 
change that were different between native tendon and ligament (Figure 6.10A). Of the 45 
proteins, 32 proteins had p < 0.05 (adjusted to FDR) (Table 6.3). Proteins more abundant in 
ligament included those also present in cartilaginous tissues, such as collagen, type II, alpha 
1, agreccan, chondroadherin, and superoxide dismutase 3. While tendon abundant proteins 
were thrombospondin 4, asporin and collagen, type XII. The abundance of collagen type III, 
agrreccan, and versican, asporin corresponds with the previously reported 
immunohistochemistry results, where increased staining was observed. (Chapter 4),  
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6.4.2.3 Quantitative differences between native tissues and 3D constructs 
Comparison of native ligament and 3D ligament construct  
Between native ligament and 3D ligament there were 363 identified proteins there were 
different. All proteins identified had more than 2 peptides (q-value ≤0.05 and more than 2-
fold change) (Figure 6.10C). 301 proteins were down-regulated in 3D ligament and 62 
proteins were up- regulated for native ligament. The top ten proteins with highest fold 
changes in each tissue are depicted in Figure 6.11A. Both Figure 6.10C and 6.11A were 
curated from Supplementary data Table S3 (Chapter 8).  
Comparison between native tendon and 3D tendon construct 
Figure 6.10D shows a subset of 383 identified proteins that were different between native 
tendon and 3D tendon. All proteins identified had more than 2 peptides with p-value ≤0.05 
(adjusted to FDR) and more than 2-fold change. 321 proteins were down-regulated in 3D 
tendon and 62 up-regulated native tendons. Figure 6.11B shows a subset of top twenty 
proteins with highest fold change. Both Figure 6.10D and 6.11B were curated from Table S4 
(Supplementary data, Chapter 8).  
Observation of abundant proteins in both native ligament and tendon against 3D ligament 
and tendon construct demonstrated not only the presence of significantly more ECM 
proteins, enzyme enhancer but also blood/plasma protein in both native tissues. On the 
other hand both 3D constructs had significantly more cellular protein, which has also been 
highlighted with qualitative proteomes of the both 3D tendon and ligament constructs. 
 
Quantitative differences between 3D ligament and 3D tendon constructs 
There were 4 proteins identified with 2 or more peptides and more than 2-fold change that 
were different between 3D ligament and 3D constructs (Figure 6.10B). Even though the 
ANOVA p-value was less than 0.05, when looking at the FDR adjust p-value (q-value), all 
values were more than 0.05. This may also be explained by looking expression plots, 
whereby an overlap between the two groups can be seen (Figure 6.12). 
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Figure 6.9.  Principal component analysis (PCA) between native tendon and ligament and 3D 
tendon and ligament constructs at peptide (A) and protein level (B). This PCA plot was 
produced by ProgenesisTM after ANOVA analysis with identified peptide and proteins at p-
value < 0.05.  PCA was used to identify the major variance between the groups. Native 
tendon (purple dots) and ligament (pink dots) are grouped together and are therefore more 
distinct, whereas both 3D tendon and ligament constructs do no split into discrete groups 
(blue and orange dots). 
Native ligament  3D ligament Native tendon 3D tendon 
Native ligament  Native tendon 3D ligament 3D tendon 
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Figure 6.10. Volcano plots (-10lgP of FDR adjusted p-value vs log2 fold change) for: (A) Native ligament vs Native tendon, (B) 3D ligament vs 3D 
tendon, (C ) Native ligament tendon vs 3D ligament,  and (D) Native tendon vs 3D tendon.  Volcano plots of quantified proteins in A, C and D 
indicated up-regulated and down-regulated proteins with up-fold and down-fold change with large significance. This was not the case in 
volcano plot D, as quantified proteins had a p-value (adjusted to FDR) >0.05. 
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P=0.05 
P=0.05 
P=0.05 
A 
B 
C 
D 
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Table 6.3. Differences in abundant proteins between native ligament and tendon*.  
Accession ID Protein description Peptide 
count 
Anova (p) q value Max 
fold 
change 
Highest 
mean 
condition 
Log2 
(L/T) 
Function 
ENSCAFP00000016949 ACAN Aggrecan core protein  12 2.8E-06 0.0002 23.38 Ligament  4.42 Large aggregating proteoglycan  that provides a hydrated gel structure 
via interaction with hyaluronan and link protein (Kiani et al. 2002) 
ENSCAFP00000025121 CHAD Chondroadherin 6 5.9E-05 0.0021 17.53 Ligament 4.13 Plays an important role in bone and cartilage homeostasis (Hessle et 
al. 2013) 
ENSCAFP00000042916 HAPLN1 Hyaluronan and proteoglycan 
link protein 1 
7 0.00014 0.0032 13.58 Ligament 3.64 Stabilizes the aggregates of proteoglycan monomers 
ENSCAFP00000013230 THBS4 Thrombospondin 4 21 0.0002 0.004 9.84 Tendon -3.28 Regulates the composition of the ECM at major sites of its deposition 
(Frolova et al. 2014) 
ENSCAFP00000041629 PCOLCE2 Procollagen C-endopeptidase 
enhancer 2 
2 1.2E-06 0.0001 8.04 Ligament 3.02 
Binds to the C-terminal propeptide of types I and II procollagens and 
may enhance the cleavage of that propeptide by BMP1 (Steiglitz et al. 
2002) 
 
ENSCAFP00000021988 MYOC Myocilin,  23 7.5E-05 0.0023 7.42 Tendon -2.88 Modulates Wnt signalling and regulates the actin cytoskeleton (Kwon 
et al. 2009) 
ENSCAFP00000018471 HTRA1 Serine protease HTRA1 9 2.3E-05 0.0014 6.65 Ligament 2.71 
Serine protease with a variety of targets, including extracellular matrix 
proteins 
ENSCAFP00000013330 COL2A1 Collagen, type II, alpha 1 26 0.00166 0.0152 6.00 Ligament  2.52 Specific for cartilaginous tissues. It is essential for the normal 
embryonic development of the skeleton 
ENSCAFP00000010055 OLFML1 Olfactomedin-like 1 3 0.00036 0.006 5.56 Tendon -2.44 Abundant expression in brain suggests that it may have an essential 
role in nerve tissue 
ENSCAFP00000013989 Abi3bp ABI gene family, member 3 
binding protein 
9 4.1E-05 0.0016 5.41 Ligament 2.46 
Exact role unclear but has been found to play an important role in 
MSC biology(Hodgkinson et al. 2013) 
 
ENSCAFP00000021176 FN1 Fibronectin 1 16 0.00338 0.0242 5.33 Ligament 2.35 Glycoprotein of the extracellular matrix that binds to membrane-
spanning receptor proteins called integrins (Pankov and Yamada 
2002). 
ENSCAFP00000033127 ASPN Asporin 17 0.00047 0.0063 5.18 Tendon -2.38 Competes with collagen binding (Kalamajski et al. 2009) 
ENSCAFP00000012600 VCAN Versican 13 0.00032 0.0043 4.77 Ligament 2.21 Large proteoglycan that plays role in cell adhesion, proliferation, 
migration and extracellular matrix assembly (Wight 2002) 
ENSCAFP00000023923 SERPINE2 Serpin peptidase inhibitor, 
clade E, member 2 
2 4E-05 0.0016 4.34 Ligament 2.08 Antiprotease activity (Bouton et al. 2012) 
ENSCAFP00000003954 COL12A1 Collagen, type XII, alpha 1 2 0.00914 0.0419 4.28 Tendon -2.05 Interacts with type I collagen-containing fibrils 
ENSCAFP00000001150 FBLN1 Fibulin 1 7 0.00014 0.0032 4.02 Ligament 1.96 Incorporated into fibronectin-containing matrix fibers and may play a 
role in cell adhesion and migration along protein fibers within the 
ECM 
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Accession ID Protein description Peptide 
count 
Anova (p) q value Max fold 
change 
Highest mean 
condition 
Log2 
(L/T) 
Function 
ENSCAFP00000005060 CAV1 Caveolin 1, caveolae protein 3 0.00171 0.0152 3.44 Tendon -1.74 May act as a scaffolding protein within caveolar membranes 
ENSCAFP00000042302 AHNAK AHNAK nucleoprotein 20 0.00116 0.0134 3.36 Tendon -1.72 Interacts with dysferlin (Huang et al. 2007) 
ENSCAFP00000017002 MFGE8 Milk fat globule-EGF factor 8 
protein 
9 0.00762 0.0402 3.12 Ligament  1.62 Important role in the maintenance of intestinal epithelial 
homeostasis and the promotion of mucosal healing (Raymond 
et al. 2009) 
ENSCAFP00000004677 UGP2 UDP-glucose 
pyrophosphorylase 2 
3 0.00124 0.0137 2.84 Ligament 1.46 Plays a central role as a glucosyl donor in cellular metabolic 
pathways 
ENSCAFP00000024271 SOD3 Superoxide dismutase 3, 
extracellular 
9 0.00703 0.0397 2.76 Ligament 1.48 Protect the extracellular space from toxic effect of reactive 
oxygen 
ENSCAFP00000021570 COMP Cartilage oligomeric matrix 
protein 
2 0.00424 0.027 2.66 Ligament 1.39 role in the structural integrity of cartilage  
ENSCAFP00000003680 COL15A1 Collagen, type XV, alpha 1 6 0.00861 0.041 2.45 Ligament 1.27 Stabilizes microvessels and muscle cells, both in heart and in 
skeletal muscle.  
ENSCAFP00000023709 GLUD1 Glutamate dehydrogenase 1 6 0.00751 0.0402 2.38 Tendon -1.21 Mitochondrial glutamate dehydrogenase that converts L-
glutamate into alpha-ketoglutarate. 
ENSCAFP00000025819 SRPX2 Sushi-repeat containing 
protein, X-linked 2 
2 0.00042 0.006 2.32 Ligament 1.19 Acts as a ligand for the urokinase plasminogen activator 
surface receptor. (Royer-Zemmour et al. 2008) 
ENSCAFP00000029164 ENO1  Enolase 1 13 0.00418 0.028 2.27 Ligament 1.93 Multifunctional enzyme. Plays role in glycolysis and other 
process such growth control and hypoxia tolerance  
ENSCAFP00000027321 MYL12A Myosin, light chain 12A, 
regulatory, non-sarcomeric 
6 0.00171 0.0152 2.23 Tendon -1.18 Responsible for many types of cell movements 
ENSCAFP00000023831 ANXA8L1  Annexin A8-like 1 3 0.00148 0.0152 2.17 Ligament 1.00 Vascular anticoagulant (Hauptmann et al. 1989) 
ENSCAFP00000034804 CLU Clusterin 7 0.00776 0.0446 2.16 Ligament 1.06 Associated with cell apoptosis(Jones and Jomary 2002) 
ENSCAFP00000025244 CILP Cartilage intermediate layer 
protein 
17 0.00536 0.0317 2.14 Ligament 1.08 Is upregulated with ageing and early OA and may be involved 
in the ectopic calcifications in the arthritic mice (Yao et al. 
2004) 
 
ENSCAFP00000039083 COL3A1 Collagen type 3, alpha 1 3 0.00052 0.0066 2.08 Ligament 1.06 Occurs in most soft connective tissues along with type I 
collagen. 
ENSCAFP00000023240 TPM4 Tropomyosin 4 10 0.0063 0.0364 2.02 Tendon -1 Binds to actin filaments in muscle and non-muscle cells. Binds 
to calcium  (Crabos et al. 1991) 
*Tables 6.3 includes 32 identified proteins that were different between native ligament and tendon with statistically significance. The following 
criteria were applied: 1) The proteins were identified and quantified with ≥ 2 unique proteins in all samples, 2) > 2-fold change and FDR 
adjusted p-value ANOVE < 0.05 as determined by ProgenesisTM. Log2 T/C indicates Log 2 of native ligament / native tendon. Ligament was 
more abundant in cartilaginous protein such as agreccan, chondroadherin, collagen type II, alpha 1, while tendon had more thrombospondin 4 
and asporin 
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Figure 6.11. Different abundant proteins between native tendon and ligament tissues and 3D tendon and ligament constructs. The histograms 
depicts results of label-free relative protein quantification using Progenesis™ software for the top ten abundant proteins in each tissue type. 
Changes in protein expression of log2 native ligament/3D ligament (A) and log 2native tendon/3D tendon (B) for proteins identified with ≥2 
peptides and FDR adjusted p-value ≤0.05 and more than 2-fold regulated are depicted. 
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Type  Proteins description ID Accession Mean Log2 
Fold change  
Collagen 
Collagen 
Collagen 
Collagen 
Collagen 
Collagen  
Collagen  
Collagen  
Collagen, type XV, alpha 1 
Collagen, type VI, alpha 1 
Collagen type VI, alpha 2 
Collagen, type VI, alpha 3 
Collagen type III, alpha 1 
Collagen, type II, alpha 1 
Collagen, type I, alpha 2 
Collagen, type I, alpha 1 
COL15A1 
COL6A1 
COL6A2 
COL6A3 
COL3A1 
COL2A1 
COL1A2 
COL1A1 
ENSCAFP00000003680 
ENSCAFP00000017530 
ENSCAFP00000041957 
ENSCAFP00000018017 
ENSCAFP00000039083 
ENSCAFP00000013330 
ENSCAFP00000029400 
ENSCAFP00000025056 
3.9 
2.7 
2.7 
2.1 
2.5 
2.7 
1.9 
1.9 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ECM protein 
ABI gene family, member 3 binding protein 
Aggrecan core protein 
Asporin 
Biglycan 
Cartilage intermediate layer protein 
Cartilage intermediate layer protein 2 
Cartilage oligomeric matrix protein 
Decorin 
Dermatopontin 
Fibulin 1 
Fibromodulin 
Fibronectin 1 
Keratocan 
Lumican 
Matrilin 2 
Osteoglycin 
Proline/arginine-rich end leucine-rich repeat 
protein 
Proteoglycan 4  
Transforming growth factor, beta-induced 
Thrombospondin 1 
Thrombospondin 4 
Tenascin C 
Tenascin XB 
Vitronectin 
Abi3bp 
ACAN  
ASPN 
BGN 
CILP 
CILP2 
COMP 
DCN 
DPT 
FBLN1 
FMOD 
FN1 
KERA 
LUM 
MATN2 
OGN 
PRELP 
 
PRG4 
TGFBI 
THBS1 
THBS4 
TNC 
TNXB 
VTN 
ENSCAFP00000013989 
ENSCAFP00000016949 
ENSCAFP00000033127 
ENSCAFP00000028297 
ENSCAFP00000025244 
ENSCAFP00000042401 
ENSCAFP00000021570 
ENSCAFP00000009230 
ENSCAFP00000022484 
ENSCAFP00000001150 
ENSCAFP00000013913 
ENSCAFP00000021176 
ENSCAFP00000009210 
ENSCAFP00000009219 
ENSCAFP00000000680 
ENSCAFP00000003355 
ENSCAFP00000013916 
 
ENSCAFP00000020163 
ENSCAFP00000001531 
ENSCAFP00000012843 
ENSCAFP00000013230 
ENSCAFP00000036170 
ENSCAFP00000043117 
ENSCAFP00000027547 
3.0 
5.4 
2.6 
4.2 
4.0 
5.1 
7.4 
5.6 
2.6 
2.6 
5.4 
2.3 
4.9 
4.4 
1.7 
6.4 
5.2 
3.7 
 
3.6 
4.0 
3.2 
2.4 
4.0 
3.8 
Enzyme/enhancer 
Enzyme/enhancer 
Enzyme/enhancer 
Enzyme/enhancer 
Enzyme/enhancer 
Procollagen C-endopeptidase enhancer 
Procollagen C-endopeptidase enhancer 2 
Superoxide dismutase 3 
Lysyl oxidase 
Matrix metallopeptidase 3  
PCOLCE 
PCOLCE2 
SOD3 
LOX 
MMP3 
ENSCAFP00000021146 
ENSCAFP00000041629 
ENSCAFP00000024271 
ENSCAFP00000038725 
ENSCAFP00000022195 
2.61 
4.69 
3.7 
6.0 
2.4 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Blood/plasma protein 
Hemoglobin subunit alpha 
Hemoglobin, beta 
Serpin peptidase inhibitor, clade A member 1 
Serpin peptidase inhibitor, clade C member 1 
Serpin peptidase inhibitor, clade F member 1 
Transferrin 
Transthyretin 
Histidine-rich glycoprotein 
Hemopexin 
Haptoglobin 
Albumin 
Apolipoprotein A-I 
C-reactive protein, pentraxin-related 
Glutathione peroxidase 3 (plasma) 
Milk fat globule-EGF factor 8 protein 
Plasminogen 
HBA 
HBB 
SERPINA1 
SERPINC1 
SERPINF1 
TF 
TTR 
HRG 
HPX 
HP 
ALB 
APOA1 
CRP 
GPX3 
MFGE8 
PLG 
ENSCAFP00000042411 
ENSCAFP00000021235 
ENSCAFP00000031948 
ENSCAFP00000021382 
ENSCAFP00000028380 
ENSCAFP00000040309 
ENSCAFP00000026675 
ENSCAFP00000020009 
ENSCAFP00000009637 
ENSCAFP00000029992 
ENSCAFP00000004489 
ENSCAFP00000019630 
ENSCAFP00000017329 
ENSCAFP00000038899 
ENSCAFP00000017002 
ENSCAFP00000001078 
4.4 
4.8 
4.4 
2.8 
3.8 
2.7 
4.2 
2.1 
2.4 
3.5 
3.1 
2.8 
4.8 
2.6 
3.6 
2.3 
Other proteins  
Other proteins  
Other proteins  
Other proteins 
Other proteins 
Angiopoietin-like 7 
Clusterin 
Glutamyl-prolyl-tRNA synthetase 
Olfactomedin-like 1 
Sushi-repeat containing protein, X-linked 2 
ANGPTL7 
CLU 
EPRS 
OLFML1 
SRPX2 
ENSCAFP00000024545 
ENSCAFP00000034804 
ENSCAFP00000016021 
ENSCAFP00000010055 
ENSCAFP00000025819 
3.5 
1.8 
2.0 
1.9 
4.4 
Table 6.4. Abundant proteins in both native tendon and ligament tissues in comparison 3D 
tendon and ligament constructs. Both native tissues had more abundant ECM, enzyme and 
blood/plasma proteins. 
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Figure 6.12. Expression plots of 3D ligament construct versus 3D tendon construct of selected proteins produced by Progenesis™ LC-MS. All 
proteins were identified by 2 or more peptides with greater than 2 fold abundance change and p values <0.05. 3D ligament constructs are blue 
dots on a blue background and 3D tendon constructs are orange dots and on a orange background. Plots display the mean Arcsinh 
transformed normalised volume for each group. Error bars demonstrate standard deviation within groups. 
prolyl 4-hydroxylase, alpha polypeptide  
p-value= 0.015  qvalue= 0.145 
Stomatin   
p-value= 0.015   q-value= 0.145 
 
Collagen, type XV, alpha 1, 
p-value=0.023  q-value=0.145                                   
Procollagen C-endopeptidase enhancer 2 
p-value= 0.043 qvalue=0.145 
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6.4.3 Post-translational modification differences between native tendon and ligament  
PTMs comparisons of collagens, proteoglycans between native tendon (LDET)  and ligament 
(CCL) tissue showed differences in the post-translational modification of collagen alpha-1(I), 
collagen alpha-1(I) and collagen alpha-1(III) with hydroxylation occasionally being present 
on different proline and lysine residues (Figure 6.13 and Figure 6.14).   
 
Figure 6.13. Post-translational modification of collagen alpha-1(I) and collagen alpha-2 (I) 
between native tendon and ligament. Differences were seen in post-translational hydroxylation, 
occasionally occurring on different proline and lysine sites. The green arrows represent the 
presence of post-translational hydroxylation and the red arrows represent the missed of post-
translational hydroxylation located on the same amino acid. The partial sequence collagen 
alpha-1 (I) and collagen alpha-1 (II) is represented. 
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Figure 6.14. Post-translational modification of collagen alpha-1(III) between native tendon and 
ligament. Differences were seen in post-translational hydroxylation, occasionally occurring on 
different proline and lysine sites.  The green arrow represent the presence of post-translational 
hydroxylation and the red arrows represent the absent of post-translational hydroxylation located 
on the same amino acid. The partial sequence of collagen alpha-1(III) is represented with PTMs 
variations.  
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6.5 DISCUSSION 
In this study the proteomic comparison between native canine LDET and the CCL was 
performed. 3D fibrin tendon and ligament constructs were created from isolated canine 
LDET and CCL tissue adults cells. The proteome of 3D tendon and ligament constructs were 
characterised and compared to native tendon and ligament tissues. Our findings indicate 
specific protein differences between native tendon and ligament and demonstrated that 3D 
in vitro culture of tendon and ligament cells are able to recapitulate tendon and ligamentous 
tissue characteristics particularly with regards to ECM proteins. 
 
6.5.1 Proteomic comparison between native tendon and ligament 
Qualitative proteome comparison- the CCL and LDET proteomes had similar matrisomal and 
cellular proteins. More proteins were identified in tendon than ligament that were 
associated with cytoplasmic localisation. Protein network analysis resulted in a highly 
connected cluster between ECM proteins and other matrisomal proteins and indicated a 
complex relationship between these proteins.  
Quantitative proteome comparison- Statistically significant quantitative proteome 
differences between (in different collagens, proteoglycans, glycoprotein and several cellular 
proteins) the ligament (CCL) and tendon (LDET) were identified  
Collagen types II and III were found to be more abundant in ligament than tendon. The 
higher proportion of collagen type III agrees with previous reports, which compared rabbit 
cruciate ligament to patellar tendon (Amiel et al. 1984) and human ACL to patellar tendon 
(Little et al. 2014). It also agrees with the increase immunostaining of collagen type III in 
CCL, where it was found to have a more widespread distribution located on the CCL 
substance and between collagen fascicles and fibre bundles (Chapter 4). This might indicate 
that in the ligament collagen type III may play more of an essential role in bridging collagens 
with adjacent matrix, which could also be important for the pliability of the ligament.    
Collagen type II has mainly been found at fibrocartilaginous regions in porcine ACL and 
posterior cruciate ligament (PCL) (Young et al. 2002) and in human ACL where it was found 
in pericellular matrix of the chondrocytes (Petersen and Tillmann 1999). In this study the 
 
 
174 
 
variance between different regions of the CCL was not discriminated, hence the higher 
collagen type II levels in the ligament may be reflected due to the localisation of collagen 
type II at the at the origin or insertion fibrocartilagenous regions. However, the presence of 
collagen type II has also been identified in mid-region of porcine ACL (Young et al. 2002), 
indicating the formation of fibrocartilage in central region of the ligament. This might alter 
the mechanical properties of the ligament, increasing its stiffness and changing the 
translation of loading across the femoro-tibial articulation (Young et al. 2002). In the canine 
CCL the localisation and organisation of collagen type II is yet to be identified.  The higher 
collagen type II mRNA gene expression in porcine patellar tendon compared than porcine 
ACL (Pearse et al. 2009), does not agree with findings in this study and may be dependent 
on the presence of post-translational regulation pathways or differences in proteins 
deposited during development as compared to gene expression at a particular time point.  
Higher levels of proteoglycan core proteins were found in ligament than in tendon, which 
corresponds with the data presented in Chapter 3, showing greater amounts of sGAG in the 
CCL. Previous studies have identified the presence of aggrecan in canine CL (Valiyaveettil et 
al. 2005) and versican in rabbit ACL (Tischer et al. 2007). Aggrecan and versican were also 
identified in human ACL but not in patellar tendon using proteomic analysis in a recent 
study (Little et al. 2014). These findings are supported by the current study, as both 
aggrecan and versican were elevated in ligament compared to tendon. Furthermore the 
elevated aggrecan and versican corresponds to the increased staining of these proteins 
located between collagen fibres (interfascicular area) of the CCL (Chapter 4, Section 4.4.2.3). 
Hyaluronic acid and link protein (HAPLN) was also found to be higher in ligament than in 
tendon, which could be due to the elevated level of aggrecan in ligament, as aggrecan has 
been demonstrated to interact with HAPLN at its globular 1 domain (Kiani et al. 2002). 
Together, these data might indicate that the increased large aggregating proteoglycans in 
the ligament may be as result to a functional response to compressive forces and might act 
as a lubricant layer that could modulate the sliding capacity between fascicles and fibre 
bundles.   
The small leucine rich proteoglycan (SLRP) chondroadherin was up-regulated in ligament 
whereas another SLRP, asporin was more abundant in tendon. The predominance of asporin 
in tendon in this study was in contrast to findings in human ACL and patellar tendon (Little 
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et al. 2014). Asporin is known to compete for type I collagen binding with decorin with a 
high affinity site located in the C-terminal part of the protein. It binds to collagen and 
induces mineralisation through its variable domain that contains a polyaspartic tail, 
indicating that asporin has a role in osteoblast-driven collagen biomineralisation activity 
(Kalamajski et al. 2009). In periodontal ligament asporin has been found to prevent 
mineralisation by regulation BMP-2 activity. This data suggests that elevated levels of 
asporin in tendon might function to prevent mineralisation in this tissue. Chondroadherin is 
particularly highly expressed in cartilaginous tissues and has been suggested to have role in 
in the regulation of chondrocyte growth and proliferation (Shen et al. 1998). The absence of 
chondroadherin leads to a distinct skeletal phenotype, demonstrating that it has an 
important role in cartilage and bone turnover (Hessle et al. 2013). Identification of 
chondroadherin in this study may indicate an important role in ligament homeostasis and 
function.  
A number of glycoproteins including cartilage oligomeric matrix protein, cartilage 
intermediate layer protein, fibronectin and fibulin were identified and were more highly 
expressed in ligament. Conversely, thrombospondin 4 was more abundant in tendon. These 
findings support previous reports on the proteomic comparison between ACL and patellar 
tendon, apart from the thrombospondin-4, which was up-regulated in ACL (Little et al. 
2014).  
ECM regulators and affiliated proteins such as annexin-8-like, clusterin, serpine protease 
inhibitor 2 were up-regulated in ligament. Principle gene ontology (GO) of ligament 
identified these proteins under the GO term ‘wound healing’. The role of annexin-8-like  has 
been identified as a vascular anticoagulant (VAC-β) (Hauptmann et al. 1989), but it has also 
been associated with cancer (Gerke and Moss 2002). Clusterin is associated with cell 
apoptosis (Jones and Jomary 2002) and has previously been identified in tendinopathy 
(Millar et al. 2012). Serine protease inhibitor 2 is part of serine protease inhibitors which are 
reported have an antiprotease activity and play a predominant role in the homeostasis of 
the cardiovascular system. They are key modulators of cell adhesion, proliferation, and 
death (Bouton et al. 2012). Together, these ECM regulators and affiliated proteins may play 
an important role in the pathophysiology of the ligament.   
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Significantly more cellular proteins were identified in tendon than ligament, which 
correlates with qualitative proteome results of tendon, whereby more cellular associated 
proteins were found in the tendon proteome. This indicates higher cell content in tendon, 
which would result in more cellular proteins. However it was previously demonstrated that 
there are no differences in DNA content between CCL and LDET (Chapter 3), therefore the 
higher cellular proteins of LDET proteome could be due to the tissue specific metabolic 
and/or functional needs. Cellular proteins such as myosin, tropomyosin, glutamate 
dehydrogenase 1 and myocillin were higher in tendon. The predominance of myocillin may 
be an important finding in this study, as myocillin modulates Wnt signalling, regulates the 
actin cytoskeleton and interacts with fibronectin (Kwon et al. 2009).  In the intervertebral 
disc the expression of myocilin appears to be up-regulated by transforming growth factor-
beta (TGFβ) and by mechanical stimuli (Gruber et al. 2006). Therefore, increased expression 
of myocillin in tendon may suggest differential ability of tendon to respond to changes in 
growth factor signalling and mechanical loading compared to ligament.  
Comparison of post-translational modifications (PTMs)- PTMs in tendon in ligament have 
not been studied before, yet they can reveal important differences that may be associated 
with tissue specific function. Here, the differences in PTMs between tendon and ligament 
collagens, SLRPS and large proteoglycan were analysed. Although no PTM variations were 
found in the SLRPS and large proteoglycans, differences in the post-translational 
modification of collagen alpha-1(I), collagen alpha-2(I) and collagen alpha-1 (III) between 
tendon and ligament were observed with hydroxylation occasionally present on different 
proline and lysine residues on each tissue. The process of hydroxylation plays an important 
role in stabilisation of collagen triple helix conformation and in the collagen synthesis 
process. An increase proline or lysine hydroxylation may indicate that the hydroxylases 
enzymes are more active, which as result could increase the collagen production. Further 
validations are required to confirm the different PTM hydroxylation pattern between 
tendon and ligament. This could be achieved through the use of high resolution mass 
spectrometry (Yang et al. 2012) or through the sequence algorithm that has been developed 
by  Hu et al. (2010) for identifying the hydroxyproline and hydroxylysine sites.  
In summary proteomic comparison between native tendon and ligament demonstrated 
differences in specific ECM proteins, in particular agreccan, chondroadherin, collagen type 
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II, alpha 1, asporin and thrombospondin-4, which is suggestive of fundamental differences 
between these tissue types. The abundance of fibrocartilage proteins in the CCL suggests 
the deposition of cartilage-like matrix in the ligament, which is most likely a physical 
adaptation of the tissue in response to intermittent compressive and shear forces.  
 
6.5.2 Proteomic comparison between native tendon and ligament and tissue engineered 
tendon and ligament 
Qualitative proteome comparison- The protein hits in the 3D tissue constructs were double 
those of the native samples of tendon and ligament (Table 6.1). 3D tendon and ligament 
constructs contained a greater proportion of cellular proteins than native tissues, as an 
average of 66.3% proteins in tendon and ligament constructs and 32.5% proteins in native 
tendon and ligament were associated with the cytoplasmic localisation. However both 3D 
engineered constructs also contained similar core matrisomal and matrisomal-associated 
proteins that were also found in the native tissues, including collagen I, III,V,VI and XII XIV, 
decorin, bigylcan, asporin, osteoglycin, fibronectin 1 and fibrillin 1. These findings indicate 
that 3D constructs are able to recapitulate specific tendon and ligament ECM proteins. 
String analysis revealed a highly connected cluster of ribosomal proteins in both 3D tendon 
and ligament constructs, while most protein-protein interactions in the native tissues were 
associated between extracellular proteins and matrisomal proteins. The principal gene 
ontology process in native tendon and ligament tissue were identified as ECM and collagen 
fibril organisation. Principal ontologies associated with the 3D tendon and ligament 
constructs involved protein translation and targeting. 
Quantitative proteome comparison- when 3D tendon construct and native tendon were 
compared, there were 383 differentially expressed proteins: 321 proteins down-regulated in 
3D tendon and 62 up-regulated in native tendon (Figure 6.10D). 3D ligament constructs and 
native ligament had 363 differentially expressed proteins: 301 proteins down-regulated in 
3D ligament and 62 proteins were up-regulated in native ligament (Figure 6.10C). Both 
native tissues in comparison to 3D constructs were significantly abundant in not only ECM 
and enzyme/enhancers proteins but also in blood/plasma proteins, which correlates with 
our histological finding of blood vessels and reflects the vascularisation of the native tissues 
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(Chapter 4, Section 4.4.1). In contrast both 3D constructs had significantly more cellular 
proteins, correlating with qualitative proteome comparisons. The higher cellularity in 3D 
ligament and tendon construct is possibly due to higher cell content in these tissues 
compared to the native tissues (Chapter 5, Section) and reflects the immature state of the 
constructs.  
Principle component analysis between native tendon, ligament and 3D tendon and ligament 
constructs demonstrated that 3D ligament and tendon groups do not split into discrete 
groups, whereas native tissues were more distinctly clustered together, indicating definite 
differences between their protein content. The results of the PCA plot might indicate why 
there were no significantly differentially expressed proteins between 3D tendon and 
ligament constructs. Although these findings suggest that there are specific protein 
characteristics between native tendon and ligament, fibroblasts of tendon and ligament do 
no result in distinct 3D constructs, thus cell source may not be an important factor for tissue 
engineering. This also indicates that tissue complexity rather than fibroblast phenotype or 
ECM composition may be a more significant challenge for tendon and ligament engineering. 
Tendon and ligament fibroblasts may become phenotypically distinct due to different 
response to the in vivo loading environment or extrinsic factors such as growth factors. 
Further optimisation and development of 3D tendon and ligaments constructs should 
provide insight into the tissue-specific modelling and remodelling mechanism of these 
tissues.  
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6.6 CONCLUSION 
Significant proteomic quantitative differences were identified between native tendon, 
native ligament and 3D tendon and ligament constructs. Specific differences in the 
composition of native tissues were identified with prominent fibrocartilaginous proteins 
such as collagen alpha-1 (II), aggrecan, chondroadherin being more abundant in ligament 
and asporin and thrombospondin 4 more abundant in tendon. Differences in the post-
translational modification of collagen alpha-1(I), collagen alpha-1 (I) and collagen alpha-1 
(III) were observed between native tendon and ligament with hydroxylation occasionally 
present on different proline and lysine residues.  
3D tendon and ligament constructs contained a greater proportion of cellular proteins than 
native tissues, reflecting their immature state. However both tissue constructs contained 
numerous ECM proteins that were also found in the native tissues, including collagen I, III, VI 
and XII, decorin, bigylcan, fibronectin 1 and fibrillin 1.  
Tendon and ligament 3D constructs did not split into discrete groups in the PCA plot, 
whereas native tendon and ligament separated into more distinct groups. This matches 
similar to our proteomic finding between ligament and tendon constructs, as no significantly 
differential expressed proteins were observed between two tissue types.  
These findings support the hypothesis that there are key structural protein differences 
between native tendon and ligament, but that tissue engineered tendon and ligament share 
similar characteristics with the native tissues particularly with regard to prominent ECM. 
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7 CHAPTER SEVEN 
GENERAL DISCUSSION AND FUTURE DIRECTION 
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7.1 GENERAL DISCUSSION 
Tendons and ligaments are important biological structures in both humans and animals. 
They are part of dense connective tissue and are crucial to the function of the 
musculoskeletal system. However, they are commonly damaged due to age-related wear 
and tear, trauma or sports related incidents (Riley 2004, Rees et al. 2009, Cimino et al. 
2010). The healing process of ligament and tendon healing is complex and varies from tissue 
to tissue (Woo, Hildebrand et al. 1999; Jung, Fisher et al. 2009). In general, these tissues 
heal slowly following injury, resulting in pain and immobility in affected individuals, which 
can lead to injury of other tissues and the development of degenerative joint disease such 
osteoarthritis (Woo et al. 1999). This has resulted in a major clinical challenge in 
orthopaedic medicine (Hoffmann and Gross 2006). Tissue engineering can offer an 
attractive therapeutic approach to treat tendon and ligament injuries, however this is 
hampered by our poor understanding of the defining characteristics between the two tissue 
types.  
The aim of this project was to understand the fundamental differences between tendon and 
ligaments at a molecular and cellular level. Information in this area is currently lacking and is 
vital for the future development of techniques to assist with tendon and ligament repair, as 
well as the preparation of tissue–engineered structures. 
In this project the canine was chosen as model, as the canine stifle anatomy is similar to the 
human knee and is prone to non-contact injury, which reflects the human joint pathology. It 
was hypothesised that tendons and ligaments around the canine stifle joint have different 
extracellular matrix (ECM) and cellular composition, morphological characteristics and 
structural protein expression. It was further hypothesised that canine tendon and ligament 
cells would retain similar biochemical, morphological and proteomic characteristics as the 
original tendon and ligament tissue.  
The first objective of this study was to determine specific measurable differences in 
composition (collagen, elastin and proteoglycans) between canine stifle joint tendons and 
ligaments with regard to the location, function and regions, as described in Chapter 3. The 
data demonstrated no significant differences between the different regions of intra-articular 
cranial cruciate ligament (CCL), extra-articular medial collateral ligament (MCL), superficial 
 
 
182 
 
digital flexor tendon (SDFT) and long digital extensor tendons (LDET). Nevertheless, 
significantly higher sulphated glycosaminoglycan (sGAG) and elastin content in canine CCL 
was measured in comparison to MCL, LDET and SDFT. The higher sGAG and elastin content 
in CCL may be due to the complex functional requirement of this tissue, where its role it to 
withstand anterior tibial translation of the tibia, rotational load and valgus angulation of the 
knee (Duthon et al. 2006, Kweon et al. 2013). The GAGs and water content are assumed to 
play a role in determining tendon and ligament viscoelastic properties (Frank et al. 1999). 
This highlights tendon or ligament ability to structurally adapt to constant or cyclic load to 
reach biomechanical equilibrium (Connizo et al. 2013). Therefore, the higher sGAG content 
measured in CCL could alter its viscoelastic properties, allowing greater degree of 
deformation in order to prevent damage or injury from activities such as running or 
jumping. This finding supports previous tendon and ligament comparison studies in the 
ovine (Rumian et al. 2007) and rabbit (Amiel et al. 1984), where higher sGAG content was 
found in cruciate ligaments compared to extra-articular collateral ligaments and several 
tendons. The greater degree of deformation in CCL may also be reflected on the increased 
elastin content that was measured against the other three tissues examined. Elastin has 
been reported to contribute to the mechanics of ligaments, primarily in the toe regions of 
the stress-strain curve of porcine MCL, thus contributing to its viscoelastic properties 
(Henninger et al. 2013). In addition, elastin has also been documented to provide significant 
resistance to ligament transverse and shear deformation (Henninger, 2015). These data 
indicate that the higher elastin content measured in CCL in this study may play a greater role 
in the mechanical integrity of this ligament tissue. Together, the increase in elastin and 
sGAG content indicate that a there is more of a stretch and recoil mechanism and a greater 
degree of deformation required in the inter-articular CCL.  
Following the work of Amiel et al. (1984), Rumian et al. (2007) and Zhu et al. (2012), the 
distinct structural and morphological characteristics of the different ligaments and tendons 
were demonstrated in Chapter 4. Amiel et al. (1984) revealed altered ECM between rabbit 
knee joint ligaments and tendons, but also indicated different cell nuclei morphology of the 
tendons in comparison to MCL and cruciate ligaments, with both the cruciate ligaments 
containing heterogeneous cell nuclei morphology. Similarly, Rumian et al. (2007) also 
demonstrated differential ECM composition in ovine intra- and extra-articular ligaments and 
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tendons, but found ligaments to have different proportions of collagen fibre diameter. Zhu 
et al. (2012) performed an structural comparison study between human anterior cruciate 
ligament (ACL) and hamstring tendons, describing a more complex arrangement of collagen 
fibres and different proteoglycan content and distribution in the ACL. While the above 
studies describe the morphology differences between tendons and ligaments to some 
extent, neither of the above mentioned studies fully investigated the complete 
characterisation of tendon and ligament tissue properties at the different anatomical 
regions. In Chapter 4, a semi-objective histology scoring system was used and for the first 
time demonstrated quantitative morphological and structural differences between CCL, 
MCL, LDET and SDFT.  This study revealed no significant differences between different 
regions of the tendons and ligaments. However, there was significantly less compact 
collagen architecture, more mixed population of cell morphology and increased staining for 
GAGs and elastic fibres specifically found in the CCL. The ligaments, in particular the CCL, 
contained less compact collagen fibres and larger interfascicular regions, while both LDET 
and SDFT consisted of more parallel and compact collagen fibres. This may be as result of 
different loading pattern in ligaments, but also indicates a more complex compositional 
architecture with regard to the matrix in CCL. The fibre bundles in the CCL could be exposed 
to different extent of loading according to the flexional or rotational location of the knee, 
resulting in structural alterations of fibre bundle orientation. One limitation of this analysis 
was that the overall ECM architecture was measured, rather than individual aspects of 
collagen structure. It would be interesting to further develop the histological analysis with 
regard to collagen architecture by measuring the exact thickness of the interfascicular 
regions, collagen fibre alignment, crimp pattern and collagen fibril diameter. Together these 
analyses will give better understanding regarding the functional and mechanical properties 
between the tissue types.  
The CCL was found to contain a more hetergenous cell population in comparison to LDET in 
the current study. Whilst the LDET cell nuclei were mainly spindle shaped, the CCL cell nuclei 
were more epileptical or round in shape, surrounded by GAGs, suggesting a “chondrocytic” 
appearance. Our finding of the chondrocytic cell phenotype in the CCL agrees with 
previously reported findings in dogs with low and high risk of CCL rupture (Comerford et al. 
2006). This may be a normal finding in the canine CCL and may be as result of physical 
 
 
184 
 
adaptation of the CCL, rather than pathological degeneration as reported in human ACL 
(Hasegawa et al. 2012). Further work is required to identify different cells types in CCL and 
the effect of aging and degeneration on the CCL structure. It may also be important to 
improve our understanding to the role of cell communication in ligament physiology and 
disease, which may be significant in the treatment of ligament failure and development of 
reparative constructs treatment. 
Another important finding of the histology scoring in this study was the significantly 
increased GAG and elastin content in CCL against the other three tissues examined, which 
were primarily located between fibre bundles and fascicles. This finding supports the 
increased sGAG and elastin content found in CCL in comparison to MCL, LDET and SDFT 
(Chapter 3). Together, these data might implicate that the higher GAGs proteoglycans 
sidechains and elastin in CCL could increase sliding and recoil capacity between adjacent 
collagen fibres and fascicles, resulting in a greater extension of the CCL. The capacity of 
fascicle sliding has been demonstrated to be different between equine SDFT and CDET, 
which is as result of interfascicular differences. In the SDFT the interfascicular matrix has 
been reported to withstand more cyclic loading and is more elastic than the CDET (Thorpe et 
al. 2015). These data imply that the increased proteoglycan and elastin content at the 
interfascicular matrix of the CCL may lead to an increase in elastic properties of this tissue. 
Nevertheless, the role and function of the interfascicular matrix in ligaments is yet to be 
estabilished. 
In this study, another aim was to define the key structural protein expression differences 
between ligament (CCL) and tendon (LDET), described in Chapter 6. This revealed 
significantly abundant fibrocartilage proteins in CCL such as aggrecan, chondroadherin, 
versican and collagen type II, while LDET contained more asporin, and thrombospondin 4. 
The increase of fibrocartilage proteins in CCL suggests the presence of a cartilage-like matrix 
in this ligament. This interpretation is supported by the presence of rounded cell 
morphology and the increase of proteoglycan content in the CCL. This could be as response 
to compressive and shear forces generated during twisting of the CCL as the stifle moves 
through flexion to extension and during rotational movements (Young et al. 2002). The 
presence of the fibrocartilage proteins is expected to alter the mechanical properties of CCL 
by increasing its tensile strength and reducing laxity, which may be physiologically beneficial 
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for the canine stifle joint during running and could protect the CCL against mechanical 
fragmentation due to repetitive compression (Comerford et al. 2006).  
The differential abundance of several proteins such as collagen type III, aggrecan, versican, 
fibronectin and cartilage oligomeric matrix proteins in CCL supported a proteomic study 
between human ACL and pattelar tendon (Little et al. 2014). However, the same study 
found that thrombospondin 4 and asporin protein levels were higher in the ACL, which is 
contradictionary with our data and may be due species differences. To validate the 
proteomic data, several significant abundant proteins were validated using 
immunohistochemistry staining, described in Chapter 4.  Chapter 4 also describes the 
distribution and localisation of several ECM proteins, which were assessed between CCL and 
LDET mid-region through immunohistochemical staining techniques. Extracellular matrix 
proteins including collagen I, decorin and biglycan, elastin, fibrillin 1 and 2 were analysed 
using immunohistochemistry staining. The distribution of aggrecan, versican, asporin and 
collagen type III was also analysed, as these proteins were found to be differentially 
abundant through proteomic data analysis (Chapter 6). Immunostaining of keratocan was 
chosen to assess its distribution in ligament, as this protein was observed in in our 
proteomic results, but had only previously been reported in tendon (Rees et al. 2009). 
Collagen type VI was also identified through proteomic data analysis in both CCL and LDET. 
This non-fibrillar collagen has been demonstrated in pericellular matrix of human rotator 
cuff tendons (Thakkar et al. 2014). The immunostaining of collagen type VI in this present 
study was also found to be pericellular, but also located at the interfascicular matrix in both 
CCL and LDET. Collagen type VI has been found to interact with decorin and biglycan 
(Wiberg et al. 2001), suggesting that the presence of collagen type VI in this study may 
provide an anchoring network with other non-collagenous proteins at the interfascicular 
and pericellular matrix.  Immunostaining results also revealed a different distribution and 
intensity of staining for collagen type III, aspirin, aggrecan and versican between CCL and 
LDET, which supports the findings from the proteomic analysis in Chapter 6. Together, the 
increased aggrecan and versican content, as well as the presence of other fibrocartilage 
proteins in CCL and the different distribution of ECM protein between the two tissue types, 
may relate to the different functioning of CCL and LDET. The increased immunostaining of 
aggrecan and versican at the CCL mid-region indicates that CCL might also undergo 
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compression at the central region where it is twisted around the caudal cruciate ligament 
under tensile strength (Comerford et al. 2006). Therefore, the CCL results in a different ECM 
composition and arrangement to protect the tissue from damage and to better withstand 
compression. One limitation of this part of the study was the lack of quantifiable data, which 
made the observations subjective. Further studies, should include quantitative software 
analysis (Tissue Gnostics) to assess the different distribution and intensity of staining. In 
addition, further validation of immunostaining between CCL and LDET are required for the 
differentially abundant proteins such as thrombospondin-4, collagen type II or 
chondroadherin.   
To answer the second hypothesis in this project, this study also aimed to ascertain whether 
canine tendon/ligament cells were able to grow in 3D fibrin cultures and to assess whether 
3D tendon and ligament constructs retained the biochemical, morphological and proteome 
characteristics of the original tissues. Chapter 5 described the formation of 3D tendon and 
ligament constructs using a 3D in vitro fibrin culture model. Constructs were found to have a 
resemblance of embryonic tendon or ligament, as they contained high cellular content and 
plasma membrane protrusions called “collagen fibripositors”, which were occasionally 
found in the extracellular space of both constructs. Biochemical analysis of 3D tendon and 
ligament constructs demonstrated that both constructs had a high DNA content and 
significantly lower collagen content compared to native tendon and ligament tissue. 
Interestingly, the constructs contained similar levels of sGAG and elastin as the native 
tissues, indicating that these components mature faster than collagen matrix. It would also 
be interesting to perform immunoshistochemical staining on the constructs to identify 
whether high sGAG content is due to the presence of small leucine rich proteoglycans or 
large aggregating proteins. In addition, it would also be interesting to verify to presence of 
blood-vessel like structures in both tendon and ligament constructs through 
immunoshistochemical staining. 
Chapter 6 also involved the proteomic analysis of 3D tendon and ligament constructs in 
comparison to native tendon and ligament. This revealed the presence of several ECM 
proteins such as collagen I, III, V, VI and XII and XIV, decorin, bigylcan, asporin, osteoglycin, 
fibronectin 1 and fibrillin 1 in both 3D tendon and ligament constructs, which are also found 
in both native tendon and ligament. This indicated that 3D constructs are able to 
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recapitulate specific tendon and ligament ECM proteins. Quantitative comparison between 
3D constructs and native tissues revealed that both native tissues were significantly 
abundant primarily in ECM proteins. In contrast, both 3D constructs had significantly more 
cellular associated proteins, which is most likely explained by their higher cellular content 
and indicate the immature state of the 3D constructs.  
Further optimisation and maturation of 3D tendon and ligament constructs could promote 
tendon or ligament tissue engineering approaches or treatments for tendon and ligament 
injuries. The typical treatment of tendon or ligament injuries involves the use of tissue 
allografts or autografts to allow patients to rapidly return to ordinary activities of daily 
living. However, evidence suggests that these procedures do not substantially convalesce 
long-term patient outcomes (Breidenbach et al. 2014, Lohmander et al. 2004, Streich et al. 
2011). The use of autografts in ACL reconstruction is known as the current golden standard, 
where the patellar tendon is the common source of the autograft (Ma et al., 2012). 
However, the patellar tendon has been shown to differ in viscoelastic properties, as the 
initial stiffness and strain to failure rate are dissimilar, leading to an increasing failure 
incidences (Danto et al. 2008, Chandrashekar  et al. 2008, Ma et al. 2012). The use of fibrin 
scaffold could provide treatment for tendon and ligament injures, as fibrin gel can be 
produced of the patients blood and can be used as an autologous scaffold for the seeding 
fibroblasts to create a three-dimensional structure (Ye et al. 2000). However, studies have 
demonstrated that the 3D tendon and ligament fibrin constructs have not fully reached the 
mechanical and structural integrity of the native tendon or ligament tissue (Bayer et al. 
2010, Herchenhan et al. 2013, Hagerty et al. 2012, Kalson et al. 2010) and would require 
further development to create the tendon or ligament-like structure possessing sufficient 
mechanical and structural properties. Herchenhan et al. (2013) demonstrated that 3D fibrin 
tendon constructs, which were derived from adult human tendon cells and cultured in vitro 
for 5 weeks had an increase in mechanical strength and stiffness and collagen fibril 
diameter.  In this study both 3D tendon and ligament constructs were cultured for 14 days, 
which may have led to low collagen content as both were not allowed to mature 
completely. Therefore, future studies will also aim to identify the optimum culture period 
with regard to the collagen content and biomechanical properties. Another future aim will 
be to measure the effect of growth factors on maturation of both canine 3D tendon and 
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ligament constructs. Transforming growth factor beta 1 and insulin growth factor 1 have 
previously been shown to have an additive effect on 3D tendons collagen synthesis from 
human adult tenocytes (Herchenhan et al. 2014) and 3D ligament construct from adult 
ligamentocytes (Hagerty et al. 2012). By measuring ECM composition, proteomic analysis, 
biomechanical properties and ultrastructural analysis, together the optimum culture period 
time and the effect of growth factor could be measured on both 3D tendon and ligament 
constructs. 
In the current study, proteomic comparison of 3D tendon and ligament constructs revealed 
no significant protein differences, which might indicate that the cell source may not be an 
important factor for tissue engineering. However, it is yet to be confirmed and could be part 
of future work to discover whether tendon and ligament fibroblasts may become 
phenotypically distinct due to different in vivo loading environments, or exposure to 
extrinsic factors such as growth factors. It would be interesting to measure the effect of 
compressive and tensile loading on both 3D tendon and ligament constructs. It would be 
important to identify whether tenocytes or ligamentocytes produce fibrocartilage proteins 
that were also found within native ligaments when subjected to compressive loading. 
Finally, It would be compelling to identify whether other cell sources such mesenchymal 
stem cells or skin dermal fibroblasts differentiate into ligament or tendon when situated in a 
ligament or tendon in-vivo environment. This could be important in clinical aspect of future 
tendon and ligament tissue engineering strategies.  
 
7.2    CONCLUSION 
The work detailed in this thesis demonstrates differences in ECM composition between 
intra-articular CCL, extra-articular MCL, LDET and SDFT, where significant differences in 
elastin and sGAG content were primarily detected in CCL. This study is the first to report a 
histological scoring system demonstrating semi-quantitative morphological and structural 
differences between CCL in comparison to the other tendon and ligament tissues examined. 
These morphological differences include les compact collagen architecture, difference in cell 
nuclei phenotype, and increased GAG and elastin content. The work also reports differences 
between tendon and ligament using proteomic profiling resulting in significantly more 
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fibrocartilaginous proteins in the ligament. The localisation of key structural protein 
differences were found to differ between the two tissue types.  Furthermore, this thesis has 
also demonstrated the development of 3D tendon and ligament constructs and novel 
proteomic methodologies that quantified distinct differences between constructs and native 
tissues.  
 
 
 
7.3 FUTURE WORK 
Further studies of native tendon and ligament comparison: 
 Identification of different cell population in CCL 
 Measure effect of ageing  and degeneration in CCL 
 Semiquantitative measurements of immunohistochemical staining  
 Further validation of key structural protein difference between CCL and LDET, such 
as collagen type II, thrombospondin 4   
 
Further development of 3D tendon and ligament constructs:  
 Immunostaining of large proteoglycans and small leucine rich proteoglycans  
 Measurement of biomechanical properties of 3D tendon and ligament constructs 
 Longer culture period of 3D tendon and ligament construct to allow maturation to 
take place  
 Measure of the growth factor including transforming growth factor β1 and insulin-
like growth factor  
 Effect of compressive and tensile loading and how do the tendon and ligament cells 
respond the different mechanical loading  
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8 CHAPTER 8 
SUPPLEMENTARY DATA 
 
Table S1 Proteins in all tissues  
Table S2 Differential expressed proteins between both native tissues and 3D tissues  
Table S3 Differential expressed protein between native ligament and 3D ligament  
Table S4 Differential expressed proteins between native tendon and 3D tendon 
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